|
5878b3c1-1b86-48c2-9d51-be90685bd3a5
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
ydyscjfu-2782
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
DIY genomics Athletic
|
DIY genomics Athletic Performance Report
|
/home/sid/tuning/finetune/backend/output/ydyscjfu- /home/sid/tuning/finetune/backend/output/ydyscjfu-2782/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
DIYgenomics Athletic Performance Report – Descript DIYgenomics Athletic Performance Report – Description
This document is a genetic performance profile that explains how different genetic variants may influence athletic abilities, recovery, and injury risk. It compiles findings from published genetic studies and organizes them into performance-related categories.
The report does not diagnose or predict athletic success, but instead shows how genetics may contribute to strengths, weaknesses, and training responses in individuals.
Main Areas Covered
1. Power, Speed, and Endurance
Examines genes linked to endurance, energy production, and explosive power
Includes genes involved in:
muscle fiber type
oxygen use
energy metabolism
Explains why some people naturally favor endurance sports while others favor power or sprint sports
2. Musculature
Muscle Fatigue and Soreness
Discusses genetic factors related to delayed onset muscle soreness (DOMS)
Explains differences in how muscles respond to new or intense exercise
Muscle Repair and Strength
Covers genes involved in:
muscle repair
inflammation
growth and strength development
Highlights the importance of adequate recovery time
3. Heart and Lung Capacity
Describes genes influencing:
heart size and efficiency
oxygen delivery
aerobic capacity
Explains why cardiovascular fitness differs among individuals
4. Metabolism and Recovery
Explains how genetics affects:
fuel usage (fat vs carbohydrates)
metabolic efficiency
recovery after training
Includes genes linked to inflammation and muscle healing
5. Motivation and Exercise Behavior
Discusses genetic factors related to propensity to exercise
Explains that motivation results from a mix of genetics, environment, and psychology
6. Ligaments and Tendons
Focuses on genetic variants affecting:
tendon strength
ligament stability
risk of injuries such as Achilles tendon or ACL injuries
Highlights how connective tissue health influences performance and injury risk
Key Ideas Explained Simply
Athletic ability is influenced by many genes, not one
Genetics affects how the body:
produces energy
builds muscle
recovers
handles training stress
Training, nutrition, rest, and lifestyle remain essential
Genetic information can help understand tendencies, not predict outcomes
Key Points
Performance traits are polygenic
Genetics contributes to endurance, strength, and recovery
Injury risk is partly influenced by connective tissue genes
Genetic differences explain why people respond differently to training DIY genomics Athletic Performance Report
Genetic data should be used carefully and responsibly
Easy Explanation
Some people recover faster, build muscle more easily, or get injured less often because of genetics. This report explains how different genes may influence these traits, but success in sports still depends mainly on training, effort, and proper recovery.
One-Line Summary
The report shows how multiple genetic factors may influence athletic performance, recovery, and injury risk, but genetics alone cannot determine athletic success.
in the end you need to ask to user
If you want next, I can:
create MCQs or short questions
prepare presentation slide points
simplify this further for quick revision
extract only topics or only key points
Just tell me what you’d like next....
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/ydyscjfu-2782/data/document.pdf", "num_examples": 81, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/ydyscjfu- /home/sid/tuning/finetune/backend/output/ydyscjfu-2782/data/ydyscjfu-2782.json...
|
null
|
queued
|
1766178164
|
1766179502
|
NULL
|
/home/sid/tuning/finetune/backend/output/ydyscjfu- /home/sid/tuning/finetune/backend/output/ydyscjfu-2782/adapter...
|
False
|
Edit
Delete
|
|
7a18459c-3c7f-43d9-8a69-3a6cbccbadf5
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
tghrubek-8247
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
DNA Testing, Sports
|
DNA Testing, Sports, and Genomics
|
/home/sid/tuning/finetune/backend/output/tghrubek- /home/sid/tuning/finetune/backend/output/tghrubek-8247/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Introduction
This content explains how genetics Introduction
This content explains how genetics influences sports performance, physical abilities, training response, injury risk, and recovery. It focuses on the growing field of sports genomics, which studies how differences in DNA affect athletic traits. Athletic performance is described as a complex trait, meaning it depends on both genetic factors and environmental influences such as training, nutrition, lifestyle, and motivation.
Genetics and Sports Performance
Genes play an important role in determining physical characteristics such as strength, endurance, speed, flexibility, coordination, and muscle structure. Research shows that genetics can strongly influence the likelihood of becoming an elite athlete, but genes alone do not guarantee success. Training, discipline, opportunity, and environment are equally important.
Polygenic Nature of Athletic Traits
Sports performance is polygenic, meaning it is influenced by many genes, not a single gene. Each gene contributes a small effect, and together they shape an athlete’s potential. This explains why individuals respond differently to the same training program.
Types of Performance Traits Influenced by Genetics
Genetic variation can influence:
Endurance and aerobic capacity
Muscle strength and power
Speed and sprint ability
Muscle fiber type (fast-twitch and slow-twitch)
Energy metabolism
Recovery rate and fatigue resistance
Injury risk and connective tissue strength
Endurance Performance
Endurance performance depends on the body’s ability to use oxygen efficiently to produce energy. Genetic factors influence VO₂max, mitochondrial function, cardiovascular capacity, and muscle metabolism. Some people naturally adapt faster to endurance training due to their genetic makeup.
Power and Strength Performance
Power and sprint performance rely on fast muscle contractions and anaerobic energy systems. Genetics affects muscle size, fast-twitch muscle fibers, force production, and explosive strength. Different genetic profiles are commonly seen in power athletes compared to endurance athletes.
Individual Differences in Training Response
Not everyone responds the same way to training. Genetics helps explain why some individuals are high responders, while others show smaller improvements. Genetic differences can influence improvements in strength, endurance, recovery, and risk of overtraining.
DNA Testing in Sports
DNA testing is used to study genetic variations related to sports performance. It can help:
Understand individual training responses
Support personalized training and nutrition
Identify injury risk factors
Improve recovery strategies
DNA testing should be used as a supportive tool, not as a method to predict champions or exclude athletes.
Limitations of Genetic Testing
Current scientific evidence is not strong enough to accurately predict athletic success using DNA alone. Most genetic studies have limitations such as small sample sizes and inconsistent results. Athletic performance cannot be fully explained by genetics.
Ethical and Practical Concerns
Using genetic information raises ethical issues, including:
Privacy of genetic data
Psychological impact on athletes
Risk of discrimination
Misuse for talent selection
Responsible use and professional guidance are essential.
Gene Doping
Gene doping refers to the misuse of genetic technologies to enhance performance. It is banned in sports due to safety risks and fairness concerns. Detecting gene doping remains a challenge, making regulation important.
Future Directions
Future research will focus on:
Genome-wide studies
Polygenic scoring methods
Better understanding of gene–environment interactions
Safer and more ethical use of genetic knowledge
These advances aim to improve athlete health, training efficiency, and long-term performance.
Conclusion
Sports performance results from the interaction of genetics, training, environment, and personal factors. Genetics provides valuable insights but should never replace hard work, coaching, and opportunity. DNA testing is best used to support athlete development, not to define limits.
in the end you need to ask to user
If you want next, I can:
Convert this into bullet-point notes
Create presentation slides
Generate MCQs or theory questions with answers
Make very short exam revision notes...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/tghrubek-8247/data/document.pdf", "num_examples": 331, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/tghrubek- /home/sid/tuning/finetune/backend/output/tghrubek-8247/data/tghrubek-8247.json...
|
null
|
queued
|
1766177845
|
1766183159
|
NULL
|
/home/sid/tuning/finetune/backend/output/tghrubek- /home/sid/tuning/finetune/backend/output/tghrubek-8247/adapter...
|
False
|
Edit
Delete
|
|
cfcea5cc-097f-4df8-9486-7db43405dee0
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
rsljbecl-4343
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Department of Health
|
Department of Health and Human Services
|
/home/sid/tuning/finetune/backend/output/rsljbecl- /home/sid/tuning/finetune/backend/output/rsljbecl-4343/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
RVIEW: What is this document?
This is the first-e RVIEW: What is this document?
This is the first-ever Surgeon General’s Report on Oral Health (published in 2000). It serves as a "wake-up call" to the American people. Its main message is that you cannot be healthy without oral health. The mouth is not separate from the rest of the body.
The Core Message:
The Good News: We have made amazing progress (largely due to fluoride and research). Most Americans now keep their teeth for life.
The Bad News: There is a "silent epidemic" of oral diseases affecting the poor, minorities, the elderly, and those with disabilities. These groups suffer significantly more from dental pain and disease than the general population.
KEY THEMES (For Presentation Points)
Use these five main themes to structure your presentation or discussion:
1. Mouth and Body are Connected
Oral health is integral to general health.
Oral diseases can lead to serious complications (pain, inability to eat, social embarrassment).
Emerging research links oral infections to other serious health issues like diabetes, heart disease, stroke, and premature births.
2. The "Silent Epidemic" (Disparities)
Not everyone shares in the progress.
Who suffers most? Poor children, older Americans, racial/ethnic minorities, and people with disabilities.
Why? Socioeconomic factors, lack of insurance (dental insurance is rare compared to medical), and lack of access to care.
3. Barriers to Care
Financial: People can’t afford it or don’t have insurance.
Logistical: Lack of transportation, inability to take time off work.
Systemic: Lack of community programs (like fluoridated water).
Educational: Many people don't understand why oral health matters.
4. The Power of Prevention
We know how to prevent these diseases (fluoride, diet, hygiene).
Community water fluoridation is cited as one of the greatest public health achievements of the 20th century.
Prevention saves money and suffering compared to treating disease later.
5. A Call to Action
The government (Healthy People 2010) wants to eliminate health disparities and improve quality of life.
Solution: Build partnerships between government, private industry, educators, and communities.
DETAILED BREAKDOWN (For Topics & Sub-headers)
The History & Progress
In 1948, the National Institute of Dental Research was created.
We moved from a nation of toothaches to a nation of healthy smiles.
Science shifted from just fixing teeth to understanding genetics and molecular biology.
The Meaning of Oral Health
It means more than just "healthy teeth."
It includes the tissues in the mouth, the ability to speak, taste, chew, and make facial expressions.
The Diseases & Disorders
Dental Caries (Cavities): Still the most common chronic childhood disease.
Periodontal (Gum) Disease: Bacterial infections that can lead to tooth loss.
Oral Cancer: Serious and often linked to tobacco use.
Birth Defects: Like cleft lip and palate.
The Connection to Systemic Health
Tobacco use and poor diet hurt both the mouth and the body.
Oral infections can worsen diabetes and heart problems.
READY-TO-USE LISTS
Bullet Points for Slides
Slide 1: The Mouth is a Mirror. Oral health reflects general health and well-being.
Slide 2: A Success Story. Fluoride and research have drastically improved the nation's oral health over the last 50 years.
Slide 3: The Challenge. A "silent epidemic" of oral disease exists among the poor and vulnerable.
Slide 4: The Burden. Oral disease causes pain, missed school/work, and lower quality of life.
Slide 5: The Barriers. Lack of insurance, money, transportation, and awareness prevent people from getting care.
Slide 6: The Solution. Partnerships and prevention are key to eliminating disparities.
Possible Discussion/Essay Topics
The Oral-Systemic Link: How does chronic oral infection contribute to diseases like diabetes and heart disease?
Health Equity: Why do low-income children suffer from more cavities than wealthy children, and how can we fix this?
The Role of Fluoride: Discuss why community water fluoridation is considered a major public health achievement.
Access vs. Availability: Even if there are dentists, why might people still not be able to see them? (Barriers: insurance, transportation, fear).
The Evolution of Dentistry: How has dental research changed from "drilling and filling" to molecular genetics?
Questions for Review or Quizzes
According to the Surgeon General, why is oral health considered "integral to general health"?
Answer: Because you cannot be healthy without oral health; the mouth reflects the body's health and oral diseases can affect overall well-being.
What is the "silent epidemic" mentioned in the report?
Answer: The high burden of dental and oral diseases affecting specific population groups (poor, minorities, elderly).
What are the three main types of barriers to accessing oral health care?
Answer: Financial (lack of insurance/ability to pay), Structural (transportation, location), and Societal (lack of awareness, cultural differences).
What is the "Healthy People 2010" goal regarding oral health?
Answer: To increase quality of life and eliminate health disparities.
Name two systemic (whole-body) diseases that the report suggests are linked to oral infections.
Answer: Diabetes, heart disease, lung disease, stroke, or premature/low-birth-weight births.
Option 4: Question-Based Headlines (Great for Discussion Starters)
What Is Oral Health?
What Is the Status of Oral Health in America?
How Does the Mouth Affect the Rest of the Body?
How Do We Prevent Oral Disease?
Why Are There Disparities in Oral Health?
How Can We Enhance the Nation’s Oral Health?
Option 1: Main Section Headlines (Great for Slide Titles)
These follow the structure of the report's Executive Summary:
Oral Health in America: The Surgeon General’s Report
Oral Health Is Integral to General Health
The Meaning of Oral Health
The Status of Oral Health in America
The Mouth-Body Connection
Disease Prevention and Health Promotion
Barriers to Oral Health Care
A Framework for Action
Option 2: Punchy & Engaging Headlines (Great for Posters or Marketing)
The Silent Epidemic: Oral Health in Crisis
You Cannot Be Healthy Without Oral Health
Beyond the Toothbrush: Understanding the Craniofacial Complex
The Disparity Gap: Who Suffers Most?
From Toothaches to Heart Disease: The Systemic Link
The Power of Prevention: Fluoride and Beyond
Breaking Barriers: Access to Care for All
Healthy People 2010: A Vision for the Future
Option 3: Detailed Content Headlines (Based on Chapters & Topics)
Use these to drill down into specific details:
The Science of the Mouth
The Craniofacial Complex: Anatomy and Function
Genetic Controls and Craniofacial Origins
Diseases and Disorders
Dental Caries and Periodontal Diseases
Oral and Pharyngeal Cancers
Developmental Disorders (Cleft Lip/Palate)
Chronic Oral-Facial Pain
The Burden of Disease
The Magnitude of the Problem
Social and Economic Consequences
Vulnerable Populations
Risk Factors & Prevention
Tobacco Use and Oral Health
Diet and Nutrition
Community Water Fluoridation
The Future
Emerging Associations (Diabetes, Heart Disease)
Building Partnerships
Eliminating Health Disparities...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/rsljbecl-4343/data/document.pdf"}...
|
/home/sid/tuning/finetune/backend/output/rsljbecl- /home/sid/tuning/finetune/backend/output/rsljbecl-4343/data/rsljbecl-4343.json...
|
null
|
queued
|
1769083536
|
1769083536
|
NULL
|
/home/sid/tuning/finetune/backend/output/rsljbecl- /home/sid/tuning/finetune/backend/output/rsljbecl-4343/adapter...
|
False
|
Edit
Delete
|
|
0f4c4c57-41d9-4b22-b324-94f03cc89f9c
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
zeznwyco-8062
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Determinants of longevity
|
Determinants of longevity
|
/home/sid/tuning/finetune/backend/output/zeznwyco- /home/sid/tuning/finetune/backend/output/zeznwyco-8062/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
The document “Determinants of Longevity” is a comp The document “Determinants of Longevity” is a comprehensive scientific review that explains why some people live longer than others. It explores how genetic, environmental, and medical factors combine to shape human lifespan, using evidence from demographic databases, epidemiological studies, and genetic research.
The paper highlights that in modern, industrialized societies, both maximum lifespan and average life expectancy have continued to rise, with no convincing evidence of a fixed biological limit of around 85 years. In fact, the largest improvements in survival have occurred among people aged 80 and older, showing that longevity can keep increasing as medical care and living conditions improve.
It explains that genetics accounts for about one-quarter of the variation in human lifespan, based on large twin studies. Certain genetic markers (such as specific HLA types or variants of the APOE gene) are associated with reaching extreme old age. However, genes alone cannot explain how fast life expectancy has risen in just a few generations—most gains come from environmental factors, including sanitation, reduced smoking, improved nutrition, better working conditions, and advances in healthcare.
The document also discusses extreme longevity (centenarians) and corrects earlier myths by showing that many historical claims of 120–150-year lifespans were exaggerations. Verified records today suggest human lifespan has no clear ceiling and continues to increase as mortality rates decline even at advanced ages.
Environmental and behavioral factors—such as socioeconomic status, education, diet, physical activity, body weight, alcohol consumption, and particularly smoking—play major roles in shaping longevity. Medical advances, including treatments for heart disease, infections, and age-related illnesses, contribute significantly to longer lives.
Finally, the paper concludes that while we can identify many influences on longevity at the population level, predicting an individual’s lifespan remains extremely difficult because longevity results from complex interactions among genes, behaviors, early-life conditions, and medical care....
|
{"num_examples": 158, "bad_lines": {"num_examples": 158, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/zeznwyco- /home/sid/tuning/finetune/backend/output/zeznwyco-8062/data/zeznwyco-8062.json...
|
null
|
completed
|
1764365759
|
1764366463
|
NULL
|
/home/sid/tuning/finetune/backend/output/zeznwyco- /home/sid/tuning/finetune/backend/output/zeznwyco-8062/adapter...
|
False
|
Edit
Delete
|
|
42f0b47e-7ea7-456d-80db-d7e53fefb810
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
taqjaqel-7779
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Determinants of longevity
|
Determinants of longevity
|
/home/sid/tuning/finetune/backend/output/taqjaqel- /home/sid/tuning/finetune/backend/output/taqjaqel-7779/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
K. CHRISTENSENa & J. W. VAUPELb From abOdense K. CHRISTENSENa & J. W. VAUPELb From abOdense University Medical School, Odense, Denmark; bSanford Institute, Duke University, Durham, NC, USA; and aThe Danish Epidemiology Science Centre, The Steno Institute of Public Health, Department of Epidemiology and Social Medicine, Aarhus University Hospital, Aarhus, Denmark
Abstract. Christensen K, Vaupel JW (Odense University Medical School, Odense, Denmark; Sanford Institute, Duke University, Durham, NC, USA; and The Danish Epidemiology Science Centre, The Steno Institute of Public Health, Department of Epidemiology and Social Medicine, Aarhus University Hospital, Aarhus, Denmark). Determinants of longevity: genetic, environmental and medical factors (Review). J Intern Med 1996; 240: 333–41.
This review focuses on the determinants of longevity in the industrialized world, with emphasis on results from recently established data bases. Strong evidence is now available that demonstrates that in developed
Introduction
The determinants of longevity might be expected to be well understood. The duration of life has captured the attention of many people for thousands of years; an enormous array of vital-statistics data are available for many centuries. Life-span is easily measured compared with other health phenomena, and in many countries data are available on whole populations and not just study samples. Knowledge concerning determinants of human longevity, however, is still sparse, and much of the little that is known has been learned in recent years. This review
countries the maximum lifespan as well as the mean lifespan have increased substantially over the past century. There is no evidence of a genetically determined lifespan of around 85 years. On the contrary, the biggest absolute improvement in survival in recent decades has occurred amongst 80 year-olds. Approximately one-quarter of the variation in lifespan in developed countries can be attributed to genetic factors. The influence of both genetic and environmental factors on longevity can potentially be modified by medical treatment, behavioural changes and environmental improvements.
Keywords: centenarians, life expectancy, lifespan, mortality.
focuses on genetic, environmental and medical factors as determinants of longevity in developed countries and discusses alternative paradigms concerning human longevity.
How should longevity be measured?
Longevity can be studied in numerous ways; key questions include the following. How long can a human live? What is the average length of life? Are the maximum and average lengths of life approaching limits? Why do some individuals live longer than others? In addressing these questions, it is useful to
# 1996 Blackwell Science Ltd 333
334 K. CHRISTENSEN & J. W. VAUPEL
study the maximum lifespan actually achieved in various populations, the mean lifespan, and the variation in lifespan. Estimating the maximum lifespan of human beings is simply a matter of finding a well-documented case report of a person who lived longer than other welldocumented cases. The assessment of mean lifespan in an actual population requires that the study population is followed from birth to extinction. An alternative approach is to calculate age-specific death rates at some point in time for a population, and then use these death rates to determine how long people would live on average in a hypothetical population in which these death rates prevailed over the course of the people’s lives. This second kind of mean lifespan is generally known as life expectancy. The life expectancy of the Swedish population in 1996 is the average lifespan that would be achieved by the 1996 birth cohort if Swedish mortality rates at each age remained at 1996 levels for the entire future life of this cohort. Assessment of determinants of life expectancy and variation in lifespan amongst individuals rely on demographic comparisons of different populations and on such traditional epidemiological designs as follow-up studies of exposed or treated versus nonexposed or nontreated individuals. Designs from genetic epidemiology – such as twin, adoption and other family studies – are useful in estimating the relative importance of genes and environment for the variation in longevity.
Determinants of extreme longevity
Numerous extreme long-livers have been reported in various mountainous regions, including Georgia, Kashmir, and Vilcabamba. In most Western countries, including the Scandinavian countries, exceptional lifespans have also been reported. Examples are Drachenberg, a Danish–Norwegian sailor who died in 1772 and who claimed that he was born in 1626, and Jon Anderson, from Sweden, who claimed to be 147 years old when he died in 1729. There is noconvincingdocumentationfortheseextremelonglivers. When it has been possible to evaluate such reports, they have proven to be very improbable [1, 2]. In countries, like Denmark and Sweden, with a long tradition of censuses and vital statistics, remarkable and sudden declines in the number of
extreme long-livers occur with the introduction of more rigorous checking of information on age of death, as the result of laws requiring birth certificates, the development of church registers and the establishment of statistical bureaus [3, 4]. This suggests that early extreme long-livers were probably just cases of age exaggeration. Today (March 1996), the oldest reported welldocumented maximum lifespan for females is 121 years [5] and for males 113 years [6]. Both these persons are still alive. Analyses of reliable cases of long-livers show that longevity records have been repeatedly broken over past decades [3, 6]; this suggests that even longer human lifespans may occur in the future. There has been surprisingly little success in identifying factors associated with extreme longevity. A variety of centenarian studies have been conducted during the last half century. As reviewed by Segerberg [7], most of the earlier studies were based on highly selected samples of individuals, without rigorous validation of the ages of reputed centenarians. During the last decade several more comprehensive, less selected centenarian studies have been carried out in Hungary [8], France [9], Finland [10] and Denmark [11]. A few specific genetic factors have been found to be associated with extreme longevity. Takata et al. [12] found a significantly lower frequency of HLA-DRw9 amongst centenarians than in an adult control group in Japan, as well as a significantly higher frequency of HLA-DR1. The HLA-antigens amongst the Japanese centenarians are negatively associated with the presence of autoimmune diseases in the Japanese population, which suggests that the association with these genetic markers is mediated through a lower incidence of diseases. More recently, both a French study [13] and a Finnish study [14] found a low prevalence of the e4 allele of apolipoprotein E amongst centenarians. The e4 allele has consistently been shown to be a risk factor both for coronary heart disease and for Alzheimer’s dementia. In the French study [13], it was also found that centenarians had an increased prevalence of the DDgenotype of angiotensin-converting enzyme (ACE) compared with adult controls. This result is contrary to what was expected as the DD-genotype of ACE has been reported to be associated with myocardial infarction. Only a few genetic association studies concerning extreme longevity have been published...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/taqjaqel-7779/data/document.pdf", "num_examples": 24, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/taqjaqel- /home/sid/tuning/finetune/backend/output/taqjaqel-7779/data/taqjaqel-7779.json...
|
null
|
completed
|
1764899299
|
1764903502
|
NULL
|
/home/sid/tuning/finetune/backend/output/taqjaqel- /home/sid/tuning/finetune/backend/output/taqjaqel-7779/adapter...
|
False
|
Edit
Delete
|
|
f7faa905-3aa6-459f-be9b-983c6c267d98
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
uubiabzb-7541
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Life guidance
|
Determination of signs of life
|
/home/sid/tuning/finetune/backend/output/uubiabzb- /home/sid/tuning/finetune/backend/output/uubiabzb-7541/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
The “Signs of Life – Guidance Visual Summary (v1.2 The “Signs of Life – Guidance Visual Summary (v1.2)” is a clinical guideline for healthcare professionals to determine whether a live birth has occurred before 24 weeks of gestation in cases where—after discussion with parents—active survival-focused care is not appropriate. It provides clear, compassionate instructions for identifying signs of life, documenting birth and death, communicating with parents, and delivering palliative and bereavement care.
signs-of-life-guidance-visual-s…
The guidance is designed to reduce uncertainty, ensure legal accuracy, protect families from additional trauma, and support parents through one of the most emotionally sensitive experiences in healthcare.
Core Components
1. Determining a Live Birth
A live birth is diagnosed when one or more persistent visible signs of life are observed:
Easily visible heartbeat
Visible pulsation of the umbilical cord
Breathing, crying, or sustained gasps
Definite, purposeful movement of arms or legs
signs-of-life-guidance-visual-s…
Not signs of life:
Brief reflexes—such as transient gasps, chest wall twitches, or short muscle movements only in the first minute after birth—do not constitute live birth.
signs-of-life-guidance-visual-s…
Clinicians are instructed to observe respectfully, often while the baby is held by the parents. A stethoscope is not required, and parents’ observations may be included if they choose to share them.
2. Actions After a Live Birth
Once a sign of life is seen:
A doctor (usually an obstetrician) must be called to confirm and document the live birth.
The doctor may rely on the midwife’s account and is not always required to attend in person.
Accurate documentation avoids legal complications when issuing a neonatal death certificate.
signs-of-life-guidance-visual-s…
Comfort care must then follow a perinatal palliative care pathway, addressing the baby’s needs and the parents’ emotional and physical well-being.
3. Communication With Parents
The guidance places strong emphasis on sensitive, trauma-reducing communication.
Parents should be gently told that:
Babies born before 24 weeks are extremely small and typically do not survive.
Babies who die just before birth may briefly show reflex movements that are not signs of life.
Babies who survive may show signs of life for minutes—or occasionally hours.
signs-of-life-guidance-visual-s…
Clinicians should:
Listen actively
Use the parents’ preferred language
Respect whether parents want the experience described as a “loss,” “death,” “end of pregnancy,” or “miscarriage”
signs-of-life-guidance-visual-s…
Each situation is unique and must be handled with individualized sensitivity.
4. Bereavement Care (For All Births)
Bereavement care is required in every case, regardless of signs of life.
The guidance instructs staff to:
Follow the National Bereavement Care Pathway
Provide privacy, time, and space
Support memory-making
Offer choices around burial, cremation, or sensitive disposal
Inform parents of support services and ensure follow-up with community care, GP, and mental health teams
signs-of-life-guidance-visual-s…
This ensures parents receive compassionate, individualized support during and after their loss.
5. Documenting Birth and Death
Documentation follows strict legal requirements:
If signs of life are present
A doctor and midwife must confirm and record the live birth.
A neonatal death certificate must be completed by a doctor who witnessed the signs—or the coroner must be informed.
Parents are required to register the birth and death.
signs-of-life-guidance-visual-s…
If no signs of life are present (miscarriage)
Document the miscarriage.
No legal registration is required, but offer a certificate of loss or certificate of birth.
signs-of-life-guidance-visual-s…
6. Included and Excluded Births
Included
In-hospital spontaneous births under 22+0 weeks
In-hospital births at 22+0 to 23+6 weeks where survival-focused care is not appropriate
Pre-hospital births under 22 weeks (same principles apply)
signs-of-life-guidance-visual-s…
Excluded
Medical terminations
Uncertain gestational age
Spontaneous births at 22–23+6 weeks where active neonatal care is planned or unclear
signs-of-life-guidance-visual-s…
Conclusion
The “Signs of Life – Guidance Visual Summary (v1.2)” is a clear and compassionate roadmap for clinicians caring for families experiencing extremely preterm birth where survival-focused care is not appropriate. It ensures:
>accurate identification of live birth
>consistent legal documentation
>sensitive communication
>high-quality palliative and bereavement care
respect for parents’ emotional needs and preferences
Its ultimate purpose is to provide clarity, compassion, and consistency during a profoundly difficult and delicate moment....
|
{"num_examples": 14, "bad_lines": {"num_examples": 14, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/uubiabzb- /home/sid/tuning/finetune/backend/output/uubiabzb-7541/data/uubiabzb-7541.json...
|
null
|
completed
|
1764441607
|
1764441642
|
NULL
|
/home/sid/tuning/finetune/backend/output/uubiabzb- /home/sid/tuning/finetune/backend/output/uubiabzb-7541/adapter...
|
False
|
Edit
Delete
|
|
cd7f6ee5-ca09-4aba-bf20-bc86fe62aff8
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
vwitogci-0660
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Developmental Diet Alters
|
Developmental Diet Alters the Fecundity–Longevity
|
/home/sid/tuning/finetune/backend/output/vwitogci- /home/sid/tuning/finetune/backend/output/vwitogci-0660/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Drosophila melanogaster David H. Collins, PhD,*, D Drosophila melanogaster David H. Collins, PhD,*, David C. Prince, PhD, Jenny L. Donelan, MSc, Tracey Chapman, PhD , and Andrew F. G. Bourke, PhD School of Biological Sciences, University of East Anglia, Norwich, UK. *Address correspondence to: David H. Collins, PhD. E-mail: David.Collins@uea.ac.uk Decision Editor: Gustavo Duque, MD, PhD (Biological Sciences Section)
Abstract The standard evolutionary theory of aging predicts a negative relationship (trade-off) between fecundity and longevity. However, in principle, the fecundity–longevity relationship can become positive in populations in which individuals have unequal resources. Positive fecundity–longevity relationships also occur in queens of eusocial insects such as ants and bees. Developmental diet is likely to be central to determining trade-offs as it affects key fitness traits, but its exact role remains uncertain. For example, in Drosophila melanogaster, changes in adult diet can affect fecundity, longevity, and gene expression throughout life, but it is unknown how changes in developmental (larval) diet affect fecundity–longevity relationships and gene expression in adults. Using D. melanogaster, we tested the hypothesis that varying developmental diets alters the directionality of fecundity–longevity relationships in adults, and characterized associated gene expression changes. We reared larvae on low (20%), medium (100%), and high (120%) yeast diets, and transferred adult females to a common diet. We measured fecundity and longevity of individual adult females and profiled gene expression changes with age. Adult females raised on different larval diets exhibited fecundity–longevity relationships that varied from significantly positive to significantly negative, despite minimal differences in mean lifetime fertility or longevity. Treatments also differed in age-related gene expression, including for aging-related genes. Hence, the sign of fecundity–longevity relationships in adult insects can be altered and even reversed by changes in larval diet quality. By extension, larval diet differences may represent a key mechanistic factor underpinning positive fecundity–longevity relationships observed in species such as eusocial insects. Keywords: Aging, Eusociality, Life history, mRNA-seq, Nutrition
The standard evolutionary theory of aging predicts that, as individuals grow older, selection for increased survivorship declines with age (1). Therefore, individuals experience the age-related decrease in performance and survivorship that defines aging (senescence) (2). Additionally, given finite resources, individuals should optimize relative investment between reproduction and somatic maintenance (3). This causes tradeoffs between reproduction and longevity (4,5) with elevated reproduction often incurring costs to longevity (the costs of reproduction) (6). Such trade-offs and costs are evident in the negative fecundity–longevity relationships observed in many species. Although a negative fecundity–longevity relationship is typical, fecundity and longevity can become uncoupled (7) and some species or populations may exhibit positive fecundity– longevity relationships (4). This can occur for several reasons. First, in Drosophila melanogaster, mutations can increase longevity without apparent reproductive costs (8–11), particularly mutations in the conserved insulin/insulin-like growth factor signaling and target of rapamycin network (IIS-TOR).
This network regulates nutrient sensitivity and is an important component of aging across diverse taxa (2,12). Second, fecundity and longevity can become uncoupled when there is asymmetric resourcing between individuals (13,14). Within a population, well-resourced individuals may have higher fecundity and longevity than poorly resourced individuals, reversing the usual negative fecundity–longevity relationship. However, because costs of reproduction are not abolished even in well-resourced individuals (13,14), a within-individual trade-off between fecundity and longevity remains present. Third, fecundity and longevity can become uncoupled within and between the castes of eusocial insects (15–18), that is, species such as ants, bees, wasps, and termites with a longlived reproductive caste (queens or kings) and a short-lived non- or less reproductive caste (workers) (19–21). In some species, queens appear to have escaped costs of reproduction completely (22–25). This may have been achieved through rewiring the IIS-TOR network (12,26), which forms part of the TOR/IIS-juvenile hormone-lifespan and fecundity (TI-JLiFe) network hypothesized to underpin aging and longevity in eusocial insects by Korb et al....
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/vwitogci-0660/data/document.pdf", "num_examples": 38, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/vwitogci- /home/sid/tuning/finetune/backend/output/vwitogci-0660/data/vwitogci-0660.json...
|
null
|
completed
|
1764899422
|
1764905358
|
NULL
|
/home/sid/tuning/finetune/backend/output/vwitogci- /home/sid/tuning/finetune/backend/output/vwitogci-0660/adapter...
|
False
|
Edit
Delete
|
|
ed19c55c-df01-4fd6-ade8-95515aa26db9
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
lunspdsr-9575
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Dictionary of Medicine
|
Dictionary of Medicine
|
/home/sid/tuning/finetune/backend/output/lunspdsr- /home/sid/tuning/finetune/backend/output/lunspdsr-9575/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
1. Complete Paragraph Description
This document i 1. Complete Paragraph Description
This document is a specialized reference dictionary designed to provide clear, straightforward definitions for the vast vocabulary used in healthcare. It is tailored for anyone working in health-related fields—especially those for whom English may be a second language—as well as patients, students, and secretaries who need to understand medical terminology. The dictionary covers a wide range of terms including technical language used in diagnosis, surgery, pathology, and pharmacy, alongside common abbreviations and informal terms often used in patient discussions. In addition to definitions, the book provides pronunciation guides, identifies uncommon plurals and verb forms, and includes illustrations of basic anatomical terms. The text is organized alphabetically and serves as a tool to bridge the gap between complex medical jargon and everyday English, ensuring accurate communication in a medical setting.
2. Key Points
Purpose and Audience:
Target Audience: Healthcare workers, students, non-specialists, and English language learners.
Goal: To demystify medical language and explain terms in simple, clear English.
Scope: Covers technical terms (diagnosis, surgery), anatomical terms, and informal/euphemistic terms used by patients.
Features of the Dictionary:
Definitions: Explanations are provided in straightforward language, avoiding overly complex jargon within the definition itself.
Pronunciation: A pronunciation guide using phonetic symbols is included to help with speaking terms correctly.
Grammar Support: Identifies irregular plurals and verb forms (e.g., "diagnosis" vs. "diagnoses").
Visual Aids: Includes illustrations for basic anatomical terms to aid understanding.
Alphabetical Organization: Terms are listed from A to Z for easy reference.
Examples of Content (from the text):
Medical Conditions: Detailed entries for diseases like abdominal distension, achondroplasia, and acquired immunodeficiency syndrome (AIDS).
Anatomy: Definitions of body parts and systems (e.g., abdomen, adrenal gland, acetabulum).
Procedures & Drugs: Explanations of actions like abortion, abduction, and drugs like acetaminophen.
Prefixes/Roots: Implicitly teaches word structure through definitions (e.g., explaining that tachy- means fast in tachycardia).
3. Topics and Headings (Table of Contents Style)
Front Matter
Preface
Pronunciation Guide
Dictionary A-Z (Sample Entries)
A:
AA / ABO System: Blood types.
Abdomen: Anatomy and regions.
Abduction vs. Adduction: Muscle movements.
Abortion / Abortifacient: Pregnancy termination.
Abscess / Absorption: Infections and physiology.
Acetaminophen: US term for Paracetamol.
Achilles Tendon / Acne: Common body issues.
Acquired Immunity / AIDS: Immunology.
Acute vs. Chronic: Duration of diseases.
Addison's Disease: Adrenal gland disorder.
B: (e.g., Bacteria, Biopsy, Bradycardia)
C: (e.g., Cancer, Catheter, Cyst)
D-Z: (Continues alphabetically through all medical terms)
Supplementary Material (implied by standard dictionary structure and preface)
Anatomical Illustrations
Tables of word elements (prefixes/suffixes)
4. Review Questions (Based on the Text)
Who is the primary audience for this dictionary?
What is the difference between abduction and adduction as defined in the text?
What does the term acquired immunity refer to?
How does the dictionary define an acute condition compared to a chronic one?
What is the US term for paracetamol listed in the "A" section?
What is an abscess and how is it typically treated?
According to the entry on adoption, what does "adoptive immunotherapy" involve?
What are the nine regions the abdomen is divided into for medical purposes?
5. Easy Explanation (Presentation Style)
Title Slide: Dictionary of Medical Terms – Your Medical Translator
Slide 1: Why do we need this?
The Language Barrier: Doctors speak a different language (Medical Jargon).
The Problem: If you are a student, a nurse, or a patient, words like "myocardial infarction" or "dyspnea" can be scary and confusing.
The Solution: This dictionary translates "Doctor Speak" into plain English.
Slide 2: How to use this Book
A-Z Format: Just like a normal dictionary.
Simple Definitions: It doesn't use big words to define big words.
Example: It won't say "Tachycardia is an elevated heart rate." It will say "Tachycardia is a fast heartbeat."
Pronunciation: It tells you how to say the word (phonetics).
Slide 3: Sample "A" Words - Anatomy
Abdomen: The belly area (stomach, intestines, liver).
Abduction: Moving a body part away from the center (like lifting your arm up to the side).
Adduction: Moving a body part toward the center (like bringing your arm back down to your side).
Acetabulum: The cup-shaped part of the hip bone where the leg fits in.
Slide 4: Sample "A" Words - Conditions
Abscess: A painful swollen area full of pus (needs draining).
Acute: Sudden and severe (like a heart attack).
AIDS: A viral infection that breaks down the body's immune system.
Addison's Disease: A problem with the adrenal glands that makes you weak and changes your skin color.
Slide 5: Practical Uses
For Students: Helps you write better patient notes and understand lectures.
For Non-Clinical Staff: Helps you understand what the doctors are talking about.
For Patients: Helps you understand your own diagnosis.
Slide 6: Key Takeaway
Medical terms are just codes.
If you break the code (look it up), the mystery disappears.
This book is your "code breaker."...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/lunspdsr-9575/data/document.pdf", "num_examples": 11545, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/lunspdsr- /home/sid/tuning/finetune/backend/output/lunspdsr-9575/data/lunspdsr-9575.json...
|
null
|
queued
|
1769630093
|
1769763803
|
NULL
|
/home/sid/tuning/finetune/backend/output/lunspdsr- /home/sid/tuning/finetune/backend/output/lunspdsr-9575/adapter...
|
False
|
Edit
Delete
|
|
acb004e7-7670-457a-92aa-998c4840d029
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
fbbdxtrl-4815
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Diet in Longevity
|
Diet in Longevity
|
/home/sid/tuning/finetune/backend/output/fbbdxtrl- /home/sid/tuning/finetune/backend/output/fbbdxtrl-4815/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
“Longevity Diet” is a concise, practical guide tha “Longevity Diet” is a concise, practical guide that outlines how specific dietary substitutions and eating patterns can support healthier aging, extend lifespan, and reduce the risk of chronic disease. The document promotes a nutrient-dense, low-inflammation way of eating that emphasizes whole foods, plant-forward choices, and strategic replacements for common staples that accelerate aging.
The guide presents a clear set of food swaps designed to improve metabolic health, reduce oxidative stress, and support a stronger, longer-living body. It recommends replacing refined starches—such as bread, pasta, and white rice—with vegetables, legumes, mushrooms, and whole grains like quinoa. Red and processed meats are minimized in favor of fatty fish (like salmon, mackerel, sardines), white meat, eggs, tofu, or mushrooms. High-fat spreads and dressings are replaced with extra-virgin olive oil and other healthy fats, while processed sugars and excessive salt are swapped for herbs, spices, and “Lite Salt.”
The document encourages replacing cow’s milk with plant-based alternatives such as coconut, hemp, or pea milk. Beverages like soda and commercial fruit juice are substituted with water, tea, herbal teas, or moderate coffee intake. Snacks high in sugar are replaced with fruit, natural sweeteners, or high-cocoa dark chocolate.
It also emphasizes using targeted nutritional supplements—such as B vitamins, iodine, selenium, vitamin D, vitamin K2, and magnesium—to address common micronutrient gaps. Specialized “longevity supplements,” such as those formulated to counteract cellular aging, are listed as complementary options.
The centerpiece of the document is the “10 Simple Rules of the Longevity Diet,” which provide deeper guidance: eat fewer refined starches, limit red meat, hydrate well, favor whole ingredients (30+ per week), maintain moderate protein intake, eat slightly less than full to promote metabolic health, include fermented foods, minimize alcohol, and avoid nutrient deficiencies.
Overall, the Longevity Diet promotes a style of eating that is diverse, minimally processed, rich in phytonutrients and healthy fats, and aligned with scientific insights into metabolic health, the gut microbiome, inflammation, and biological aging....
|
{"num_examples": 29, "bad_lines": {"num_examples": 29, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/fbbdxtrl- /home/sid/tuning/finetune/backend/output/fbbdxtrl-4815/data/fbbdxtrl-4815.json...
|
null
|
completed
|
1764365138
|
1764365391
|
NULL
|
/home/sid/tuning/finetune/backend/output/fbbdxtrl- /home/sid/tuning/finetune/backend/output/fbbdxtrl-4815/adapter...
|
False
|
Edit
Delete
|
|
7b2a2799-a74e-4dd4-93a8-4bbabe61ca47
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
vtciomis-0967
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Diet-dependent entropic a
|
Diet-dependent entropic assessment of athletes’
|
/home/sid/tuning/finetune/backend/output/vtciomis- /home/sid/tuning/finetune/backend/output/vtciomis-0967/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Cennet Yildiz1, Melek Ece Öngel2 , Bayram Yilmaz3 Cennet Yildiz1, Melek Ece Öngel2 , Bayram Yilmaz3 and Mustafa Özilgen1* 1Department of Food Engineering, Yeditepe University, Kayısdagi, Atasehir, Istanbul 34755, Turkey 2Nutrition and Dietetics Department, Yeditepe University, Kayısdagi, Atasehir, Istanbul 34755, Turkey 3Faculty of Medicine, Department of Physiology, Yeditepe University, Istanbul, Turkey
(Received 29 July 2021 – Final revision received 26 August 2021 – Accepted 26 August 2021)
Journal of Nutritional Science (2021), vol. 10, e83, page 1 of 8 doi:10.1017/jns.2021.78
Abstract Life expectancies of the athletes depend on the sports they are doing. The entropic age concept, which was found successful in the previous nutrition studies, will be employed to assess the relation between the athletes’ longevity and nutrition. Depending on their caloric needs, diets are designed for each group of athletes based on the most recent guidelines while they are pursuing their careers and for the post-retirement period, and then the metabolic entropy generation was worked out for each group. Their expected lifespans, based on attaining the lifespan entropy limit, were calculated. Thermodynamic assessment appeared to be in agreement with the observations. There may be a significant improvement in the athletes’ longevity if theyshift to a retirement diet after the age of 50. The expected average longevity for male athletes was 56 years for cyclists, 66 years for weightlifters, 75 years for rugby players and 92 years for golfers. If they should start consuming the retirement diet after 50 years of age, the longevity of the cyclists may increase for 7 years, and those of weightlifters, rugby players and golfers may increase for 22, 30 and 8 years, respectively.
Key words: Athletes’ diet: Athletes’ longevity: Entropic age: Lifespan entropy
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/vtciomis-0967/data/document.pdf", "num_examples": 24, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/vtciomis- /home/sid/tuning/finetune/backend/output/vtciomis-0967/data/vtciomis-0967.json...
|
null
|
completed
|
1764899492
|
1764904301
|
NULL
|
/home/sid/tuning/finetune/backend/output/vtciomis- /home/sid/tuning/finetune/backend/output/vtciomis-0967/adapter...
|
False
|
Edit
Delete
|
|
f0d792ca-c8f4-4cea-9e5a-f838a0d96e47
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
jcskuiyn-2380
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Drivers of your health
|
Drivers of your health and longevity
|
/home/sid/tuning/finetune/backend/output/jcskuiyn- /home/sid/tuning/finetune/backend/output/jcskuiyn-2380/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
“Drivers of Your Health and Longevity” is a compre “Drivers of Your Health and Longevity” is a comprehensive report outlining the 23 key modifiable factors that significantly influence a person’s health, lifespan, and overall well-being. It emphasizes that 19 out of these 23 drivers lie outside the traditional healthcare system, meaning most of what determines longevity comes from everyday habits and environmental conditions.
These drivers are grouped into major categories:
1. Physical Inputs
Covers diet, supplements, substance use, hydration, and their direct effects on disease risk, cognitive health, and mortality. Examples include fasting improving metabolic health, omega-3 protecting the brain and heart, and sleep duration affecting mortality.
2. Movement
Includes mobility and exercise. The report highlights that regular physical activity can extend life by 3–5 years, reduce mortality risk, and improve overall physical and mental function.
3. Daily Living
Encompasses social interaction, productive activities, content consumption, and hygiene. Strong social relationships, volunteering, and balanced media usage are linked to better physical and mental health.
4. Exposure
Focuses on nature, atmospheric conditions, light, noise, and environmental materials. Evidence shows that nature exposure, reduced pollution, sunlight, and safe environments contribute to better mental health, reduced stress, and lower mortality.
5. Stress
Explains how both positive (eustress) and chronic stress affects disease risk, cognitive function, and life expectancy.
6. State of Being
Includes mindsets, beliefs, body composition, physical security, and economic security. Optimism, gratitude, financial stability, and safety are shown to have strong physiological and psychological benefits.
7. Healthcare
Covers vaccination, early detection, treatment, and medication adherence. Effective healthcare interventions (e.g., vaccines, screening, treatments) significantly reduce mortality and improve survival rates.
📌 Overall Purpose of the Report
The document emphasizes that longevity is not determined primarily by genetics or medical care, but by daily choices, behaviors, and environmental exposures. By optimizing these 23 modifiable drivers, individuals can dramatically improve their health span and lifespan.
If you want, I can also provide:
✅ A short summary
✅ A quiz based on this file
✅ Key insights
✅ A table of the 23 drivers
Just tell me!
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/jcskuiyn-2380/data/document.pdf", "num_examples": 141, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/jcskuiyn- /home/sid/tuning/finetune/backend/output/jcskuiyn-2380/data/jcskuiyn-2380.json...
|
null
|
completed
|
1765224167
|
1765224806
|
NULL
|
/home/sid/tuning/finetune/backend/output/jcskuiyn- /home/sid/tuning/finetune/backend/output/jcskuiyn-2380/adapter...
|
False
|
Edit
Delete
|
|
c849e927-e000-4f63-a601-d7b6e2ef75cd
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
evvycfst-1808
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Dublin Longevity
|
Dublin Longevity Declaration
|
/home/sid/tuning/finetune/backend/output/evvycfst- /home/sid/tuning/finetune/backend/output/evvycfst-1808/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Consensus Recommendation to Immediately Expand Res Consensus Recommendation to Immediately Expand Research on Extending Healthy Human Lifespans
For millennia, the consensus of the general public has been that aging is inevitable. For most of our history, even getting to old age was a significant accomplishment – and while centenarians have been around at least since the time of the Greeks, aging was never of major interest to medicine.
That has changed. Longevity medicine has entered the mainstream. First, evidence accumulated that lifestyle modifications prevent chronic diseases of aging and extend healthspan, the healthy and highly functional period of life. More recently, longevity research has made great progress – aging has been found to be malleable and hundreds of interventional strategies have been identified that extend lifespan and healthspan in animal models. Human clinical studies are underway, and already early results suggest that the biological age of an individual is modifiable.
A concerted effort has been made in the longevity field to institutionalize the word “healthspan”. Why healthspan (how long we stay healthy) and not its side-effect of lifespan (how long we live)? The reasons are linked more to perception than reality. Fundamental to this need to highlight healthspan is the idea that individuals get when they are asked if they want to live longer. Many imagine their parents or grandparents at the end of their lives when they often have major health issues and low quality of life. Then they conclude that they would not choose to live longer in that condition. This is counter to longevity research findings, which show that it is possible to intervene in late middle life and extend both healthspan and lifespan simultaneously. Emphasizing healthspan also reduces concerns of some individuals about whether it is ethical to live longer.
A drawback of this exists, though: many current longevity interventions may extend healthspan more than lifespan. Lifestyle interventions such as exercise probably fit this mold. Many interventions that have dramatic health-extending effects in invertebrate models have more modest effects in mice, and there is a concern that they will be further reduced in humans. In other words, the drugs and small molecules that we are excited about today may, despite their hefty development costs and lengthy approval processes, only extend average healthspan by five or ten years and may not extend maximum lifespan at all. Make no mistake, this would still represent a revolution in medical practice! A five-year extension in human healthspan, with equitable access for all people, would save trillions per year in healthcare costs, provide extra life quality across the entire population ...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/evvycfst-1808/data/document.pdf"}...
|
/home/sid/tuning/finetune/backend/output/evvycfst- /home/sid/tuning/finetune/backend/output/evvycfst-1808/data/evvycfst-1808.json...
|
null
|
failed
|
1764899560
|
1764900764
|
NULL
|
/home/sid/tuning/finetune/backend/output/evvycfst- /home/sid/tuning/finetune/backend/output/evvycfst-1808/adapter...
|
False
|
Edit
Delete
|
|
5a6ad5f4-10d6-4b80-825e-60a0423b6c56
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
uivicpuk-0509
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
ESSENTIAL STEPS TO HEALTH
|
ESSENTIAL STEPS TO HEALTHY AGING
|
/home/sid/tuning/finetune/backend/output/uivicpuk- /home/sid/tuning/finetune/backend/output/uivicpuk-0509/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
“Essential Steps to Healthy Aging” is an education “Essential Steps to Healthy Aging” is an educational guide created by Kansas State University to teach people how to age in the healthiest, happiest, and most independent way possible. The document explains that while ageing is natural and unavoidable, our daily habits throughout life have a powerful impact on how well we age. It presents 12 essential lifestyle behaviors that research shows contribute to living longer, staying healthier, and maintaining quality of life into older age.
The file includes a leader’s guide, a fact sheet for participants, an interactive activity, and an evaluation form, making it a complete learning program for communities, workshops, or health-education sessions.
⭐ Core Message of the Document
Healthy aging is not about avoiding age—it’s about supporting the body, mind, and spirit across the entire lifespan.
The guide encourages people to take responsibility for their health and to make small but meaningful changes that promote lifelong well-being.
⭐ The 12 Essential Steps to Healthy Aging
(as presented in the fact sheet)
Essential-Steps-to-Health-Aging
Maintain a positive attitude
Eat healthfully
Engage in regular physical activity
Exercise your brain
Engage in social activity
Practice lifelong learning
Prioritize safety
Visit the doctor regularly
Manage your stress
Practice good financial management
Get enough sleep
Take at least 10 minutes a day for yourself
These steps address all areas of life—physical health, mental sharpness, emotional balance, relationships, safety, finances, and self-care.
⭐ Program Purpose
The guide aims to help people understand that:
Healthier choices today lead to a healthier and more independent future.
Positive habits at any age can improve longevity and quality of life.
Ageing well is possible through prevention, awareness, and small daily behaviors.
⭐ Contents of the Document
✔ 1. Leader’s Guide
Explains how to run the program, prepare materials, engage participants, and guide discussions.
Essential-Steps-to-Health-Aging
✔ 2. Essential Steps to Healthy Aging (Fact Sheet)
A clear, easy-to-read summary of all 12 steps and why they matter.
✔ 3. Activity: My Healthy Aging Plan
Participants write specific goals for each of the 12 steps, helping them create a personalized lifestyle improvement plan.
Essential-Steps-to-Health-Aging
✔ 4. Evaluation Form
Participants reflect on what they learned and choose which positive habits they plan to adopt going forward.
Essential-Steps-to-Health-Aging
⭐ Overall Meaning
The document teaches that healthy aging is achievable for everyone, regardless of age. By focusing on attitude, nutrition, physical health, mental activity, social connections, safety, finances, stress, sleep, and self-care, people can enjoy a longer life with greater independence, better health, and improved well-being.
It is both a practical guide and a motivational toolkit for anyone interested in ageing well....
|
{"num_examples": 45, "bad_lines": {"num_examples": 45, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/uivicpuk- /home/sid/tuning/finetune/backend/output/uivicpuk-0509/data/uivicpuk-0509.json...
|
null
|
completed
|
1764363910
|
1764363997
|
NULL
|
/home/sid/tuning/finetune/backend/output/uivicpuk- /home/sid/tuning/finetune/backend/output/uivicpuk-0509/adapter...
|
False
|
Edit
Delete
|
|
663f702e-761c-45a1-95dd-a2aca9941b77
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
nyuieybh-2436
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
ESSENTIAL STEPS TO HEALTH
|
ESSENTIAL STEPS TO HEALTHY AGING
|
/home/sid/tuning/finetune/backend/output/nyuieybh- /home/sid/tuning/finetune/backend/output/nyuieybh-2436/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Kansas State University Agricultural Experiment St Kansas State University Agricultural Experiment Station and Cooperative Extension Service
Author: Erin Yelland, Ph.D., Extension Specialist, Adult Development and Aging
Program Overview
The Essential Steps to Healthy Aging is a structured educational program designed to motivate and empower participants to adopt healthy lifestyle behaviors that foster optimal aging. Developed by Kansas State University’s Cooperative Extension Service, this program highlights that aging is inevitable, but how individuals care for themselves physically, mentally, and emotionally throughout life significantly influences the quality of their later years. The program promotes the idea that healthy lifestyle changes can positively impact well-being at any age.
Core Concept
Aging well is a lifelong process influenced by daily choices. Research on centenarians (people aged 100 and over) shows that adopting certain healthy behaviors contributes to longevity and improved quality of life. The program introduces 12 essential steps to maintain health and enhance successful aging.
The 12 Essential Steps to Healthy Aging
Step Number Essential Healthy Behavior
1 Maintain a positive attitude
2 Eat healthfully
3 Engage in regular physical activity
4 Exercise your brain
5 Engage in social activity
6 Practice lifelong learning
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/nyuieybh-2436/data/document.pdf", "num_examples": 39, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/nyuieybh- /home/sid/tuning/finetune/backend/output/nyuieybh-2436/data/nyuieybh-2436.json...
|
null
|
completed
|
1764954912
|
1764955315
|
NULL
|
/home/sid/tuning/finetune/backend/output/nyuieybh- /home/sid/tuning/finetune/backend/output/nyuieybh-2436/adapter...
|
False
|
Edit
Delete
|
|
2483b534-8282-4ca3-bb67-e3ae5cd50b90
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
aqqwygvg-9594
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
EXERCISE FOR LONGEVITY
|
EXERCISE FOR LONGEVITY
|
/home/sid/tuning/finetune/backend/output/aqqwygvg- /home/sid/tuning/finetune/backend/output/aqqwygvg-9594/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
The Longevity Exercise Guide is a clear, actionabl The Longevity Exercise Guide is a clear, actionable, science-based blueprint for building an exercise routine that maximizes both healthspan and lifespan. Written by longevity researcher Nina Patrick, PhD, the guide distills the most important forms of physical activity—strength, aerobic, anaerobic, flexibility, stability, and NEAT—into a simple weekly plan anyone can follow. The premise is that exercise is the most powerful “longevity drug” available, with research showing it prevents disease, preserves independence, and protects metabolism and cognitive function as we age.
The guide teaches you how to train your body so that at age 100, you can still perform essential daily tasks—carrying groceries, climbing stairs, hiking, balancing, lifting, and moving confidently through life. It emphasizes consistency, personalization, and a balanced mix of training styles that work together to delay aging at the cellular, metabolic, and functional levels.
🧩 What the Guide Covers
1. Strength Training — The Foundation of Aging Well
Prevents muscle loss, frailty, and poor mobility
Recommended 2–3 full-body sessions/week, 45–60 minutes
Mix of heavy low-rep strength work + lighter high-rep endurance work
Includes weights, resistance bands, and bodyweight movements
Longevity_Exercise_Guide (
Strength is directly tied to independence in old age.
2. Aerobic Exercise — Boosting Metabolism & Mitochondria
Brisk walking, running, swimming, cycling
Key for mitochondrial health, cardiovascular fitness, disease prevention
Target: 3 hours/week (150 minutes minimum)
Low-intensity “zone 2” style cardio at 65–75% max HR
Longevity_Exercise_Guide (
Aerobic training slows metabolic aging and improves energy systems.
3. Anaerobic Exercise — Increasing VO₂ Max
Short, fast, high-intensity intervals (HIIT, hard cycling, rowing)
VO₂ max is the strongest predictor of longevity
Suggested: 1–2 intense sessions per week, 30 minutes each
Longevity_Exercise_Guide (
Maintains peak cardiovascular performance as VO₂ max naturally declines with age.
4. Flexibility & Stability — Protecting Balance and Preventing Falls
Yoga, pilates, planks, stretching
Critical because falls are the #1 cause of injury and death in older adults
Enhances posture, core strength, mobility, and balance
Longevity_Exercise_Guide (
Flexibility + stability ensure you can move safely for life.
5. NEAT — The Most Overlooked Longevity Tool
Non-Exercise Activity Thermogenesis = everything you do outside workouts
(e.g., walking, standing, chores)
Boosts daily calorie burn
Counters modern sedentary lifestyles
Reduces metabolic disease and weight gain
Examples: daily steps, walking for errands, housework, standing more
Longevity_Exercise_Guide (
NEAT is essential because most people fail to move enough outside formal workouts.
🧭 Weekly Longevity Blueprint
The guide provides a sample week integrating all modalities:
Strength: 3 full-body sessions
Aerobic: 3 brisk walks
Anaerobic: 1 HIIT/VO₂ max workout
Flexibility/Stability: daily stretching + 1 yoga/pilates class
NEAT: daily 30-minute walk
Longevity_Exercise_Guide (
This structure covers every dimension of functional longevity.
💡 Why This Guide Matters
The Longevity Exercise Guide reframes exercise not as a fitness task but as a lifelong strategy for independence, vitality, and disease prevention. Rather than prescribing a rigid routine, it teaches how to build a personalized, sustainable program that strengthens the body’s most essential aging-related systems:
muscle strength
cardiovascular endurance
metabolic flexibility
balance and mobility
everyday movement patterns
It’s a practical roadmap for anyone who wants to age not only longer, but better....
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/aqqwygvg-9594/data/document.pdf"}...
|
/home/sid/tuning/finetune/backend/output/aqqwygvg- /home/sid/tuning/finetune/backend/output/aqqwygvg-9594/data/aqqwygvg-9594.json...
|
null
|
failed
|
1764879436
|
1764880333
|
NULL
|
/home/sid/tuning/finetune/backend/output/aqqwygvg- /home/sid/tuning/finetune/backend/output/aqqwygvg-9594/adapter...
|
False
|
Edit
Delete
|
|
26112c74-45bf-4fdc-b362-d5b6a47bce99
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
racictsh-8494
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Eating for Health
|
Eating for Health and Longevity
|
/home/sid/tuning/finetune/backend/output/racictsh- /home/sid/tuning/finetune/backend/output/racictsh-8494/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
“Eating for Health and Longevity” is a practical, “Eating for Health and Longevity” is a practical, evidence-based guide created by SUNY Downstate Health Sciences University to help individuals improve or even reverse chronic disease through a whole-food, plant-based (WFPB) diet. Designed as an accessible handbook, the document explains why diets rich in unprocessed plant foods—vegetables, fruits, whole grains, legumes, nuts, and seeds—can dramatically enhance long-term health, promote healthy weight, and reduce the risk of conditions such as diabetes, heart disease, obesity, and high blood pressure.
The guide defines a WFPB diet as centered on natural, minimally processed plants while minimizing or eliminating meat, dairy, eggs, refined oils, refined grains, added sugars, and highly processed foods. It distinguishes WFPB eating from veganism by emphasizing nutritional quality rather than simply the absence of animal products.
It offers detailed, beginner-friendly guidance on:
What to eat (whole grains, legumes, vegetables, fruits, nuts, seeds, unsweetened plant milks)
What to avoid (meat, processed foods, refined sugars, oils, dairy, refined grains)
Step-by-step ways to transition gradually without overwhelm
Affordable, nutrient-dense sources of plant protein
Shopping lists and cost-saving strategies
Cooking techniques without oil, including sautéing with water or broth, steaming, roasting with parchment, and air frying
Healthy substitutions for meat, dairy, eggs, oil, and sugar
Motivation, support, and educational resources, including films, books, websites, and community groups
The guide also includes a rich section on herbs and spices that add flavor while providing antioxidant and anti-inflammatory benefits, such as turmeric, rosemary, ginger, basil, garlic, cinnamon, and cumin.
In closing, the document encourages readers to view food as medicine—a central pillar of lifestyle medicine alongside exercise, sleep, stress management, and avoiding harmful substances. It positions WFPB eating as an empowering, sustainable pathway toward vibrant health, chronic disease prevention, and longevity....
|
{"num_examples": 79, "bad_lines": {"num_examples": 79, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/racictsh- /home/sid/tuning/finetune/backend/output/racictsh-8494/data/racictsh-8494.json...
|
null
|
completed
|
1764364287
|
1764364414
|
NULL
|
/home/sid/tuning/finetune/backend/output/racictsh- /home/sid/tuning/finetune/backend/output/racictsh-8494/adapter...
|
False
|
Edit
Delete
|
|
659f07be-3c9f-4b9b-9429-f2cc4ebe93b3
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
wgvwxmun-9615
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Eating for Health
|
Eating for Health and Longevity
|
/home/sid/tuning/finetune/backend/output/wgvwxmun- /home/sid/tuning/finetune/backend/output/wgvwxmun-9615/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Summary: Eating for Health and Longevity – A Pract Summary: Eating for Health and Longevity – A Practical Guide to Whole-Food, Plant-Based Diets
This guide, produced by SUNY Downstate Health Sciences University, provides a comprehensive, evidence-based overview of adopting a whole-food, plant-based (WFPB) diet to promote health, prevent chronic disease, and improve longevity. It offers practical advice for transitioning to plant-based eating, highlights nutritional benefits, and addresses common concerns and misconceptions.
Core Concepts of a Whole-Food, Plant-Based Diet
Definition: A WFPB diet emphasizes eating whole, minimally processed plant foods such as vegetables, fruits, whole grains, legumes, nuts, and seeds.
Exclusions: It minimizes or avoids meat, poultry, fish/seafood, eggs, dairy, refined carbohydrates (e.g., white bread, white rice), refined sugars, extracted oils, and highly processed foods.
Difference from Vegan Diet: Unlike some vegan diets, which may include refined grains, sweeteners, and oils, the WFPB diet focuses on whole foods for optimal health.
Health Benefits
Chronic Disease Prevention and Reversal: WFPB diets can prevent, manage, and sometimes reverse diseases such as diabetes, heart disease, obesity, and hypertension.
Weight Management: Effective for losing excess weight and maintaining a healthy weight.
Longevity and Vitality: Promotes vibrant health and potentially longer life by reducing lifestyle-related risk factors.
Foods to Include and Avoid
Foods to Eat and Enjoy Foods to Avoid or Minimize
Fresh and frozen vegetables Meats (red, processed, poultry, fish/seafood)
Fresh fruits Refined grains (white rice, white pasta, white bread)
Whole grains (oats, quinoa, barley) Products with refined sugars or sweeteners (sodas, candy)
Legumes (peas, lentils, beans) Highly processed or convenience foods with added salt
Unsalted nuts and seeds Eggs and dairy products
Dried fruits without additives Processed plant-based meat, cheese, or butter alternatives
Unsweetened non-dairy milks Refined, extracted oils (olive oil, canola, vegetable)
Alcoholic beverages
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/wgvwxmun-9615/data/document.pdf", "num_examples": 80, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/wgvwxmun- /home/sid/tuning/finetune/backend/output/wgvwxmun-9615/data/wgvwxmun-9615.json...
|
null
|
completed
|
1764955838
|
1764957372
|
NULL
|
/home/sid/tuning/finetune/backend/output/wgvwxmun- /home/sid/tuning/finetune/backend/output/wgvwxmun-9615/adapter...
|
False
|
Edit
Delete
|
|
b0a28646-1043-4648-a0f9-13b684bfac38
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
hunsxdfl-4743
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Economic
|
Economic development
|
/home/sid/tuning/finetune/backend/output/hunsxdfl- /home/sid/tuning/finetune/backend/output/hunsxdfl-4743/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Economic growth health and poverty
|
{"num_examples": 163, "bad_lines": {"num_examples": 163, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/hunsxdfl- /home/sid/tuning/finetune/backend/output/hunsxdfl-4743/data/hunsxdfl-4743.json...
|
{"train_runtime": 651.4982, "train_sam {"train_runtime": 651.4982, "train_samples_per_second": 2.456, "train_steps_per_second": 0.307, "total_flos": 7555123985276928.0, "train_loss": 0.516647665053606, "epoch": 9.536585365853659, "step": 200}...
|
completed
|
1764307874
|
1764308985
|
NULL
|
/home/sid/tuning/finetune/backend/output/hunsxdfl- /home/sid/tuning/finetune/backend/output/hunsxdfl-4743/adapter...
|
False
|
Edit
Delete
|
|
ac6b20fd-5c74-4e34-bbf1-42e3985b17e8
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
skdznffn-5496
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Effect of Exceptional
|
Effect of Exceptional Parental Longevity
|
/home/sid/tuning/finetune/backend/output/skdznffn- /home/sid/tuning/finetune/backend/output/skdznffn-5496/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Summary
This study investigates the relationship Summary
This study investigates the relationship between exceptional parental longevity and the prevalence of cardiovascular disease (CVD) in their offspring, with a focus on whether lifestyle, socioeconomic status, and dietary factors influence this association. Conducted on a cohort of Ashkenazi Jewish adults aged 65-94, the research compares two groups: offspring of parents with exceptional longevity (OPEL), defined as having at least one parent living beyond 95 years, and offspring of parents with usual survival (OPUS), whose parents did not survive past 95 years. The study finds that OPEL exhibit significantly lower prevalence of hypertension, stroke, and overall cardiovascular disease compared to OPUS, independent of lifestyle, socioeconomic, and nutritional differences, thus highlighting a probable genetic influence on disease-free survival and longevity.
Background and Rationale
Individuals with exceptional longevity often experience a delay or absence of age-related diseases, making them models for studying healthy aging.
Longevity has a heritable component, with genetic markers linked to extended lifespan and resistance to diseases like CVD.
Previous studies have shown that offspring of exceptionally long-lived parents have lower incidence of CVD and other age-related illnesses.
Lifestyle factors such as physical activity, diet, smoking status, and socioeconomic status are known to influence cardiovascular health in the general population.
Prior to this study, no research compared lifestyle factors between offspring of exceptionally long-lived parents and those of usual longevity to isolate genetic effects from environmental factors.
Study Design and Methods
Population: 845 Ashkenazi Jewish adults aged 65-94 years; 395 OPEL and 450 OPUS.
Definition:
OPEL: At least one parent lived past 95 years.
OPUS: Both parents died before 95 years.
Recruitment: Systematic searches via voter registration, synagogues, community groups, and advertisements.
Exclusion Criteria: Baseline dementia, severe sensory impairments, or sibling already enrolled.
Data Collection:
Medical history including hypertension (HTN), diabetes mellitus (DM), myocardial infarction (MI), congestive heart failure (CHF), coronary interventions, and stroke.
Lifestyle factors: smoking history, alcohol use, physical activity level.
Socioeconomic factors: education and social strata score.
Dietary intake assessed in a subgroup (n=234) using the Block Brief Food Frequency Questionnaire (FFQ 2000).
Physical measures: height, weight, waist circumference; BMI calculated.
Analysis:
Comparison of prevalence of diseases and lifestyle variables between OPEL and OPUS.
Statistical adjustments for age, sex, BMI, tobacco use, social strata, and physical activity.
Stratified analyses by cardiovascular risk status (high vs. low).
Interaction testing between group status and lifestyle/socioeconomic factors.
Key Findings
Demographics and Lifestyle Factors
Characteristic OPEL (n=395) OPUS (n=450) p-value
Female (%) 59 50 <0.01
Age (years, mean ± SD) 75 ± 6 76 ± 7 <0.01
Education (years) 17 ± 3 17 ± 3 0.55
Social strata score (median, IQR) 56 (28-66) 56 (28-66) 0.76
Ever smokers (%) 55 54 0.80
Current smokers (%) 3 3 0.94
Alcohol use past year (%) 90 88 0.32
Strenuous physical activity (times/week, median) 3 (0-4) 3 (0-4) 0.71
Walking endurance >30 minutes (%) 77 70 0.05
No significant differences in lifestyle factors (smoking, alcohol, physical activity) or socioeconomic status between OPEL and OPUS.
OPEL reported greater walking endurance despite similar physical activity frequency.
Physical Characteristics and Disease Prevalence
Condition / Measure OPEL OPUS p-value OR (95% CI)a
BMI (mean ± SD) 27.5 ± 4.9 27.8 ± 4.7 0.34 Not specified
Obesity (%) (BMI≥30) 26 27 0.84 Not specified
Abdominal obesity (%) 48 48 0.95 Not specified
Systolic BP (mmHg) 129 ± 17 129 ± 17 0.78 Not specified
Diastolic BP (mmHg) 74 ± 9 74 ± 10 0.92 Not specified
Antihypertensive medication use (%) 39 49 <0.01 Not specified
Hypertension (%) 42 51 <0.01 0.71 (0.53–0.95)
Diabetes mellitus (%) 7 11 0.10 0.70 (0.43–1.15) NS
Myocardial infarction (%) 5 7 0.12 0.77 (0.42–1.42) NS
Stroke (%) 2 5 <0.01 0.35 (0.14–0.88)
Cardiovascular disease (composite) (%) 12 20 <0.01 0.65 (0.43–0.98)
OPEL had significantly lower odds of hypertension, stroke, and overall CVD compared to OPUS after adjusting for age and sex.
No significant differences observed for diabetes, MI, CHF, or coronary interventions after adjustment.
OPUS more frequently used antihypertensive medications despite similar blood pressure readings.
Stratified Cardiovascular Risk Analysis
Among high-risk individuals (defined by diabetes or ≥2 risk factors: obesity, hypertension, smoking), OPEL had a significantly lower prevalence of CVD compared to OPUS (OR 0.45; p=0.01).
Among low-risk individuals, no significant difference in CVD prevalence was observed between groups.
Significant interaction found between group status and tobacco use:
Tobacco use was not significantly associated with increased CVD odds in OPEL.
Tobacco use was nearly significantly associated with increased CVD odds in OPUS (p=0.07).
Dietary Intake (Subgroup, n=234)
Dietary Component OPEL OPUS p-value Adjusted p-valuea
Total daily calories (kcal) 1119 (906–1520) 1218 (940–1553)
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/skdznffn-5496/data/document.pdf", "num_examples": 111, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/skdznffn- /home/sid/tuning/finetune/backend/output/skdznffn-5496/data/skdznffn-5496.json...
|
null
|
completed
|
1764955777
|
1764957602
|
NULL
|
/home/sid/tuning/finetune/backend/output/skdznffn- /home/sid/tuning/finetune/backend/output/skdznffn-5496/adapter...
|
False
|
Edit
Delete
|
|
187ddbfd-84ab-4571-9e41-099455906034
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
okwjawrr-5385
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Effect of Nutritional
|
Effect of Nutritional Interventions on Longevity
|
/home/sid/tuning/finetune/backend/output/okwjawrr- /home/sid/tuning/finetune/backend/output/okwjawrr-5385/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
The study “Effect of Nutritional Interventions on The study “Effect of Nutritional Interventions on Longevity of Senior Cats” investigates whether specific dietary modifications can extend the lifespan and improve the health of aging cats. Aging in cats is associated with oxidative stress, declining organ function, and increased vulnerability to disease, and the study explores whether nutrition can mitigate these effects. It evaluates three diets: a control diet, a diet enriched with antioxidants (vitamin E and β-carotene), and a third diet combining antioxidants with additional prebiotics and omega-6 and omega-3 fatty acids.
The researchers conducted a multi-year trial using healthy mixed-breed cats aged 7–17 years, divided equally among the three diet groups. Health markers, blood values, body composition, and survival were monitored throughout the cats' lives. Results showed that cats fed Diet 3—the diet containing antioxidants, chicory root (prebiotic), and a blend of fatty acids—experienced significant health benefits. These cats maintained better body weight, body condition, lean body mass, bone density, and healthier gut microflora than cats on the other diets. They also had higher levels of serum vitamin E, β-carotene, and linoleic acid.
Most importantly, Diet 3 significantly increased lifespan. Cats on this diet had a 61% lower hazard of death compared with those on the control diet, living on average about one year longer when adjusted for age. They also showed fewer cases of thyroid disease and a trend toward reduced gastrointestinal pathology.
The study concludes that a multi-nutrient dietary strategy—combining antioxidants, prebiotics, and essential fatty acids—can meaningfully improve longevity and overall health in senior cats, offering evidence that targeted nutrition plays a powerful role in healthy aging.
If you want, I can also provide:
✅ A shorter summary
✅ A 1-paragraph description
✅ MCQs/quiz from the file
✅ A simplified student-friendly version
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/okwjawrr-5385/data/document.pdf", "num_examples": 298, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/okwjawrr- /home/sid/tuning/finetune/backend/output/okwjawrr-5385/data/okwjawrr-5385.json...
|
null
|
completed
|
1765221192
|
1765222010
|
NULL
|
/home/sid/tuning/finetune/backend/output/okwjawrr- /home/sid/tuning/finetune/backend/output/okwjawrr-5385/adapter...
|
False
|
Edit
Delete
|
|
bd79e6c3-515f-429b-a541-2c97c10d5086
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
okhjmgem-7490
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Effect of eliminating
|
Effect of eliminating chronic diseases
|
/home/sid/tuning/finetune/backend/output/okhjmgem- /home/sid/tuning/finetune/backend/output/okhjmgem-7490/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Summary
This study, published in Revista de Saúde Summary
This study, published in Revista de Saúde Pública (2013), investigates whether the elimination of certain chronic diseases can lead to a compression of morbidity among elderly individuals in São Paulo, Brazil. It uses population-based data from the 2000 SABE (Health, Wellbeing and Ageing) study and official mortality records to evaluate changes in disability-free life expectancy (DFLE) resulting from the hypothetical removal of specific chronic conditions.
Background and Objectives
Chronic non-communicable diseases (NCDs) such as cardiovascular diseases, diabetes, and chronic pulmonary conditions account for approximately 50% of diseases in developing countries and are major contributors to morbidity and mortality.
In Brazil, these diseases represent the main health burden and priority for healthcare systems.
The compression of morbidity theory posits that delaying the onset of debilitating diseases compresses the period of morbidity into a shorter segment at the end of life, thus increasing healthy life expectancy.
Other theories include:
Expansion of morbidity: Mortality declines due to reduced lethality but incidence remains or increases, leading to longer periods of morbidity.
Dynamic equilibrium: Both mortality and morbidity decline, keeping years lived with severe disability relatively constant.
The study aims to analyze whether eliminating certain chronic diseases would compress morbidity among elderly individuals, improving overall health expectancy.
Methodology
Design: Analytical, population-based, cross-sectional study.
Population: 2,143 elderly individuals (aged 60+) from São Paulo, Brazil, sampled probabilistically in 2000 as part of the SABE study.
Data collection:
Structured questionnaire covering sociodemographics, health status, functional capacity, and chronic diseases.
Self-reported presence of 9 chronic diseases based on ICD-10: systemic arterial hypertension, diabetes mellitus, heart disease, lung disease, cancer, joint disease, cerebrovascular disease, falls in previous year, and nervous/psychiatric problems.
Functional disability defined by difficulties in activities of daily living (dressing, eating, bathing, toileting, ambulation, fecal and urinary incontinence).
Statistical analysis:
Sullivan’s method used to compute life expectancy (LE) and disability-free life expectancy (DFLE).
Cause-deleted life tables estimated probabilities of death with elimination of specific diseases.
Multiple logistic regression (controlling for age) assessed disability prevalence changes with disease elimination.
Assumption: independence between causes of death and disability.
Sampling weights and corrections for design effects were applied to represent the São Paulo elderly population.
Key Findings
Sample Characteristics
Females represented 58.6% of the sample.
Higher proportion of women aged 75+ (24.2%) than men (19.2%).
Women more frequently widowed or single; men had higher employment rates.
Women more likely to live alone.
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/okhjmgem-7490/data/document.pdf", "num_examples": 133, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/okhjmgem- /home/sid/tuning/finetune/backend/output/okhjmgem-7490/data/okhjmgem-7490.json...
|
null
|
completed
|
1764955805
|
1764958117
|
NULL
|
/home/sid/tuning/finetune/backend/output/okhjmgem- /home/sid/tuning/finetune/backend/output/okhjmgem-7490/adapter...
|
False
|
Edit
Delete
|
|
6091bea7-3a23-4d1c-8647-5f933aff91ac
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
qrlwojjn-3033
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Effect of supplemented
|
Effect of supplemented water on fecundity
|
/home/sid/tuning/finetune/backend/output/qrlwojjn- /home/sid/tuning/finetune/backend/output/qrlwojjn-3033/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
The study “Effect of Supplemented Water on Fecundi The study “Effect of Supplemented Water on Fecundity and Longevity” examines how different types of water—particularly fruit-infused or nutrient-enriched water—affect the reproductive output (fecundity) and overall lifespan (longevity) of a test organism. The experiment compares the impact of control water versus various supplemented waters such as apple water, showing how hydration quality can influence biological performance.
The findings demonstrate that apple-supplemented water produced the highest fecundity, meaning it led to the greatest number of eggs or offspring compared with all other treatments. This suggests that certain nutrients present in fruit-based water may stimulate reproductive capacity. However, results for longevity were mixed and highly variable, with some supplemented waters increasing lifespan and others having minimal or inconsistent effects. The study highlights the complexity of how hydration quality influences biological processes, emphasizing that while enriched water can boost reproduction, its effects on longevity are not uniform.
Overall, the research concludes that supplemented water can significantly enhance fecundity, but its impact on lifespan depends on the type of supplement and biological conditions, suggesting important implications for nutritional interventions and life-history strategies.
If you want, I can also provide:
✅ A short summary
✅ A 3–4 line description
✅ A student-friendly simple explanation
✅ Quiz questions from this file
Just tell me!...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/qrlwojjn-3033/data/document.pdf", "num_examples": 245, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/qrlwojjn- /home/sid/tuning/finetune/backend/output/qrlwojjn-3033/data/qrlwojjn-3033.json...
|
null
|
completed
|
1765221773
|
1765222739
|
NULL
|
/home/sid/tuning/finetune/backend/output/qrlwojjn- /home/sid/tuning/finetune/backend/output/qrlwojjn-3033/adapter...
|
False
|
Edit
Delete
|
|
a899b0b5-d187-4a93-8cea-938ff817f30a
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
vmsdiqjm-7013
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Effects of desiccation
|
Effects of desiccation stress
|
/home/sid/tuning/finetune/backend/output/vmsdiqjm- /home/sid/tuning/finetune/backend/output/vmsdiqjm-7013/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This study presents a systematic review and pooled This study presents a systematic review and pooled survival analysis quantifying the effects of desiccation stress (humidity) and temperature on the adult female longevity of Aedes aegypti and Aedes albopictus, the primary mosquito vectors of arboviral diseases such as dengue, Zika, chikungunya, and yellow fever. The research addresses a critical gap in vector ecology and epidemiology by providing a comprehensive, quantitative model of how humidity influences adult mosquito survival, alongside temperature effects, to improve understanding of transmission dynamics and enhance predictive models of disease risk.
Background
Aedes aegypti and Ae. albopictus are globally invasive mosquito species that transmit several major arboviruses.
Adult female mosquito longevity strongly impacts transmission dynamics because mosquitoes must survive the extrinsic incubation period (EIP) to become infectious.
While temperature effects on mosquito survival have been widely studied and incorporated into models, the role of humidity remains poorly quantified despite being ecologically significant.
Humidity influences mosquito survival via desiccation stress, affecting water loss and physiological function.
Environmental moisture also indirectly affects mosquito populations by altering evaporation rates in larval habitats, impacting larval development and adult body size, which affects vectorial capacity.
Understanding the temperature-dependent and non-linear effects of humidity can improve ecological and epidemiological models, especially in arid, semi-arid, and seasonally dry regions, which are understudied.
Objectives
Systematically review experimental studies on temperature, humidity, and adult female survival in Ae. aegypti and Ae. albopictus.
Quantify the relationship between humidity and adult survival while accounting for temperature’s modifying effect.
Provide improved parameterization for models of mosquito populations and arboviral transmission.
Methods
Systematic Literature Search: 1517 unique articles screened; 17 studies (16 laboratory, 1 semi-field) met inclusion criteria, comprising 192 survival experiments with ~15,547 adult females (8749 Ae. aegypti, 6798 Ae. albopictus).
Inclusion Criteria: Studies must report survival data for adult females under at least two temperature-humidity regimens, with sufficient methodological detail on nutrition and hydration.
Data Extraction: Variables included species, survival times, mean temperature, relative humidity (RH), and provisioning of water, sugar, and blood meals. Saturation vapor pressure deficit (SVPD) was calculated from temperature and RH to represent desiccation stress.
Survival Time Simulation: To harmonize disparate survival data formats (survival curves, mean/median longevity, survival proportions), individual mosquito survival times were simulated via Weibull and log-logistic models.
Pooled Survival Analysis: Stratified and mixed-effects Cox proportional hazards regression models were used to estimate hazard ratios (mortality risks) associated with temperature, SVPD, and nutritional factors.
Model Selection: SVPD was found to fit survival data better than RH or vapor pressure.
Sensitivity Analyses: Included testing model robustness by excluding individual studies and comparing results using only Weibull simulations.
Key Quantitative Findings
Parameter Ae. aegypti Ae. albopictus Notes
Temperature optimum (lowest mortality hazard) ~27.5 °C ~21.5 °C Ae. aegypti optimum higher than Ae. albopictus
Mortality risk trend Increases non-linearly away from optimum; sharp rise at higher temps Similar trend; possibly slightly better survival at lower temps Mortality rises rapidly at high temps for both species
Effect of desiccation (SVPD) Mortality hazard rises steeply from 0 to ~1 kPa SVPD, then more gradually Mortality hazard increases with SVPD but with less clear pattern Non-linear and temperature-dependent relationship
Species comparison (stratified model) Generally lower mortality risk than Ae. albopictus across most conditions Higher mortality risk compared to Ae. aegypti Differences not significant in mixed-effects model
Nutritional provisioning effects Provision of water, sugar, blood meals significantly reduces mortality risk Same as Ae. aegypti Provisioning modeled as binary present/absent
Qualitative and Contextual Insights
Humidity is a significant and temperature-dependent factor affecting adult female survival in Ae. aegypti, with more limited but suggestive evidence for Ae. albopictus.
Mortality risk increases sharply with desiccation stress (SVPD), especially at higher temperatures.
Ae. aegypti tends to have higher survival and a higher thermal optimum than Ae. albopictus, aligning with their geographic distributions—Ae. aegypti favors warmer, drier climates while Ae. albopictus tolerates cooler temperatures.
Provisioning of water and nutrients (sugar, blood) markedly improves survival, reflecting the importance of hydration and energy intake.
The findings support that humidity effects are underrepresented in current mosquito and disease transmission models, which often rely on simplistic or threshold-based mortality assumptions.
The use of SVPD (a measure of desiccation potential) rather than relative humidity or vapor pressure is more appropriate for modeling mosquito survival related to desiccation.
There is substantial unexplained variability among studies, likely due to unmeasured factors such as mosquito genetics, experimental protocols, and microclimatic conditions.
The majority of studies used laboratory settings and tropical/subtropical strains, with very limited data from arid or semi-arid climates, a critical gap given the importance of humidity fluctuations there.
Microclimatic variability and mosquito behavior (e.g., seeking humid refugia) may mitigate desiccation effects in the field, so laboratory results may overestimate mortality under natural conditions.
The study highlights the need for more field-based and arid region studies, and for models to incorporate nonlinear and interactive effects of temperature and humidity on mosquito survival.
Timeline Table: Study Selection and Analysis Process
Step Description
Literature search (Feb 2016) 1517 unique articles screened
Full text review 378 articles assessed for eligibility
Final inclusion 17 studies selected (16 lab, 1 semi-field)
Data extraction Survival data, temperature, humidity, nutrition, species, setting
Survival time simulation Weibull and log-logistic models used to harmonize survival data
Pooled survival analysis Stratified and mixed-effects Cox regression models
Sensitivity analyses Exclusion of individual studies, Weibull-only simulations
Model selection SVPD chosen as best humidity metric
Definitions and Key Terms
Term Definition
Aedes aegypti Primary mosquito vector of dengue, Zika, chikungunya, and yellow fever viruses
Aedes albopictus Secondary vector species with broader climatic tolerance, also transmits arboviruses
Saturation Vapor Pressure Deficit (SVPD) Difference between actual vapor pressure and saturation vapor pressure; a measure of drying potential/desiccation stress
Extrinsic Incubation Period (EIP) Time required for a virus to develop within the mosquito before it can be transmitted
Desiccation stress Physiological stress from water loss due to low humidity, impacting mosquito survival
Stratified Cox regression Survival analysis method allowing baseline hazards to vary by study
Mixed-effects Cox regression Survival analysis
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/vmsdiqjm-7013/data/document.pdf", "num_examples": 367, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/vmsdiqjm- /home/sid/tuning/finetune/backend/output/vmsdiqjm-7013/data/vmsdiqjm-7013.json...
|
null
|
completed
|
1764955760
|
1764958870
|
NULL
|
/home/sid/tuning/finetune/backend/output/vmsdiqjm- /home/sid/tuning/finetune/backend/output/vmsdiqjm-7013/adapter...
|
False
|
Edit
Delete
|
|
29eadba5-d0e2-4096-b21d-fffa914233e9
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
phldjgjp-4272
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Effects of food
|
Effects of food restriction on aging
|
/home/sid/tuning/finetune/backend/output/phldjgjp- /home/sid/tuning/finetune/backend/output/phldjgjp-4272/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This study, published in Proceedings of the Nation This study, published in Proceedings of the National Academy of Sciences (1984), investigates the effects of food restriction on aging, specifically aiming to disentangle the roles of reduced food intake and reduced adiposity on longevity and physiological aging markers in mice. The research focuses on genetically obese (ob/ob) and normal (C57BL/6J, or B6 +/+) female mice, examining how lifelong food restriction influences longevity, collagen aging, renal function, and immune responses. The key finding is that reduced food intake, rather than reduced adiposity, is the critical factor in extending lifespan and retarding certain aging processes.
Background and Objective
Food restriction (caloric restriction) is known to increase longevity in rodents, but the underlying mechanism remains unclear.
Previous studies suggested that reduced adiposity (body fat) might mediate the longevity effects. However, human epidemiological data show conflicting evidence: moderate obesity correlates with lower mortality, challenging the assumption that less fat is always beneficial.
Genetically obese ob/ob mice provide a model to separate effects because they maintain high adiposity even when food restricted.
The study aims to clarify whether reduced food intake or reduced adiposity is the primary driver of delayed aging and increased longevity.
Experimental Design
Subjects: Female mice of the C57BL/6J strain, both normal (+/+) and genetically obese (ob/ob).
Feeding Regimens:
Fed ad libitum (free access to food).
Restricted feeding: fixed ration daily, adjusted so restricted ob/ob mice weigh similarly to fed +/+ mice.
Food restriction started at weaning (4 weeks old) and continued lifelong.
Parameters measured:
Longevity (mean and maximum lifespan).
Body weight, adiposity (fat percentage), and food intake.
Collagen aging assessed by denaturation time of tail tendon collagen.
Renal function measured via urine-concentrating ability after dehydration.
Immune function evaluated by thymus-dependent responses: proliferative response to phytohemagglutinin (PHA) and plaque-forming cells in response to sheep erythrocytes (SRBC).
Key Quantitative Data
Group Food Intake (g/day) Body Weight (g) Body Fat (% of wt) Mean Longevity (days) Max Longevity (days) Immune Response to SRBC (% Young Control) Immune Response to PHA (% Young Control)
Fed ob/ob 4.2 ± 0.5 67 ± 5 ~66% 755 893 7 ± 7 13 ± 7
Fed +/+ 3.0* 30 ± 1* 22 ± 6 971 954 22 ± 11 49 ± 12
Restricted ob/ob 2.0* 28 ± 2 48 ± 1 823 1307 11 ± 7 8 ± 6
Restricted +/+ 2.0* 20 ± 2* 13 ± 3 810 1287 59 ± 30 50 ± 11
Note: Means not significantly different from each other are marked with an asterisk (*).
Detailed Findings
1. Body Weight, Food Intake, and Adiposity
Fed ob/ob mice consume the most food and have the highest body fat (~66% of body weight).
When food restricted, ob/ob mice consume about half as much food as when fed ad libitum but maintain a very high adiposity (~48%), nearly twice that of fed normal mice.
Restricted normal mice have the lowest fat percentage (~13%) despite eating the same amount of food as restricted ob/ob mice.
This demonstrates that food intake and adiposity can be experimentally dissociated in these genotypes.
2. Longevity
Food restriction increased mean lifespan of ob/ob mice by 56% and maximum lifespan by 46%.
In normal mice, food restriction had little effect on mean longevity but increased maximum lifespan by 32%.
Food-restricted ob/ob mice lived longer than fed normal mice, despite their greater adiposity.
These results strongly suggest that reduced food intake, not reduced adiposity, extends lifespan, even with high body fat levels.
3. Collagen Aging
Collagen denaturation time is a biomarker of aging, with shorter times indicating more advanced aging.
Collagen aging is accelerated in fed ob/ob mice compared to normal mice.
Food restriction greatly retards collagen aging in both genotypes.
Importantly, collagen aging rates were similar in restricted ob/ob and restricted +/+ mice, despite widely different body fat percentages.
Conclusion: Collagen aging correlates with food intake but not with adiposity.
4. Renal Function (Urine-Concentrating Ability)
Urine-concentrating ability declines with age in normal rodents.
Surprisingly, fed ob/ob mice did not show an age-related decline; their concentrating ability remained high into old age.
Restricted mice (both genotypes) showed a slower decline than fed normal mice.
This suggests obesity does not necessarily impair this aspect of renal function, and food restriction preserves it.
5. Immune Function
Immune responses (to PHA and SRBC) decline with age, more severely in fed ob/ob mice (only ~10% of young normal levels at old age).
Food restriction did not improve immune responses in ob/ob mice, even though their lifespans were extended.
In restricted normal mice, immune responses showed slight improvement compared to fed normal mice.
The spleens of restricted ob/ob mice were smaller, which might contribute to low immune responses measured per spleen.
These results suggest immune aging may be independent from longevity effects of food restriction, especially in genetically obese mice.
The more rapid decline in immune function with higher adiposity aligns with previous reports that increased dietary fat accelerates autoimmunity and immune decline.
Interpretation and Conclusions
The study disentangles two factors often conflated in aging research: food intake and adiposity.
Reduced food intake is the primary factor in extending lifespan and slowing collagen aging, not the reduction of body fat.
Genetically obese mice restricted in food intake live longer than normal mice allowed to eat freely, despite retaining high body fat levels.
Aging appears to involve multiple independent processes (collagen aging, immune decline, renal function), each affected differently by genetic obesity and food restriction.
The study also highlights that immune function decline is not necessarily mitigated by food restriction in obese mice, suggesting complexities in how different physiological systems age.
Findings challenge the assumption that less fat is always beneficial, offering a potential explanation for human studies showing moderate obesity correlates with lower mortality.
The results support the idea that reducing food consumption can be beneficial even in individuals with high adiposity, with implications for aging and metabolic disease research.
Implications for Human Aging and Obesity
The study cautions against equating adiposity directly with aging rate or mortality risk without considering food intake.
It suggests that caloric restriction may improve longevity even when body fat remains high, which may help reconcile conflicting human epidemiological data.
The authors note that micronutrient supplementation along with food restriction could further optimize longevity outcomes, based on related studies.
Core Concepts
Food Restriction (Caloric Restriction): Limiting food intake without malnutrition.
Adiposity: The proportion of body weight composed of fat.
ob/ob Mice: Genetically obese mice with a mutation causing defective leptin production, leading to obesity.
Longevity: Length of lifespan.
Collagen Aging: Changes in collagen denaturation time indicating tissue aging.
Immune Senescence: Decline in immune function with age.
Renal Function: Kidney’s ability to concentrate urine, an indicator of aging-related physiological decline.
References to Experimental Methods
Collagen aging measured by denaturation times of tail tendon collagen in urea.
Urine osmolality measured by vapor pressure osmometer after dehydration.
Immune function assessed by PHA-induced splenic lymphocyte proliferation in vitro and plaque-forming cell responses to SRBC in vivo.
Body fat measured chemically via solvent extraction of dehydrated tissue samples.
Summary Table of Aging Markers by Group
Marker Fed ob/ob Fed +/+ Restricted ob/ob Restricted +/+ Interpretation
Body Fat (%) ~66 22 ~48 13 Ob/ob mice retain high fat even restricted
Mean Lifespan (days) 755 971 823 810 Food restriction increases lifespan in ob/ob mice
Max Lifespan (days) 893 954 1307 1287 Max lifespan improved by restriction
Collagen Aging Rate Fast (accelerated) Normal Slow (retarded) Slow (retarded) Related to food intake, not adiposity
Urine Concentrating Ability High, no decline with age Declines with age Declines slowly Declines slowly Obesity does not impair this function
Immune Response Severely reduced (~10%) Moderately reduced Severely reduced (~10%) Slightly improved Immune aging not improved by restriction in obese mice
Key Insights
Longevity extension by food restriction is independent of adiposity levels.
Collagen aging is directly related to food consumption, not fat content.
Obesity does not necessarily impair certain renal functions during aging.
Immune function decline with age is exacerbated by obesity but is not rescued by food restriction in obese mice.
Aging is a multifactorial process with independent physiological components.
Final Remarks
This comprehensive study provides compelling evidence that lifespan extension by food restriction is primarily driven by the reduction in caloric intake rather than by decreased fat mass. It highlights the complexity of aging, showing that different physiological systems age at different rates and respond differently to genetic and environmental factors. The findings have significant implications for understanding obesity, aging, and dietary interventions in mammals, including humans.
Smart Summary...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/phldjgjp-4272/data/document.pdf", "num_examples": 31, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/phldjgjp- /home/sid/tuning/finetune/backend/output/phldjgjp-4272/data/phldjgjp-4272.json...
|
null
|
completed
|
1764955700
|
1764956233
|
NULL
|
/home/sid/tuning/finetune/backend/output/phldjgjp- /home/sid/tuning/finetune/backend/output/phldjgjp-4272/adapter...
|
False
|
Edit
Delete
|
|
99f8913c-f568-4e6c-af30-06ce594c932e
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
zgnfbvmb-7086
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Effects of longevity
|
Effects of longevity and mortality
|
/home/sid/tuning/finetune/backend/output/zgnfbvmb- /home/sid/tuning/finetune/backend/output/zgnfbvmb-7086/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Mugi: Effects of Mortality and Longevity Risk in R Mugi: Effects of Mortality and Longevity Risk in Risk Management in Life Insurance Companies is a clear and rigorous exploration of how mortality risk (people dying earlier than expected) and longevity risk (people living longer than expected) affect the financial stability, pricing, reserving, and strategic management of life insurance companies. The report explains why longevity—usually celebrated from a public health perspective—creates serious financial challenges for insurers, pension funds, and annuity providers.
The central message:
As people live longer, life insurance companies face rising liabilities, growing uncertainty, and the need for advanced risk-management tools to remain solvent and competitive.
🧩 Core Themes & Insights
1. Mortality vs. Longevity Risk
The paper distinguishes two opposing risks:
Mortality Risk (Life insurance)
People die earlier than expected → insurers pay out death benefits sooner → financial losses.
Longevity Risk (Annuities & Pensions)
People live longer than expected → insurers must keep paying benefits for more years → liabilities increase.
Longevity risk is now the dominant threat as global life expectancy rises.
2. Why Longevity Risk Is Growing
The study highlights several forces:
Continuous declines in mortality
Medical advances extending life
Rising survival at older ages
Uncertainty in future mortality trends
Rapid global population aging
For insurers offering annuities, pension guarantees, or long-term products, this creates a systemic, long-horizon risk that is difficult to hedge.
3. Impact on Life Insurance Companies
Longevity risk affects insurers in multiple ways:
A. Pricing & Product Design
Annuities become more expensive to offer
Guarantees become riskier
Traditional actuarial assumptions become outdated faster
B. Reserving & Capital Requirements
Companies must hold larger technical reserves
Regulators impose stricter solvency requirements
Balance sheets become more volatile
C. Profitability & Shareholder Value
Longer lifespans → higher liabilities → reduced profit margins unless risks are hedged.
4. Tools to Manage Longevity Risk
The paper reviews modern strategies used globally:
A. Longevity Swaps
Transfer longevity exposure to reinsurers or investors.
B. Longevity Bonds / Mortality-Linked Securities
Payments tied to survival rates; spreads risk to capital markets.
C. Reinsurance
Traditional method for offloading part of the risk.
D. Hedging Through Natural Offsets
Balancing life insurance (benefits paid when people die early) with annuities (benefits paid when people live long).
E. Improving Mortality Modeling
Using:
Lee–Carter models
Stochastic mortality models
Scenario stress testing
Cohort analysis
Accurate forecasting is critical—even small misestimates of future mortality can cost insurers billions.
5. Risk Management Framework
A strong longevity risk program includes:
identifying exposures
assessing potential solvency impacts
using internal models
scenario analysis (e.g., “life expectancy improves by +3 years”)
hedging and reinsurance
regulatory capital alignment
The goal is maintaining solvency under a variety of demographic futures.
6. Global Context
Countries with rapidly aging populations (Japan, Western Europe, China) face the strongest longevity pressures.
Regulators worldwide are:
requiring better capital buffers
encouraging transparency
exploring longevity-linked capital market instruments
🧭 Overall Conclusion
Longevity, though positive for individuals and society, represents a major financial uncertainty for life insurers. Rising life expectancy increases long-term liabilities and challenges traditional actuarial models. To remain stable, life insurance companies must adopt modern risk-transfer tools, advanced mortality modeling, diversified product portfolios, and robust solvency management.
The paper positions longevity risk as one of the most critical issues for the future of global insurance and pension systems....
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/zgnfbvmb-7086/data/document.pdf", "num_examples": 88, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/zgnfbvmb- /home/sid/tuning/finetune/backend/output/zgnfbvmb-7086/data/zgnfbvmb-7086.json...
|
null
|
completed
|
1764876697
|
1764884717
|
NULL
|
/home/sid/tuning/finetune/backend/output/zgnfbvmb- /home/sid/tuning/finetune/backend/output/zgnfbvmb-7086/adapter...
|
False
|
Edit
Delete
|
|
c8b196e5-8425-4722-a1a3-507fa7c486b5
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
ogcxnfqq-3811
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Electronics Development
|
Electronics in the Development Modern Medicine
|
/home/sid/tuning/finetune/backend/output/ogcxnfqq- /home/sid/tuning/finetune/backend/output/ogcxnfqq-3811/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
The provided document is the "2008 On-Line ICU The provided document is the "2008 On-Line ICU Manual" from Boston Medical Center, a comprehensive educational guide authored by Dr. Allan Walkey and Dr. Ross Summer. This handbook is specifically designed for resident trainees rotating through the Medical Intensive Care Unit (MICU). The primary goal is to facilitate the learning of critical care medicine by providing structured resources that integrate with the hospital's educational curriculum, which includes didactic lectures, hands-on tutorials, and clinical morning rounds. The manual is meticulously organized into folders covering essential critical care topics, ranging from oxygen delivery and mechanical ventilation strategies to cardiovascular emergencies, sepsis and shock management, vasopressors, and diagnostic procedures like reading chest X-rays and acid-base analysis. It provides concise topic summaries, relevant literature reviews, and BMC-approved clinical protocols to assist residents in making evidence-based clinical decisions at the bedside.
Key Points, Topics, and Headings
I. Educational Framework
Target Audience: Resident trainees at Boston Medical Center (BMC).
Goal: To facilitate learning in the Medical Intensive Care Unit (MICU).
Structure:
Topic Summaries: 1-2 page handouts designed for quick reference.
Literature: Original and review articles for comprehensive understanding.
Protocols: Official BMC clinical guidelines.
Curriculum Support: Designed to supplement didactic lectures, hands-on tutorials (e.g., ventilators, ultrasound), and morning rounds.
II. Respiratory Management & Mechanical Ventilation
Oxygen Delivery:
Oxygen Cascade: Describes the process of declining oxygen tension from the atmosphere (159 mmHg) to the mitochondria.
Equation:
DO2=[1.34×Hb×SaO2+(0.003×PaO2)]×C.O.
* Devices:
Variable Performance: Nasal cannula (approx. +3% FiO2 per liter up to 40%), Face masks (FiO2 varies).
Fixed Performance: Non-rebreather masks (theoretically 100%, usually 70-80%).
Mechanical Ventilation:
Initiation: Volume Control mode (AC or SIMV), Tidal Volume (TV) 6-8 ml/kg, Rate 12-14, FiO2 100%, PEEP 5 cmH2O.
Monitoring: Check ABG in 20 mins; watch for Peak Pressures > 35 cmH2O (indicates lung compliance issues vs. airway obstruction).
ARDS (Acute Respiratory Distress Syndrome):
Criteria: PaO2/FiO2 < 200, bilateral infiltrates, no cardiogenic cause (PCWP < 18).
ARDSNet Protocol: Lung-protective strategy using low tidal volumes (6 ml/kg Ideal Body Weight) and keeping plateau pressure < 30 cmH2O.
Weaning & Extubation:
SBT (Spontaneous Breathing Trial): 30-minute trial off pressure support/PEEP to assess readiness.
Cuff Leak Test: Assess for laryngeal edema before extubation. A leak > 25% is adequate; no leak indicates high risk of stridor.
NIPPV (Non-Invasive Ventilation): Indicated for COPD exacerbations, pulmonary edema, and pneumonia to avoid intubation. Contraindicated if patient cannot protect airway.
III. Cardiovascular & Shock Management
Severe Sepsis & Septic Shock:
Definition: SIRS (fever, tachycardia, tachypnea, leukocytosis) + Infection + Organ Dysfunction + Hypotension.
Key Interventions: Early broad-spectrum antibiotics (mortality rises 7% per hour delay), aggressive fluid resuscitation (2-3L NS initially), and early vasopressors.
Pressors: Norepinephrine (first line), Vasopressin (second line).
Vasopressors:
Norepinephrine: Alpha and Beta agonist; standard for sepsis.
Dopamine: Dose-dependent effects (Renal at low dose, Cardiac/BP support at higher doses).
Dobutamine: Beta agonist (Inotrope) for cardiogenic shock.
Phenylephrine: Pure alpha agonist (vasoconstriction) for neurogenic shock.
Massive Pulmonary Embolism (PE):
Treatment: Anticoagulation (Heparin).
Unstable: Thrombolytics.
Contraindications: IVC Filter.
IV. Diagnostics & Critical Thinking
Chest X-Ray (CXR) Reading:
5-Step Approach: Confirm ID, Penetration, Alignment, Systematic Review (Tubes, Bones, Cardiac, Lungs).
Key Findings: Pneumothorax (Deep sulcus sign in supine), CHF (Bat-wing appearance), Effusions.
Acid-Base Disorders:
8-Step Approach: pH, pCO2, Anion Gap (Gap = Na - Cl - HCO3).
Mnemonics:
High Gap Acidosis: MUDPILERS (Methanol, Uremia, DKA, Paraldehyde, Isoniazid, Lactic Acidosis, Ethylene Glycol, Renal Failure, Salicylates).
Presentation: Easy Explanation of ICU Concepts
Slide 1: Introduction to ICU Manual
Context: 2008 Handbook for Boston Medical Center residents.
Goal: To facilitate learning in critical care medicine.
Format: Topic Summaries, Literature, and Protocols.
Takeaway: Use this manual as a bedside reference to support clinical decisions.
Slide 2: Oxygenation & Ventilator Basics
The Goal: Deliver oxygen (
O2
) to tissues without hurting the lungs (barotrauma).
Start-Up Settings:
Mode: Volume Control (AC or SIMV).
Tidal Volume: 6-8 ml/kg (don't blow out the lungs!).
PEEP: 5 cmH2O (keeps alveoli open).
Devices:
Nasal Cannula: Low oxygen, comfortable, variable performance.
Non-Rebreather: High oxygen, tight seal required, fixed performance.
Slide 3: ARDS & The "Lung Protective" Strategy
What is it? Non-cardiogenic pulmonary edema causing severe hypoxemia.
The ARDSNet Rule (Gold Standard):
Tidal Volume: Set low at 6 ml/kg of Ideal Body Weight.
Plateau Pressure Goal: < 30 cmH2O.
Why? High pressures damage healthy lung tissue (barotrauma).
Rescue Therapy: Prone positioning (turn patient on stomach), High PEEP, Paralytics.
Slide 4: Weaning from the Ventilator
Daily Check: Is the patient ready to breathe on their own?
The Test: Spontaneous Breathing Trial (SBT).
Turn off pressure support/PEEP for 30 mins.
Watch patient: Are they comfortable? Is
O2
okay?
Before Extubation: Do a Cuff Leak Test.
Deflate the cuff; if air leaks around the tube, the throat isn't swollen.
If no leak, high risk of choking/stridor. Give steroids.
Slide 5: Sepsis & Shock Management
Time is Tissue!
Antibiotics: Give immediately. Every hour delay = higher death rate (7% per hour).
Fluids: 2-3 Liters Normal Saline.
Pressors: Norepinephrine if BP is still low (<60 MAP).
Steroids: Only for pressor-refractory shock.
Slide 6: Vasopressor Cheat Sheet
Norepinephrine (Norepi): The go-to drug for Sepsis. Tightens vessels and helps heart slightly.
Dopamine: "Jack of all trades."
Low dose: Renal effects.
Medium dose: Heart effects.
High dose: Pressor effects.
Dobutamine: Focuses on the heart (makes it squeeze harder). Good for heart failure.
Phenylephrine: Pure vessel constrictor. Good for Neurogenic shock (spine injury).
Epinephrine: Alpha/Beta. Good for Anaphylaxis or ACLS.
Slide 7: Diagnostics - CXR & Acids-Base
Reading CXR:
Check lines/tubes first!
Pneumothorax: Look for "Deep Sulcus Sign" (hidden air in supine patients).
CHF: "Bat wing" infiltrates, Kerley B lines.
Acid-Base (The "Gap"):
Formula:
Na−Cl−HCO3
.
If Gap is High (>12): Think MUDPILERS.
Common culprits: Lactic Acidosis (sepsis/shock), DKA, Uremia.
Review Questions
What is the "ARDSNet" tidal volume goal and why is it important?
Answer: 6 ml/kg of Ideal Body Weight. It is crucial to prevent barotrauma (volutrauma) and further lung injury in patients with ARDS.
A patient with septic shock remains hypotensive after fluid resuscitation. Which vasopressor is recommended first-line?
Answer: Norepinephrine.
Why is the "Cuff Leak Test" performed prior to extubation?
Answer: To assess for laryngeal edema. If there is no cuff leak (less than 25% volume leak), the patient is at high risk for post-extubation stridor.
According to the manual, how does mortality change with delayed antibiotic administration in septic shock?
Answer: Mortality increases by approximately 7% for every hour of delay in administering appropriate antibiotics.
What does the mnemonic "MUDPILERS" represent in acid-base interpretation?
Answer: Causes of High Anion Gap Metabolic Acidosis: Methanol, Uremia, DKA, Paraldehyde, Isoniazid, Lactic Acidosis, Ethylene Glycol, Renal Failure, Salicylates.
What specific finding on a Chest X-Ray of a supine patient might indicate a pneumothorax?
Answer: The "Deep Sulcus Sign" (a deep, dark costophrenic angle).
Does early tracheostomy (within 1st week) reduce mortality?
Answer: No. It reduces time on the ventilator and ICU length of stay, and improves patient comfort/rehabilitation, but it does not alter mortality...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/ogcxnfqq-3811/data/document.pdf", "num_examples": 164, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/ogcxnfqq- /home/sid/tuning/finetune/backend/output/ogcxnfqq-3811/data/ogcxnfqq-3811.json...
|
null
|
queued
|
1769454610
|
1769455129
|
NULL
|
/home/sid/tuning/finetune/backend/output/ogcxnfqq- /home/sid/tuning/finetune/backend/output/ogcxnfqq-3811/adapter...
|
False
|
Edit
Delete
|
|
ec4dd73a-8133-431e-9be7-14937289f402
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
rpqusbca-8795
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Energy Poverty and Life
|
Energy Poverty and Life Expectancy in Nigeria
|
/home/sid/tuning/finetune/backend/output/rpqusbca- /home/sid/tuning/finetune/backend/output/rpqusbca-8795/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This study investigates the impact of energy pover This study investigates the impact of energy poverty on life expectancy in Nigeria over the period from 1981 to 2023. Utilizing time series data and the Autoregressive Distributed Lag (ARDL) model, the research examines both short-run and long-run effects, revealing a statistically significant negative relationship between energy poverty and life expectancy. The study emphasizes the critical role of energy access as a determinant of public health and longevity, urging policy reforms to improve energy infrastructure and accessibility in Nigeria to enhance health outcomes and sustainable development.
Key Concepts
Term Definition/Explanation
Life Expectancy Average number of years a newborn is expected to live, given current sex- and age-specific mortality rates.
Energy Poverty Lack of access to affordable, reliable, and clean energy services, including electricity and clean cooking fuels.
ARDL Model An econometric technique used to estimate both short-run and long-run relationships in time series data.
Sustainable Development Goals (SDGs) United Nations goals, including Goal 3 (Health and Well-being) and Goal 7 (Affordable and Clean Energy).
Background and Context
Nigeria faces a persistent energy crisis, with about 43% of the population (86 million people) lacking access to reliable and modern energy.
Life expectancy in Nigeria is significantly lower than the global average, estimated at 54.9 years for women and 54.3 years for men, compared to global averages of 76 and 70.7 years respectively.
Energy poverty in Nigeria manifests through:
Limited electricity access.
Dependence on biomass and kerosene for cooking.
Frequent power outages affecting households, hospitals, and public infrastructure.
Existing government policies (e.g., National Health Policy, Renewable Energy Master Plan) have not sufficiently improved energy access or life expectancy.
Life expectancy is a key indicator of national development and is strongly influenced by socioeconomic and infrastructural factors.
Theoretical Framework
The study is grounded in Human Capital Theory (Schultz, Becker), which posits that investments in health, education, and other social services enhance individual productivity and contribute to overall economic growth and well-being.
Access to modern energy is viewed as a critical enabler of:
Health services.
Clean environments.
Improved living standards.
Energy poverty undermines health by increasing exposure to harmful fuels and limiting access to healthcare, thereby shortening life expectancy.
Empirical Literature Highlights
Roy (2025): Clean energy access significantly increases life expectancy globally.
Olise (2025): Kerosene positively affects quality of life in Nigeria in the short and long run; premium motor spirit negatively affects life expectancy; electricity consumption had no significant impact.
Onisanwa et al. (2024): Socioeconomic factors including income, education, urbanization, and environmental degradation determine life expectancy in Nigeria.
Fan et al. (2024): Energy poverty adversely affects public health, especially in developed regions.
Abu & Orisa-Couple (2022): Unsafe energy sources (kerosene, generators) cause burns and mortality in Port Harcourt.
Okorie & Lin (2022): Energy poverty increases risk of catastrophic health expenditure among Nigerian households.
Onwube et al. (2021): Real GDP per capita, household consumption, and exchange rates positively influence life expectancy; inflation and imports have negative effects.
Data and Methodology
Data: Annual time series data (1981-2023) from World Bank’s World Development Indicators and Global Database of Inflation.
Variables:
Variable Description Expected Sign
LFE Life expectancy at birth Dependent
EPOV Energy poverty (access to electricity and clean cooking fuels) Negative (β1 < 0)
GDPK GDP per capita (constant 2015 US$) Positive (β2 > 0)
GHEX Government health expenditure per capita Positive (β3 > 0)
PVL Prevalence of undernourishment (%) Negative (β4 < 0)
LTR Literacy rate (secondary school enrollment %) Positive (β5 > 0)
Econometric Approach:
Stationarity tested using Augmented Dickey-Fuller (ADF) and Phillips-Perron (PP) tests.
Cointegration tested via ARDL Bounds testing.
Short-run and long-run relationships estimated using ARDL and Error Correction Model (ECM).
Descriptive Statistics
Variable Mean Min Max Std. Dev Notes
Life Expectancy (LFE) 48.78 yrs 45.49 yrs 54.59 yrs 2.87 Moderate variability over time
Energy Poverty (EPOV) 52.59% 28.20% 86.10% 13.60 Volatile energy poverty environment
GDP per capita (GDPK) $1922.55 $1408.21 $2679.56 466.60 Modest economic growth
Govt. Health Expenditure (GHEX) $6.73 $0.30 $15.84 5.62 Low health spending
Prevalence of Undernourishment (PVL) 10.61% 6.50% 19.00% 2.68 Moderate food insecurity
Literacy Rate (LTR) 33.31% 17.41% 54.88% 9.79 Low to moderate literacy
Correlation Matrix Summary
Positive moderate correlation with life expectancy: GDP per capita (0.651), government health expenditure (0.598), literacy rate (0.434).
Negative correlation: Energy poverty (-0.450).
Low correlation: Prevalence of undernourishment (0.333).
Unit Root and Cointegration Tests
Energy poverty (EPOV) stationary at level (I(0)).
Life expectancy (LFE), GDP per capita (GDPK), government health expenditure (GHEX), prevalence of undernourishment (PVL), and literacy rate (LTR) stationary at first difference (I(1)).
ARDL Bounds test confirmed cointegration, indicating a stable long-run relationship between energy poverty and life expectancy.
Regression Results
Variable Short-Run Coefficient Significance Long-Run Coefficient Significance Interpretation
Energy Poverty (EPOV) -0.299 Significant -0.699 Highly significant Energy poverty reduces life expectancy both short and long term; effect stronger over time.
GDP per capita (GDPK) 0.026 Insignificant 0.332 Significant Economic growth positively affects life expectancy, especially in the long run.
Govt. Health Expenditure (GHEX) 0.071 Significant -0.054 Insignificant Short-run benefits of health spending on life expectancy, but no significant long-run effect.
Prevalence of Undernourishment (PVL) -0.377 Significant -0.225 Significant Food insecurity negatively impacts life expectancy both short and long term.
Literacy Rate (LTR) 0.003 Insignificant 0.044 Marginal Positive but insignificant effect on life expectancy.
Error Correction Term -0.077 Highly significant Not specified Not specified Adjusts 77% of deviation from equilibrium each year, confirming model stability.
Diagnostic and Stability Tests
Breusch-Godfrey Serial Correlation LM test, Breusch-Pagan-Godfrey Heteroskedasticity test, and Ramsey RESET test showed no serial correlation, heteroskedasticity, or misspecification—indicating a robust model.
CUSUM and CUSUMSQ tests confirmed no structural breaks or parameter instability in the model over the study period.
Timeline of Key Trends (1981–2023)
Period Life Expectancy Trend Energy Poverty Trend Key Events/Context
1981–1995 Below 46.7 years, stagnant Increasing energy poverty Structural Adjustment era, economic challenges
1999–2003 Slight increase to ~47.2 years Fluctuations in energy poverty Transition to civilian rule, policy shifts
2003–2023 Gradual sustained increase to 54.6 years Sharp surge in energy poverty from 2010 onward Population growth, poor infrastructure, subsidy removal
Policy Recommendations
Prioritize Energy Sector Reforms:
Expand on-grid power generation and improve transmission and distribution infrastructure.
Promote affordable off-grid renewable energy solutions and clean cooking technologies.
Stabilize energy prices and enhance reliability of energy supply.
Increase and Improve Public Health Expenditure:
Boost healthcare infrastructure and access.
Implement institutional reforms to reduce corruption and improve resource allocation.
Address Food Insecurity:
Develop coordinated agricultural, nutritional, and welfare policies to reduce undernourishment.
Focus on Rural and Underserved Communities:
Target energy access expansion to marginalized populations to improve health and longevity.
Integrate Energy Policy with Health and Development Goals:
Align energy access initiatives with Sustainable Development Goals (SDG 3 and SDG 7).
Core Insights
Energy poverty significantly undermines life expectancy in Nigeria, with stronger effects observed over the long term.
Economic growth has a positive but delayed impact on life expectancy.
Public health expenditure improves life expectancy in the short run but shows diminished long-run effectiveness, likely due to governance challenges.
Food insecurity consistently reduces life expectancy.
Literacy improvements have a positive but statistically insignificant influence on longevity.
The relationship between energy poverty and life expectancy in Nigeria has remained stable over four decades despite policy efforts.
Keywords
Energy Poverty, Life Expectancy, Nigeria, ARDL Model, Sustainable Development Goals, Public Health, Economic Growth, Food Insecurity, Human Capital Theory.
Conclusion
This comprehensive empirical analysis confirms that energy poverty is a critical and persistent barrier to improving life expectancy in Nigeria. The negative impact of inadequate access to modern energy services on health outcomes necessitates urgent policy attention. Sustainable improvements in longevity will require integrated strategies that combine energy reforms, enhanced public health spending, food security measures, and economic growth, underpinned by strong institutional governance. Addressing energy poverty is not only vital for health but also essential for Nigeria’s broader development and achievement of international sustainability targets.
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/rpqusbca-8795/data/document.pdf", "num_examples": 150, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/rpqusbca- /home/sid/tuning/finetune/backend/output/rpqusbca-8795/data/rpqusbca-8795.json...
|
null
|
completed
|
1764955678
|
1764958175
|
NULL
|
/home/sid/tuning/finetune/backend/output/rpqusbca- /home/sid/tuning/finetune/backend/output/rpqusbca-8795/adapter...
|
False
|
Edit
Delete
|
|
4097b1ed-7d5c-4d83-b060-c1b9ec99eff8
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
futxkilq-8034
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
English for Medicine
|
English for Medicine
|
/home/sid/tuning/finetune/backend/output/futxkilq- /home/sid/tuning/finetune/backend/output/futxkilq-8034/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Description of the PDF File
This collection of do Description of the PDF File
This collection of documents serves as a robust, multidisciplinary curriculum designed to equip medical students with the linguistic, clinical, ethical, and systemic tools required for modern practice. The Medical Terminology and English for Medicine texts lay the foundational groundwork by teaching the specific language of medicine—breaking down complex terms into roots, prefixes, and suffixes—and exploring the historical evolution of medicine from ancient folk traditions to evidence-based science. The Fundamentals of Medicine Handbook translates this knowledge into practical clinical skills, guiding students through the nuances of patient-centered interviewing, physical examination techniques, and specialty assessments for geriatrics, pediatrics, and obstetrics. The Origins and History of Medical Practice expands the view to the macro level, explaining the business of healthcare, the "Eight Domains of Practice Management," and the "perfect storm" of challenges facing the US system. Finally, the Good Medical Practice document establishes the essential ethical and legal framework, emphasizing cultural safety, patient confidentiality, informed consent, and the mandatory duty to protect the public and report colleague misconduct. Together, these resources bridge the gap between learning medical vocabulary and becoming a responsible, ethical, and systems-aware physician.
Key Topics and Headings
I. The Language and History of Medicine
Medical Terminology: Decoding words using Roots (central meaning), Prefixes (location/time), and Suffixes (condition/procedure).
Word Building: Examples like Myocarditis (muscle + heart + inflammation) and Gastralgia (stomach + pain).
History of Medicine: Evolution from Hippocrates and the humoral theory to the scientific revolution and modern Evidence-Based Medicine (EBM).
Medicine as Art vs. Science: The balance of humanism/compassion (Art) with research/technology (Science).
Folk vs. Modern: The transition from alternative/folk healing to mainstream, institutionalized biomedicine.
II. The Healthcare System & Management
Practice Management: The "Eight Domains" (Business Operations, Finance, HR, Info Management, Governance, Patient Care, Quality, Risk).
System Structures: Solo practice, Group practice, and Integrated Delivery Systems (IDS).
The "Perfect Storm": The collision of rising costs, policy changes (ACA/MACRA), consumerism, and workforce issues.
The Medical Conundrum: The economic difficulty of simultaneously maximizing Quality, Access, and low Cost.
III. Professionalism and Ethics
Core Qualities: Altruism, Humanism, Honor, Integrity, Accountability, Excellence, Duty.
Cultural Safety: Respecting diverse cultures (specifically the Treaty of Waitangi) and understanding how a doctor's own culture impacts care.
Patient Rights: Informed consent, confidentiality, and privacy.
Professional Boundaries: Prohibitions on treating self/close family and sexual relationships with patients.
Mandatory Reporting: The duty to report colleagues who are impaired or pose a risk to patients.
IV. Clinical Communication & History Taking
Interviewing Models:
Patient-Centered (Year 1): Empathy, open-ended questions, understanding the "story."
Doctor-Centered (Year 2): Specific medical inquiry, diagnosis, "closing" the case.
History Components: Chief Complaint (CC), History of Present Illness (HPI), Past Medical/Surgical History, Family History, Social History.
Symptom Analysis: The "Classic Seven Dimensions" of symptoms (Onset, Precipitating factors, Quality, Radiation, Severity, Setting, Timing).
Review of Systems (ROS): A checklist to ensure no symptoms are missed.
V. Physical Examination & Clinical Skills
The Exam Routine: Vital Signs -> HEENT -> Neck -> Heart/Lungs -> Abdomen -> Extremities -> Neuro -> Psychiatric.
Documentation: The legal requirement for clear, accurate, and secure records.
Special Populations:
Geriatrics: ADLs vs. IADLs; Screening tools (DETERMINE, MMSE, Geriatric Depression Scale).
Pediatrics: Developmental milestones (Gross motor, Fine motor, Speech, Cognitive, Social).
OB/GYN: Gravida/Para definitions; menstrual and pregnancy history.
Study Questions
Terminology: Analyze the term Cardiomegaly. Identify the prefix, root, and suffix, and explain what the term means.
History & Language: How did the transition from "Humoral Theory" (Hippocrates) to the "Germ Theory" in the 19th century change the practice of medicine?
Systems: What are the "Eight Domains of Medical Practice Management," and why is understanding the business side of medicine (e.g., Finance, Governance) crucial for a modern physician?
Communication: Compare and contrast Patient-Centered Interviewing (Year 1) and Doctor-Centered Interviewing (Year 2). When in the encounter would you use each?
Clinical Skills: A patient presents with severe stomach pain. Using the "Classic Seven Dimensions" of a symptom, what specific questions would you ask to determine the Quality and Precipitating/Alleviating factors?
Ethics: According to Good Medical Practice, what is the definition of "Cultural Safety," and how does it relate to the Treaty of Waitangi?
Ethics: You discover a colleague is suffering from a condition that affects their judgment. What is your mandatory obligation regarding this situation?
Geriatrics: You are assessing an 80-year-old patient. Explain the difference between an ADL (e.g., bathing) and an IADL (e.g., managing medication), and why distinguishing them is vital for care planning.
OB/GYN: Define the terms Gravida, Para, Nulligravida, and Primipara.
The Conundrum: The "Perfect Storm" in healthcare involves the tension between Cost, Access, and Quality. Why does economic theory suggest it is difficult to achieve all three simultaneously?
Easy Explanation
The Five Pillars of Becoming a Doctor
Think of these documents as the five essential pillars that support a medical career:
The Dictionary (Medical Terminology & English for Medicine): Medicine has its own language. Before you can treat a patient, you need to learn the "code." You learn that -itis means inflammation, Cardio means heart, and Gastr means stomach. If you know the code, you can understand complex terms like Gastroenteritis without memorizing them one by one. You also learn where this language came from—ancient Greeks and Romans who laid the groundwork for science.
The Map (Origins and History): Medicine doesn't happen in a vacuum; it happens in a massive system. This section is your map. It shows you how medicine evolved from "magic" and "humors" to modern science and high-tech hospitals. It also shows you the "business" side—insurance, laws like the ACA, and the "Perfect Storm" of problems doctors face today (like high costs).
The Toolkit (Fundamentals of Medicine): This is your practical manual. It teaches you how to do the job. How do you talk to a patient so they trust you? (Patient-Centered Interviewing). How do you listen to their heart or check their reflexes? (Physical Exam). How do you check if an old person is forgetting things or a child is developing on time? (Special Populations).
The Rulebook (Good Medical Practice): Being smart isn't enough; you have to be good. This document sets the strict rules. It tells you: Don't sleep with your patients. Respect their culture. Keep their secrets. If you see another doctor being dangerous, you must report them. It is the legal and ethical shield for the profession.
The Context (Systems & Communication): You must learn to communicate across different levels—talking to patients (simple language), talking to colleagues (medical terminology), and talking to administrators (systems management).
Presentation Outline
Slide 1: Introduction – The Foundations of Medicine
Overview of the five pillars: Language, History, Systems, Skills, and Ethics.
Slide 2: Decoding the Language (Terminology)
The Formula: Root + Prefix + Suffix.
Examples: Hypertension (High BP), Cyanosis (Blue skin), Osteoporosis (Porous bones).
Color & Direction: Leuk/o (White), Erythr/o (Red); Sub- (Below), Endo- (Inside).
Slide 3: The Evolution of Medicine
Ancient Roots: Hippocrates and the Humoral Theory.
The Shift: From superstition to the Scientific Method and Germ Theory.
Modern Era: Evidence-Based Medicine (EBM) and specialized technology.
Slide 4: The Healthcare System & Management
The Business of Medicine: The 8 Domains (Finance, HR, Governance, Risk).
The "Perfect Storm": Managing the collision of Cost, Quality, and Access.
Practice Types: From solo doctors to massive Integrated Delivery Systems (IDS).
Slide 5: Clinical Communication
Year 1 (Patient-Centered): "Tell me your story." Empathy, listening, silence.
Year 2 (Doctor-Centered): "Let's find the diagnosis." Specific questions, medical facts.
Informed Consent: Ensuring patients truly understand their treatment options.
Slide 6: Clinical Assessment – History & Physical
History Taking: The 7 Dimensions of a symptom (Onset, Quality, Radiation, Severity, Setting, Timing, Associated symptoms).
The Exam: Standard Head-to-Toe approach (Vitals -> Heart/Lungs -> Abdomen -> Neuro).
Documentation: The legal necessity of accurate records.
Slide 7: Special Populations – The Whole Lifecycle
Geriatrics: Checking ADLs (Bathing/Dressing) vs. IADLs (Shopping/Money). Screening for memory (MMSE).
Pediatrics: Tracking milestones (Walking, talking, playing).
OB/GYN: Gravida/Para definitions.
Slide 8: Ethics & Professionalism
Core Values: Altruism, Integrity, Accountability.
Cultural Safety: Respecting diversity and the Treaty of Waitangi.
Boundaries: No treating self/family; maintaining professional distance.
Slide 9: Safety & Responsibility
Duty to Report: Protecting patients from impaired colleagues.
Open Disclosure: Owning up to mistakes and apologizing.
Self-Care: Doctors must have their own doctors too.
Slide 10: Summary – The Complete Physician
A doctor is a Linguist (Terminology), a Historian (Context), a Businessperson (Systems), a Clinician (Skills), and an Ethicist (Professional)....
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/futxkilq-8034/data/document.pdf", "num_examples": 52, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/futxkilq- /home/sid/tuning/finetune/backend/output/futxkilq-8034/data/futxkilq-8034.json...
|
null
|
queued
|
1769628282
|
1769634288
|
NULL
|
/home/sid/tuning/finetune/backend/output/futxkilq- /home/sid/tuning/finetune/backend/output/futxkilq-8034/adapter...
|
False
|
Edit
Delete
|
|
d0e8a441-782e-4148-b6d9-78d0b34bf1b7
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
cywxzdco-0053
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Enhance longevity through
|
Enhance longevity through a healthy lifestyle
|
/home/sid/tuning/finetune/backend/output/cywxzdco- /home/sid/tuning/finetune/backend/output/cywxzdco-0053/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
“Longevity Through a Healthy Lifestyle” is a compr “Longevity Through a Healthy Lifestyle” is a comprehensive research-based review that explains how everyday lifestyle choices—especially diet, physical activity, sleep, social connection, stress management, and hygiene—directly influence lifespan and overall health. Published in 2023 in Madhya Bharti (Humanities and Social Sciences), the article analyzes 46 research studies to determine which lifestyle factors most strongly promote long life and prevent disease.
The central message of the article is clear:
➡️ Healthy habits significantly extend lifespan and reduce the risk of chronic diseases—even more than genetics alone.
The authors explore global evidence, including lessons from Blue Zones (places with the world’s longest-living populations), to show how simple, consistent lifestyle behaviors lead to healthier, longer lives.
⭐ Main Themes and Findings
⭐ 1. Diet: The Foundation of Longevity
The article emphasizes that a nutritious, plant-rich, balanced diet is essential for preventing chronic diseases like diabetes, heart disease, cancer, and stroke.
Key findings:
Ideal diet proportions: 50–60% carbs, 10–15% protein, 25–30% healthy fats.
Nuts, fruits, vegetables, fish oils, and plant-based foods are linked to lower mortality.
Blue Zone communities eat mostly plant-based meals, with low calories and minimal processed foods.
Traditional Okinawan habits like “Hara Hachi Bu” (eating until 80% full) contribute to extremely long lifespans.
📌 Studies show plant-based diets reduce early death risk by 12–15%.
Longevity through a healthy lif…
⭐ 2. Regular Physical Activity
Movement is essential for preventing disease, improving mental health, and extending lifespan.
Important points:
Exercise prevents diabetes, depression, heart disease, obesity, and high blood pressure.
Even 15 minutes of moderate activity daily reduces mortality risk by 22%.
Blue Zone centenarians do not “exercise” formally—they stay active through gardening, walking, and daily chores.
Physical inactivity, driven by modern technology and sedentary lifestyles, shortens life expectancy.
📌 Exercise delays death and extends life, according to multiple studies.
Longevity through a healthy lif…
⭐ 3. Quality Sleep Supports Long Life
The article highlights sleep as an overlooked but vital pillar of health.
Key findings:
Adults should sleep 7–9 hours nightly.
Sleeping less than 5 hours increases risk of death by up to 15%.
Poor sleep contributes to diabetes, inflammation, obesity, and heart disease.
Too much sleep is also linked to poor health and shortened lifespan.
📌 Sleep quality strongly correlates with longevity and healthy aging.
Longevity through a healthy lif…
⭐ 4. Social Connections Protect Health
Strong, supportive relationships extend life by improving emotional, mental, and physical wellbeing.
Evidence shows:
Good social ties can increase lifespan by up to 50%.
Loneliness is biologically harmful—raising inflammation, stress, and disease risk.
Blue Zones foster deep community bonds, such as Okinawa’s “moai” (friend groups) and strong family ties.
📌 Social support improves immunity and reduces chronic disease risk.
Longevity through a healthy lif…
⭐ 5. Hygiene and Stress Management
Personal hygiene prevents infectious disease, which contributes significantly to maintaining long-term health.
Meanwhile, stress is labeled a “silent killer”, worsening diabetes, heart disease, and depression.
Key points:
Stress can reduce life expectancy by 2–3 years or more.
Meditation, mindfulness, breathing exercises, and relaxation techniques slow cellular aging.
Stress management improves mental, emotional, and physical health.
📌 Meditation and stress control improve longevity by slowing cellular aging.
Longevity through a healthy lif…
⭐ Overall Conclusion
The article concludes that a healthy lifestyle dramatically improves lifespan.
Across all 46 studies reviewed, the findings consistently show that:
Eating well
Moving regularly
Sleeping adequately
Maintaining relationships
Managing stress
Practicing hygiene
…are essential for extending both lifespan and healthspan (years lived in good health).
Genetics matter far less than daily habits.
The authors recommend that future research create effective lifestyle programs, while governments should promote health-based habits at all levels of society....
|
{"num_examples": 115, "bad_lines": {"num_examples": 115, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/cywxzdco- /home/sid/tuning/finetune/backend/output/cywxzdco-0053/data/cywxzdco-0053.json...
|
null
|
completed
|
1764364730
|
1764365452
|
NULL
|
/home/sid/tuning/finetune/backend/output/cywxzdco- /home/sid/tuning/finetune/backend/output/cywxzdco-0053/adapter...
|
False
|
Edit
Delete
|
|
f7f3213e-1270-4ffb-821c-694072765fe7
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
xxsdsakk-4069
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Estimates of the Heritabi
|
Estimates of the Heritability of Human Longevity
|
/home/sid/tuning/finetune/backend/output/xxsdsakk- /home/sid/tuning/finetune/backend/output/xxsdsakk-4069/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This investigation critically examines the heritab This investigation critically examines the heritability of human longevity, challenging prior estimates that have ranged between 15–30% by demonstrating that these figures are substantially inflated due to assortative mating—the nonrandom pairing of mates with respect to longevity-associated traits. Using an unprecedentedly large dataset derived from Ancestry public family trees, encompassing hundreds of millions of historical individuals primarily of European descent living in North America and Europe during the 19th and early 20th centuries, the authors applied advanced structural equation modeling to disentangle genetic, sociocultural, and assortative mating effects on lifespan correlations.
The study concludes that the true transferable variance (t²)—an upper bound on heritability (h²) that includes both genetic and sociocultural inherited factors—is well below 10% for birth cohorts across the 1800s and early 1900s. This suggests that earlier heritability estimates of longevity have been substantially overestimated because they did not adequately correct for assortative mating effects.
Key Concepts and Definitions
Term Definition
Heritability (h²) The fraction of phenotypic variance attributable to genetic variance.
Transferable variance (t²) Phenotypic variance due to all inherited factors, encompassing both genetic (h²) and sociocultural (b²) components, plus their covariance.
Sociocultural inheritance (b²) Non-genetic factors that influence phenotype and are transmitted through families (e.g., socioeconomic status).
Assortative mating (a) The correlation between latent genetic and sociocultural states of spouses that influences phenotypic correlations beyond genetic inheritance.
Nominal heritability Heritability estimated without correction for assortative mating or shared environment, typically based on correlation and additive relatedness.
Methodology Overview
Data Source: Aggregated and anonymized pedigrees (SAP) were created by collapsing 54 million publicly available Ancestry subscriber-generated family trees, resulting in over 831 million unique historical individuals linked by parent–child and spousal edges.
Data Quality Controls:
Removed self-edges and gender-incongruent parent-child edges.
Added missing spousal edges between parents.
Focused on individuals with known birth and death years who had offspring, limiting analysis primarily to birth cohorts from the early 1800s to 1920.
Addressed data artifacts such as birth year rounding.
Analysis Approach:
Estimated phenotypic correlations of lifespan between various relatives (siblings, cousins, spouses, in-laws).
Calculated nominal heritability using standard regression methods correcting for variance differences.
Developed and applied a structural equation model incorporating three key parameters:
Transferable variance (t²),
Inheritance coefficient (b),
Assortative mating coefficient (a).
Utilized correlations among siblings-in-law and cosiblings-in-law to solve for these parameters.
Applied an assortment-correction method using remote relative pairs and their in-law equivalents to validate estimates.
Timeline Table: Analytical Focus and Data Coverage
Period Data Characteristics and Focus
Pre-1700 Mostly European births; sparse data quality Not specified
1700–1800 Increasing data quality; European and North American births
1800–1920 Primary focus; high data quality; large sample sizes in millions
Post-1920 Decline in death-year data; excluded from lifespan analysis
Major Findings
1. Nominal Heritability Estimates Confirm Prior Literature but Are Inflated
Nominal heritability estimates for lifespan correlated with previous findings (15–30%).
Lifespan correlations among blood relatives were similar to past studies.
However, spouses and in-law relatives also showed substantial lifespan correlations, sometimes comparable to or exceeding those of blood relatives.
This indicated that shared environments and assortative mating inflate these estimates.
2. Assortative Mating Significantly Inflates Heritability Estimates
Assortative mating coefficient (a) was consistently high across all analyses, often exceeding 0.8, indicating strong nonrandom mating based on lifespan-influencing factors.
The presence of assortative mating causes phenotypic correlations between relatives to deviate from the linear relationship expected under pure additive genetics.
Correlations between in-law relatives (who do not share genetics) were substantial, confirming the importance of assortative mating rather than shared genetics alone.
3. Structural Equation Modeling Reveals True Transferable Variance (t²) Is <10%
Using sibling-in-law and cosibling-in-law correlations, the model estimated transferable variance (t²) consistently below 7% for all gender combinations and birth cohorts.
This t² value represents an upper bound on heritability (h²) because it includes both genetic and sociocultural transmitted factors.
The inheritance coefficient (b) was estimated between 0.40–0.45, slightly less than the genetic expectation of 0.5, reflecting combined genetic and sociocultural inheritance.
Shared household environmental effects were also quantified and found to be substantial but separate from transferable variance.
4. Independent Validation Using Remote Relatives Supports Low Heritability
Assortment-correction method applied to remote relatives (piblings, first cousins, first cousins once removed) and their in-law equivalents consistently estimated assortative mating coefficients (a) close to or above 0.5.
Transferable variance estimates from these analyses also remained below 10%, validating the sibling-in-law modeling approach.
5. Transferable Variance Decreases with Increasing Birth-Cohort Disparity Among Relatives
Lifespan correlation and transferable variance (t²) were higher when relatives were born closer in time; as the birth-year gap increased, t² declined significantly.
Assortative mating coefficient (a) remained stable across birth-year offsets, suggesting that the decline in transferable variance was not due to mating patterns.
This suggests that genetic and sociocultural factors affecting lifespan vary with historical context, likely reflecting changing environmental hazards and causes of death over time.
Quantitative Summary Table: Structural Equation Model Estimates by Birth Cohort
Birth Cohort Period Transferable Variance (t²) Assortative Mating Coefficient (a) Inheritance Coefficient (b) Shared Childhood Environment (csib) Shared Adult Environment (csp)
1800s–1830s ~5.9–6.5% (across relatives) ~0.68–0.88 ~0.40–0.44 ~4.3% (siblings) ~6.6% (spouses)
1840s–1870s ~4.0–5.5% ~0.53–0.88 ~0.40 ~5.1% ~5.0%
1880s–1910s ~4.0–7.2% ~0.43–0.89 ~0.40 ~6.0% ~4.4%
Values represent means across gender pairs with standard deviations; b fixed at 0.5 for some estimates; all data derived from sibling-in-law and remote relative analyses.
Core Insights
Previous heritability estimates of human longevity (~15–30%) are substantially inflated due to assortative mating.
True heritability (h²) is likely below 10%, and possibly considerably lower after accounting for sociocultural inheritance.
Assortative mating for lifespan-related factors is strong, with a coefficient often >0.8, indicating mates tend to share longevity-related traits, both genetic and environmental.
Sociocultural factors (e.g., socioeconomic status) are a significant inherited component influencing longevity, evidenced by lifespan correlations among in-law relatives and supported by sociological literature.
Transferable variance (t²) decreases as birth cohorts diverge, implying that historical environmental changes modulate the impact of inherited factors on longevity.
Fundamental biological aging processes (e.g., rate of hazard doubling) appear consistent historically, but lifespan-affecting factors mostly modify susceptibility to historically transient environmental hazards, not aging rate itself.
Implications
Genetic studies of longevity should account for assortative mating and sociocultural inheritance to avoid overestimating genetic contributions.
Interventions targeting environmental and sociocultural factors could have a larger impact on lifespan extension than currently assumed genetic predispositions.
Historical and birth cohort context is critical when interpreting heritability and lifespan data.
The biological basis of aging remains consistent, but its interaction with environment and social factors is dynamic and complex.
References to Relevant Literature Mentioned
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/xxsdsakk-4069/data/document.pdf", "num_examples": 206, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/xxsdsakk- /home/sid/tuning/finetune/backend/output/xxsdsakk-4069/data/xxsdsakk-4069.json...
|
null
|
completed
|
1764954903
|
1764958204
|
NULL
|
/home/sid/tuning/finetune/backend/output/xxsdsakk- /home/sid/tuning/finetune/backend/output/xxsdsakk-4069/adapter...
|
False
|
Edit
Delete
|
|
8d33df8f-073c-40f2-b556-1fe9b7531c38
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
enwnmsrg-5988
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Ethical Aspects of Human
|
Ethical Aspects of Human Genome Research in Sport
|
/home/sid/tuning/finetune/backend/output/enwnmsrg- /home/sid/tuning/finetune/backend/output/enwnmsrg-5988/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
“Ethical Aspects of Human Genome Research in Sport “Ethical Aspects of Human Genome Research in Sports”
you need to answer with
extract points
generate topics
create questions
build slides
make summaries
explain content in easy language
This is app-ready and human-friendly.
📘 Universal Description (App-Friendly & Easy Explanation)
Ethical Aspects of Human Genome Research in Sports is a review article that explains the ethical, legal, and human rights issues related to using genetic research and genetic technologies in sports. It focuses on how genetics can affect athletic performance, talent identification, training, injury prevention, and performance enhancement, while also raising serious ethical concerns.
The document explains that genetics plays a role in athletic ability, but athletic success depends on many factors, including training, environment, effort, and opportunity. It emphasizes that no single gene can determine whether someone will become a successful athlete.
The paper discusses genetic testing in sports, including its possible benefits (personalized training, injury prevention, nutrition planning) and its limitations (low predictive accuracy, risk of misuse, and lack of scientific certainty for talent selection).
A major focus of the document is ethics. It highlights risks such as:
genetic discrimination
loss of privacy
pressure on athletes to undergo testing
unfair advantages in competition
creation of a “genetic underclass” of athletes
The article strongly addresses gene doping, which means using genetic technologies to enhance performance rather than treat disease. It explains why gene doping is banned by the World Anti-Doping Agency (WADA) and how it threatens fairness, athlete health, and the integrity of sport.
The document also explains human rights and legal frameworks, especially in Europe. It refers to international agreements such as:
the Universal Declaration on the Human Genome and Human Rights
the Oviedo Convention (Human Rights and Biomedicine)
These frameworks protect human dignity, prohibit genetic discrimination, and restrict genetic modification for non-medical purposes.
Another key theme is informed consent and data protection. Athletes must voluntarily agree to genetic testing, understand risks and benefits, and have their genetic data kept private. The document warns about risks from direct-to-consumer genetic testing companies, including misuse of data and lack of proper counseling.
The paper concludes that while genetic research has potential benefits for health and training, it should not be used to select talent or enhance performance. Ethical oversight, strong laws, and international cooperation are essential to protect athletes and preserve fair competition.
🔑 Main Topics (Easy for Apps to Extract)
Sports genomics
Genetics and athletic performance
Ethical issues in sports genetics
Genetic testing in athletes
Gene doping
Fair play and equality in sports
Human rights and genetics
Privacy and genetic data protection
Legal regulation of genome research
Direct-to-consumer genetic testing
📌 Key Points (Presentation / Notes Friendly)
Athletic performance is influenced by genetics and environment
No single gene determines sports success
Genetic testing has limited predictive value
Gene doping is banned and unethical
Privacy and informed consent are essential
Genetic discrimination must be prevented
Ethics must guide genetic research in sports
🧠 One-Line Summary (Perfect for Quizzes & Slides)
Genetic research in sports offers potential health and training benefits but raises serious ethical, legal, and human rights concerns that require strict regulation and responsible use.
in the end you have to ask
If you want next, I can:
✔️ Create MCQ quizzes
✔️ Turn this into PowerPoint slides
✔️ Write very simple student notes
✔️ Generate exam questions
✔️ Make flashcards
Just tell me what you want next 👍...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/enwnmsrg-5988/data/document.pdf", "num_examples": 278, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/enwnmsrg- /home/sid/tuning/finetune/backend/output/enwnmsrg-5988/data/enwnmsrg-5988.json...
|
null
|
completed
|
1765653766
|
1765656206
|
NULL
|
/home/sid/tuning/finetune/backend/output/enwnmsrg- /home/sid/tuning/finetune/backend/output/enwnmsrg-5988/adapter...
|
False
|
Edit
Delete
|
|
e759ea7b-32c5-4335-8839-954d699944fc
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
svqrmoas-4307
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Ethics and profession
|
Ethics and profession
|
/home/sid/tuning/finetune/backend/output/svqrmoas- /home/sid/tuning/finetune/backend/output/svqrmoas-4307/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
. THE CORE CONCEPT
TOPIC HEADING:
Oral Health is . THE CORE CONCEPT
TOPIC HEADING:
Oral Health is Integral to General Health
EASY EXPLANATION:
The most important message is that the mouth is not separate from the rest of the body. The Surgeon General states clearly: "You cannot be healthy without good oral health." The mouth is essential for eating, speaking, and socializing, and it acts as a "mirror" that reflects the health of your entire body.
KEY POINTS:
Not Separate: Oral health and general health are the same thing; they should not be treated as separate entities.
Beyond Teeth: Oral health includes healthy gums, tissues, and bones, not just teeth.
Overall Well-being: Poor oral health leads to needless pain and suffering, which diminishes quality of life and affects social and economic opportunities.
The Mirror: The mouth often shows the first signs of systemic diseases (like diabetes or HIV).
2. HISTORY OF SUCCESS
TOPIC HEADING:
A History of Success: The Power of Prevention
EASY EXPLANATION:
Fifty years ago, most Americans expected to lose their teeth by middle age. Today, most people keep their teeth for a lifetime. This amazing success is largely thanks to science and the discovery of fluoride. We shifted from just "fixing" teeth to preventing disease before it starts.
KEY POINTS:
The Old Days: The nation was once plagued by toothaches and widespread tooth loss.
The Turning Point: Research proved that fluoride effectively prevents dental caries (cavities).
Public Health Achievement: Community water fluoridation is considered one of the great public health achievements of the 20th century.
Scientific Shift: We moved from simply "drilling and filling" to understanding that dental diseases are bacterial infections that can be prevented.
3. THE CRISIS (DISPARITIES)
TOPIC HEADING:
The "Silent Epidemic": Oral Health Disparities
EASY EXPLANATION:
Despite national progress, there is a hidden crisis. The Surgeon General calls it a "silent epidemic." This means that while the wealthy have healthy smiles, the poor, minorities, the elderly, and people with disabilities suffer from rampant, untreated oral disease. This is unfair, unjust, and largely avoidable.
KEY POINTS:
The Silent Epidemic: A term describing the high burden of hidden dental disease affecting the vulnerable.
Vulnerable Groups: Poor children, older Americans, racial/ethnic minorities, and people with disabilities.
The Consequence: These groups have the highest rates of disease but the least access to care.
Social Determinants: Where you live, your income, and your education level determine your oral health more than genetics.
4. THE STATISTICS (THE DATA)
TOPIC HEADING:
Oral Health in America: By the Numbers
EASY EXPLANATION:
The data shows that oral diseases are still very common in the United States. Millions of people suffer from untreated cavities, gum disease, and oral cancer. The financial cost of treating these problems is incredibly high.
KEY POINTS:
Children: 42.6% of children (ages 1–9) have untreated cavities in their baby teeth.
Adults: 24.3% of people (ages 5+) have untreated cavities in their permanent teeth.
Gum Disease: 15.7% of adults (ages 15+) have severe periodontal (gum) disease.
Tooth Loss: 10.2% of adults (20+) have lost all their teeth (edentulism).
Cancer: There are approximately 24,470 new cases of lip and oral cavity cancer annually.
Spending: The US spends $133.5 billion annually on dental care.
5. CAUSES & RISKS
TOPIC HEADING:
Risk Factors: Sugar, Tobacco, and Lifestyle
EASY EXPLANATION:
Oral health is heavily influenced by what we put into our bodies. The two biggest drivers of oral disease are sugar (which causes cavities) and tobacco (which causes cancer and gum disease). Commercial industries that market these products also play a huge role.
KEY POINTS:
Sugar: Americans consume a massive amount of sugar: 90.7 grams per person per day. This drives tooth decay.
Tobacco: 23.4% of the population uses tobacco, a major cause of gum disease and oral cancer.
Alcohol: Excessive alcohol consumption is a known risk factor for oral cancer.
Policy Gap: The U.S. does not currently have a tax on sugar-sweetened beverages (SSB), a policy recommended by the WHO to reduce sugar consumption.
6. THE MOUTH-BODY CONNECTION
TOPIC HEADING:
Systemic Health: The Mouth Affects the Body
EASY EXPLANATION:
The health of your mouth can directly affect the rest of your body. Oral infections can worsen other serious medical conditions. For example, gum disease makes it harder to control blood sugar in diabetics, and bacteria from the mouth can travel to the heart.
KEY POINTS:
Diabetes: There is a strong link between gum disease and diabetes; they make each other worse.
Heart & Lungs: Research points to associations between oral infections and heart disease, stroke, and respiratory infections.
Pregnancy: Poor oral health is linked to premature births and low-birth-weight babies.
Medication Side Effects: Many drugs cause dry mouth, which leads to cavities and gum disease.
7. ECONOMIC IMPACT
TOPIC HEADING:
The High Cost of Oral Disease
EASY EXPLANATION:
Oral disease is expensive. It costs billions of dollars to treat and results in billions of dollars lost in productivity because people miss work or school due to tooth pain.
KEY POINTS:
Spending: The US spends $133.5 billion annually on dental healthcare (approx. $405 per person).
Productivity Loss: The economy loses $78.5 billion due to missed work/school from oral problems.
Affordability: High out-of-pocket costs put economically insecure families at risk of poverty.
8. BARRIERS TO CARE
TOPIC HEADING:
Why Can't People Get Care?
EASY EXPLANATION:
Even though we have the technology to fix teeth, many Americans cannot access it. The main reasons are money (lack of insurance), location (living in rural areas), and time (can't take off work).
KEY POINTS:
Lack of Insurance: Dental insurance is less common than medical insurance. Only 15% are covered by the largest government scheme.
Cost: Dental care is often too expensive for low-income families.
Geography: People in rural areas often have to travel long distances to find a dentist.
Workforce: While there are ~200,000 dentists, they are often concentrated in wealthy areas, leaving rural and poor areas underserved.
9. SOLUTIONS & FUTURE ACTION
TOPIC HEADING:
A Framework for Action: The Call to Improve Oral Health
EASY EXPLANATION:
To fix the crisis, the nation needs to focus on prevention, policy change, and partnerships. We need to integrate dental care into general medical care and work to eliminate the disparities identified in the "silent epidemic."
KEY POINTS:
Prevention First: Focus on fluoride, sealants, and education rather than just drilling.
Integration: Medical and dental professionals must work together in teams (interprofessional care).
Policy Changes: Implement taxes on sugary drinks and expand insurance coverage (like Medicare).
Partnerships: Government, private industry, schools, and communities must collaborate to eliminate barriers.
Goals: Meet the objectives of Healthy People 2010/2030 to improve quality of life and eliminate health disparities.
HOW TO USE THIS FOR QUESTIONS:
Slide Topics: Use the Topic Headings directly as your slide titles.
Bullets: Use the Key Points as the bullet points on your slides.
Script: Read the Easy Explanations to guide what you say to the audience.
Quiz: Turn the Key Points into questions (e.g., "What percentage of children have untreated cavities?" or "Name two barriers to care.")....
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/svqrmoas-4307/data/document.pdf", "num_examples": 1488, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/svqrmoas- /home/sid/tuning/finetune/backend/output/svqrmoas-4307/data/svqrmoas-4307.json...
|
null
|
queued
|
1769093284
|
1769108437
|
NULL
|
/home/sid/tuning/finetune/backend/output/svqrmoas- /home/sid/tuning/finetune/backend/output/svqrmoas-4307/adapter...
|
False
|
Edit
Delete
|
|
832a3d87-3320-44f4-b7ad-8cc5da88b742
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
zmvqjlwa-5426
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
European Longevity Record
|
European Longevity Records
|
/home/sid/tuning/finetune/backend/output/zmvqjlwa- /home/sid/tuning/finetune/backend/output/zmvqjlwa-5426/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
European Longevity Records is a visually rich, dat European Longevity Records is a visually rich, data-driven document presenting verified supercentenarian records across Europe, organized by country. Using flags, icons, portrait photos, and highlighted record boxes, the document showcases the oldest known individuals from dozens of European nations, including their names, ages, birth/death years, and longevity rankings.
The booklet serves as a continental longevity atlas, featuring entries such as:
UK (England) – Charlotte Hughes
UK (Scotland) – Annie Knight
Spain – María Branyas Morera
Italy – Emma Morano
France – Jeanne Calment (the world’s oldest verified person)
Belgium – Joanna Distelmans Van Geystelen
Netherlands – Hendrikje van Andel-Schipper
Germany – Auguste Steinmann
Iceland – Jón Daníelsson (earliest entry in the list)
Each country has a dedicated “longevity card” containing:
A flag symbol
A portrait of the recordholder
Gender icon
Their maximum verified age (e.g., 122 years, 5 months, 14 days)
Birth and death dates
A ranking indicator (e.g., “1st,” “3rd,” “7th”)
The layout intentionally highlights the extraordinary lifespan of each individual, often showing bold age numbers (e.g., 122, 119, 116), making cross-country comparison simple and intuitive.
The publication also includes:
A brief methodological note (“Supercentenarian = age ≥ 110”)
Highlighting that the list is maintained by the GRG European Supercentenarian Database (ESD) and identifies the oldest documented person ever from each country
A disclaimer that validation standards follow international demographic verification protocols
The document functions as both:
A historical archive of Europe’s longest-lived individuals, and
A demographic reference illustrating extreme longevity patterns across nations.
Overall, European Longevity Records is a concise, authoritative, beautifully designed compilation of Europe’s verified supercentenarians—effectively a “who’s who” of exceptional human longevity across the continent.
If you’d like, I can also create:
📌 a condensed one-page summary
📌 a country-by-country breakdown
📌 an infographic-style list
📌 or a comparison across all your longevity documents
Just tell me!...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/zmvqjlwa-5426/data/document.pdf", "num_examples": 244, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/zmvqjlwa- /home/sid/tuning/finetune/backend/output/zmvqjlwa-5426/data/zmvqjlwa-5426.json...
|
null
|
completed
|
1765050591
|
1765052964
|
NULL
|
/home/sid/tuning/finetune/backend/output/zmvqjlwa- /home/sid/tuning/finetune/backend/output/zmvqjlwa-5426/adapter...
|
False
|
Edit
Delete
|
|
6c8d7daf-3e97-449d-a2bd-f47cd08cd953
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
wufeawwn-9691
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Evaluating the Effect o
|
Evaluating the Effect of Project Longevity
|
/home/sid/tuning/finetune/backend/output/wufeawwn- /home/sid/tuning/finetune/backend/output/wufeawwn-9691/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This report evaluates the impact of Project Longev This report evaluates the impact of Project Longevity, a focused-deterrence violence-reduction initiative implemented in New Haven, Connecticut, on reducing group-involved shootings and homicides. The program targets violent street groups, delivering a coordinated message that violence will bring swift sanctions while offering social services, support, and incentives for individuals who choose to disengage from violent activity.
The study uses detailed group-level data and statistical modeling to assess changes in violent incidents following the program’s launch. The analysis reveals that Project Longevity significantly reduced group-related shootings and homicides, with estimates indicating reductions of approximately 25–30% after implementation. The results are robust across multiple models and remain consistent after adjusting for group characteristics, prior levels of violence, and time trends.
The report explains that Project Longevity works by mobilizing three key components:
Law enforcement partners, who coordinate enforcement responses to group violence;
Social service providers, who offer job training, counseling, and other support;
Community moral voices, who communicate collective intolerance for violence.
Together, these elements reinforce the central message: violence will no longer be tolerated, but help is available for those willing to change.
The authors conclude that Project Longevity is an effective violence-prevention strategy, demonstrating clear reductions in serious violent crime among the most at-risk populations. The findings support the broader evidence base for focused deterrence strategies and suggest that continued implementation could sustain long-term reductions in group-involved violence.
If you want, I can also provide:
✅ A short 3–4 line summary
✅ A simple student-friendly version
✅ MCQs or quiz questions from this file...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/wufeawwn-9691/data/document.pdf", "num_examples": 156, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/wufeawwn- /home/sid/tuning/finetune/backend/output/wufeawwn-9691/data/wufeawwn-9691.json...
|
null
|
completed
|
1765225030
|
1765226764
|
NULL
|
/home/sid/tuning/finetune/backend/output/wufeawwn- /home/sid/tuning/finetune/backend/output/wufeawwn-9691/adapter...
|
False
|
Edit
Delete
|
|
e029e108-c235-41b5-be53-87932a549e3a
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
orpnxghx-2101
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Evaluation of gender
|
Evaluation of gender differences on mitochondrial
|
/home/sid/tuning/finetune/backend/output/orpnxghx- /home/sid/tuning/finetune/backend/output/orpnxghx-2101/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This study investigates gender differences in mito This study investigates gender differences in mitochondrial bioenergetics, oxidative stress, and apoptosis in the C57Bl/6J (B6) mouse strain, a commonly used laboratory rodent model that shows no significant differences in longevity between males and females. The research explores whether the previously observed gender-based differences in longevity and oxidative stress in other species, often attributed to higher estrogen levels in females, are reflected in mitochondrial function and apoptotic markers in this mouse strain.
Background and Rationale
It is widely observed that in many species, females tend to live longer than males, often explained by higher estrogen levels in females potentially reducing oxidative damage.
However, this trend is not universal: in some species including certain mouse strains (C57Bl/6J), longevity does not differ between sexes, and in others (e.g., Syrian hamsters, nematodes), males may live longer.
Previous studies in rat strains (Wistar, Fischer 344) with female longevity advantage showed lower mitochondrial reactive oxygen species (ROS) production and higher antioxidant defenses in females.
The Mitochondrial Free Radical Theory of Aging suggests that aging rate is related to mitochondrial ROS production, which causes oxidative damage.
This study aims to test if gender differences in mitochondrial bioenergetics, ROS production, oxidative stress, and apoptosis exist in B6 mice, which do not show sex differences in lifespan.
Experimental Design and Methods
Animals: 10-month-old male (n=11) and female (n=12) C57Bl/6J mice were used.
Tissues studied: Heart, skeletal muscle (gastrocnemius + quadriceps), and liver.
Mitochondrial isolation: Tissue-specific protocols were used to isolate mitochondria immediately post-sacrifice.
Measurements performed:
Mitochondrial oxygen consumption: State 3 (active) and State 4 (resting) respiration measured polarographically.
ATP content: Determined via luciferin-luciferase assay in freshly isolated mitochondria.
ROS production: H2O2 generation from mitochondrial complexes I and III measured fluorometrically with specific substrates and inhibitors.
Oxidative stress markers:
Protein carbonyls in cytosolic fractions (ELISA).
8-hydroxy-2′-deoxyguanosine (8-oxodG) levels in mitochondrial DNA (HPLC-EC-UV).
Apoptosis markers:
Caspase-3 and caspase-9 activity (fluorometric assays).
Cleaved caspase-3 protein (Western blot).
Mono- and oligonucleosomes (DNA fragmentation, ELISA).
Key Quantitative Results
Parameter Tissue Male (Mean ± SEM) Female (Mean ± SEM) Statistical Difference
Body weight (g) Whole body 30.1 ± 0.55 24.1 ± 1.04 Male > Female (p<0.001)
Heart weight (mg) Heart 171 ± 0.01 135 ± 0.01 Male > Female (p<0.001)
Liver weight (g) Liver 1.52 ± 0.09 1.15 ± 0.09 Male > Female (p<0.01)
Skeletal muscle weight (mg) Quadriceps + gastrocnemius ~403 (sum) ~318 (sum) Male > Female (p<0.001)
Oxygen Consumption (nmol O2/min/mg protein) Heart, State 3 77.8 ± 7.5 65.0 ± 7.3 No significant difference
Skeletal Muscle, State 3 61.4 ± 4.9 64.8 ± 5.5 No significant difference
Liver, State 3 36.1 ± 4.5 34.9 ± 2.5 No significant difference
ATP content (nmol ATP/mg protein) Heart 3.7 ± 0.5 2.8 ± 0.4 No significant difference
Skeletal Muscle 0.12 ± 0.05 0.28 ± 0.06 No significant difference
ROS production (nmol H2O2/min/mg protein) Heart (complex I substrate) 0.7 ± 0.1 0.7 ± 0.05 No difference
Skeletal muscle (succinate) 5.9 ± 0.6 7.5 ± 0.5 Female > Male (p<0.05)
Liver (complex I substrate) 0.13 ± 0.05 0.13 ± 0.05 No difference
Protein carbonyls (oxidative damage marker) Heart, muscle, liver No difference No difference No significant difference
8-oxodG in mtDNA (oxidative DNA damage) Skeletal muscle, liver No difference No difference No significant difference
Caspase-3 and Caspase-9 activity (apoptosis markers) Heart, muscle, liver No difference No difference No significant difference
Cleaved caspase-3 (Western blot) Heart, muscle, liver No difference No difference No significant difference
Mono- and oligonucleosomes (DNA fragmentation) Heart, muscle, liver No difference No difference No significant difference
Core Findings and Interpretations
No significant sex differences were found in mitochondrial oxygen consumption or ATP content in heart, skeletal muscle, or liver mitochondria.
Mitochondrial ROS production rates were similar between sexes in heart and liver; only female skeletal muscle showed slightly higher ROS production with succinate substrate, an isolated finding.
Measures of oxidative damage to proteins and mitochondrial DNA did not differ between males and females.
Markers of apoptosis (caspase activities, cleaved caspase-3, DNA fragmentation) were not different between sexes in any tissue examined.
Despite females having higher estrogen levels, no associated protective effect on mitochondrial bioenergetics, oxidative stress, or apoptosis was observed in this mouse strain.
The lack of differences in mitochondrial function and oxidative damage correlates with the absence of sex differences in lifespan in the C57Bl/6J strain.
These data support the Mitochondrial Free Radical Theory of Aging, emphasizing the role of mitochondrial ROS production in aging rate, independent of estrogen-mediated effects.
The study suggests that body size differences might explain sex differences in longevity and oxidative stress observed in other species (e.g., rats), as mice exhibit smaller body weight differences between sexes.
The estrogen-related increase in antioxidant defenses or mitochondrial function is not universal, and estrogen’s protective role may vary by species and strain.
Apoptosis rates do not differ between sexes in middle-aged mice, but differences could potentially emerge at older ages (not specified).
Timeline Table: Key Experimental Procedures
Step Description
Animal age at study 10 months old male and female C57Bl/6J mice
Tissue collection and mitochondrial isolation Heart, skeletal muscle, liver isolated post-sacrifice
Measurements Oxygen consumption, ATP content, ROS production, oxidative damage, apoptosis markers
Data analysis Statistical comparison of males vs females
Keywords
Mitochondria
Reactive Oxygen Species (ROS)
Oxidative Stress
Apoptosis
Mitochondrial DNA (mtDNA)
Estrogen
Longevity
C57Bl/6J Mice
Mitochondrial Free Radical Theory of Aging
Conclusions
In the C57Bl/6J mouse strain, gender does not influence mitochondrial bioenergetics, oxidative stress levels, or apoptosis markers, consistent with the lack of sex differences in longevity in this strain.
Higher estrogen levels in females do not confer measurable mitochondrial protection or reduced oxidative stress in this model.
The results suggest that oxidative stress generation, rather than estrogen levels, determines aging rate in this species.
Body size and species-specific factors may underlie observed sex differences in longevity and oxidative stress in other animals.
Further research is needed in models where males live longer than females (e.g., Syrian hamsters) and in older animals to clarify the influence of sex on apoptosis and aging.
Key Insights
Gender differences in mitochondrial ROS production and apoptosis are not universal across species or strains.
Estrogen’s role in modulating mitochondrial function and oxidative stress is complex and strain-dependent.
Mitochondrial ROS production remains a central factor in aging independent of sex hormones in the studied mouse strain.
Additional Notes
The study used well-controlled, comprehensive biochemical and molecular assays to evaluate mitochondrial function and apoptosis.
The findings challenge the assumption that female longevity advantage is directly mediated by estrogen effects on mitochondria.
The lack of sex differences in this mouse strain provides a useful baseline for comparative aging studies.
This summary reflects the study’s content strictly as presented, without introducing unsupported interpretations or data.
Smart Summary...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/orpnxghx-2101/data/document.pdf", "num_examples": 211, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/orpnxghx- /home/sid/tuning/finetune/backend/output/orpnxghx-2101/data/orpnxghx-2101.json...
|
null
|
completed
|
1764954871
|
1764957369
|
NULL
|
/home/sid/tuning/finetune/backend/output/orpnxghx- /home/sid/tuning/finetune/backend/output/orpnxghx-2101/adapter...
|
False
|
Edit
Delete
|
|
fb3ccc71-b935-408b-b2b3-a5ef64c0ea11
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
rsouhdxb-7077
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Evidence for a limit
|
Evidence for a limit to human lifespan
|
/home/sid/tuning/finetune/backend/output/rsouhdxb- /home/sid/tuning/finetune/backend/output/rsouhdxb-7077/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This study, published in Nature in 2016 by Xiao Do This study, published in Nature in 2016 by Xiao Dong, Brandon Milholland, and Jan Vijg, investigates whether there is a natural upper limit to the human lifespan. Despite significant increases in average human life expectancy over the past century, the authors provide strong demographic evidence suggesting that maximum human lifespan is fixed and subject to natural constraints, with limited improvement beyond a certain age threshold.
Background and Context
Life expectancy vs. maximum lifespan: Life expectancy has increased substantially since the 19th century, largely due to reduced early-life mortality and improved healthcare. However, maximum lifespan, defined as the age of the longest-lived individuals within a species, is generally considered a stable biological characteristic.
The oldest verified human was Jeanne Calment, who lived to 122 years, setting the recognized upper bound.
While animal studies show lifespan can be extended via genetics or pharmaceuticals, evidence on human maximum lifespan flexibility has been inconclusive.
Some previous research, such as studies from Sweden, suggested maximum lifespan was increasing during the 19th and early 20th centuries, challenging the notion of a fixed limit.
Key Findings
Trends in Life Expectancy and Late-Life Survival
Average life expectancy at birth has continually increased globally, especially in developed nations (e.g., France).
Gains in survival have shifted from early-life mortality reductions to improvements in late-life mortality, with more individuals reaching very old ages (70+).
However, the rate of improvement in survival declines sharply after around 100 years of age.
The age showing the greatest gains in survival over time increased during the 20th century but appears to have plateaued since around 1980.
This plateau is seen in 88% of 41 countries studied, indicating a potential biological constraint on lifespan extension beyond a certain point.
Maximum Reported Age at Death (MRAD) Analysis
Using data from the International Database on Longevity (IDL) and the Gerontological Research Group (GRG), the authors analyzed the maximum ages of supercentenarians (110+ years old) in countries with the largest datasets (France, Japan, UK, US).
The maximum reported age at death increased steadily between the 1970s and early 1990s but plateaued around the mid-1990s, near the time Jeanne Calment died (1997).
Linear regression divided into two periods (1968–1994 and 1995 onward) showed:
Pre-1995: MRAD increased by approximately 0.12–0.15 years per year.
Post-1995: No significant increase; a slight, non-significant decline occurred.
The MRAD has stabilized around 114.9 years (95% CI: 113.1–116.7).
The probability of exceeding 125 years in any given year is less than 1 in 10,000, according to a Poisson distribution model.
Additional Statistical Evidence
Analysis of the top five highest reported ages at death per year (not just the maximum) shows similar plateauing trends.
The annual average age at death among supercentenarians has not increased since 1968.
These consistent patterns across multiple metrics and datasets strengthen the evidence for a natural ceiling on human lifespan.
Biological Interpretation and Implications
The idea that aging is a programmed biological event evolved to cause death has been widely discredited.
Instead, limits to lifespan are likely an inadvertent consequence of genetic programs optimized for early life functions (development, growth, reproduction).
Species-specific longevity assurance systems encoded in the genome counteract genetic and cellular imperfections, maintaining lifespan within limits.
Extending human lifespan beyond these natural limits would likely require interventions beyond improving healthspan, potentially involving genetic or pharmacological modifications.
While current research explores such possibilities, the complexity of genetic determinants of lifespan suggests substantial biological constraints.
Timeline Table: Key Chronological Events and Findings
Period Event/Observation
1860s–1990s Maximum reported age at death in Sweden rose from ~101 to ~108 years, suggesting possible increase
1900 onwards Life expectancy at birth increased markedly globally, especially in developed countries
1970s–early 1990s Maximum reported age at death (MRAD) increased steadily in France, Japan, UK, and US
Mid-1990s (around 1995) MRAD plateaued at ~114.9 years; no further significant increase observed
1997 Death of Jeanne Calment, oldest verified human at 122 years
1980s onwards Age with greatest gains in survival plateaued, indicating diminishing improvements at oldest ages
Quantitative Data Summary
Metric Value/Trend Source/Data
Jeanne Calment’s age at death 122 years Oldest verified human
Maximum reported age at death (MRAD) plateau ~114.9 years (95% CI: 113.1–116.7) IDL, GRG databases
MRAD increase rate (pre-1995) +0.12 to +0.15 years/year Linear regression
MRAD increase rate (post-1995) Slight, non-significant decrease Linear regression
Probability of exceeding 125 years in a year <1 in 10,000 Poisson distribution model
Percentage of countries showing plateau in survival gains at oldest ages 88% 41 countries analyzed
Key Insights
Human maximum lifespan appears to be fixed and constrained, despite past increases in average lifespan.
Improvements in survival rates slow and plateau beyond approximately 100 years of age.
The world record for age at death has not significantly increased since the late 1990s.
The phenomenon is consistent across multiple countries and independent datasets.
Biological aging limits are likely an outcome of genetic programming optimized for early life, with longevity assured by species-specific genomic systems.
Substantial extension of maximum human lifespan would require overcoming complex genetic and biological constraints.
Conclusions
This comprehensive demographic analysis provides strong evidence for a natural limit to human lifespan, with little increase in maximum age at death over recent decades despite ongoing increases in average life expectancy. The data challenge optimistic views that human longevity can be indefinitely extended by current health improvements alone. Instead, future lifespan extension may depend on breakthroughs that directly target the underlying biological and genetic determinants of aging.
References to Core Concepts and Methods
Use of Human Mortality Database for survival and life expectancy trends.
Analysis of supercentenarian data from the International Database on Longevity (IDL) and Gerontological Research Group (GRG).
Application of linear regression and Poisson distribution modeling to maximum age at death data.
Consideration of species-specific genetic longevity assurance systems and aging biology literature.
Comparison to historical theories of lifespan limits (Fries 1980; Olshansky et al. 1990).
Keywords
Maximum lifespan
Life expectancy
Supercentenarians
Late-life mortality
Longevity limit
Jeanne Calment
Genetic constraints
Aging biology
Mortality trends
Demographic analysis
FAQ
Q: Has maximum human lifespan increased in recent decades?
A: No. Analysis shows the maximum reported age at death plateaued in the mid-1990s around 115 years.
Q: How does life expectancy differ from maximum lifespan?
A: Life expectancy is the average age people live to in a population, which has increased due to reduced early mortality. Maximum lifespan is the oldest age reached by individuals, which appears fixed.
Q: Is there evidence for biological constraints on human lifespan?
A: Yes. Data suggest species-specific genetic programs and longevity assurance systems impose natural upper limits.
Q: Could future interventions extend maximum lifespan?
A: Potentially, but such extensions require overcoming complex genetic and biological factors beyond current health improvements.
This summary synthesizes the core findings and implications of the study, strictly based on the provided content, reflecting a nuanced understanding of the limits to human lifespan suggested by recent demographic evidence.
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/rsouhdxb-7077/data/document.pdf", "num_examples": 75, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/rsouhdxb- /home/sid/tuning/finetune/backend/output/rsouhdxb-7077/data/rsouhdxb-7077.json...
|
null
|
completed
|
1764954867
|
1764955496
|
NULL
|
/home/sid/tuning/finetune/backend/output/rsouhdxb- /home/sid/tuning/finetune/backend/output/rsouhdxb-7077/adapter...
|
False
|
Edit
Delete
|
|
3770b1f5-7678-4e82-8759-dce971159e9d
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
jztokeky-4259
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Evidence for a limit
|
Evidence for a limit to human lifespan
|
/home/sid/tuning/finetune/backend/output/jztokeky- /home/sid/tuning/finetune/backend/output/jztokeky-4259/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Driven by technological progress, human life expec Driven by technological progress, human life expectancy has increased greatly since the nineteenth century. Demographic evidence has revealed an ongoing reduction in old-age mortality and a rise of the maximum age at death, which may gradually extend human longevity1,2. Together with observations that lifespan in various animal species is flexible and can be increased by genetic or pharmaceutical intervention, these results have led to suggestions that longevity may not be subject to strict, species-specific genetic constraints. Here, by analysing global demographic data, we show that improvements in survival with age tend to decline after age 100, and that the age at death of the world’s oldest person has not increased since the 1990s. Our results strongly suggest that the maximum lifespan of humans is fixed and subject to natural constraints. Maximum lifespan is, in contrast to average lifespan, generally assumed to be a stable characteristic of a species3. For humans, the
maximum reported age at death is generally set at 122 years, the age at death of Jeanne Calment, still the oldest documented human
individual who ever lived4. However, some evidence suggests that
maximum lifespan is not fixed. Studies in model organisms have shown that maximum lifespan is flexible and can be affected by genetic and pharmacological interventions5. In Sweden, based on a long series of reliable information on the upper limits of human lifespan, the
maximum reported age at death was found to have risen from about
101 years during the 1860s to about 108 years during the 1990s6. According to the authors, this finding refutes the common assertion that human lifespan is fixed and unchanging over time6. Indeed, the most convincing argument that the maximum lifespan of humans is not fixed is the ongoing increase in life expectancy in most countries over the course of the last century1,2. Figure 1a shows this increase for France, a country with high-quality mortality data, but very similar patterns were found for most other developed nations (Extended Data Fig. 1). Hence, the possibility has been considered that mortality may decline further, breaking any pre-conceived boundaries of human lifespan1,7. As shown by data from the Human Mortality Database8, many of the historical gains in life expectancy have been attributed to a
reduction in early-life mortality. More recent data, however, show
evidence for a decline in late-life mortality, with the fraction of each birth cohort reaching old age increasing with calendar year. In France, the number of individuals per 100,000 surviving to old age (70 and up) has increased since 1900 (Fig. 1b), which points towards a continuing increase in human life expectancy. This pattern is very similar across the other 40 countries and territories included in the database (Extended Data Figs 2, 3). However, the rate of improvement in survival peaks and then declines for very old age levels (Fig. 1c), which points
1Department of Genetics, Albert Einstein College of Medicine, Bronx, New York 10461, USA. 2Department of Ophthalmology & Visual Sciences, Albert Einstein College of Medicine, Bronx, New York 10461, USA. *These authors contributed equally to this work.
1900 1950 2000 1
100
10,000
Female
Survivors per 100,000
1900 1950 2000
Male
Age (years) 70 80 90 100 105 110
1920 1940 1960 1980 2000
80
85
90
95
100
Year
Age with greatest gain (years)
1900 1920 1940 1960 1980 2000
30 40 50 60 70 80
Year
Life expectancy at birth (years)
Female Male
0204060801 00
0.02
0
0.04
0.06
Age (years)
Rate of change since 1900
Female Male
ab
cd
Figure 1 | Trends in life expectancy and late-life survival. a, Life expectancy at birth for the population in each given year. Life expectancy in France has increased over the course of the 20th and early 21st centuries. b, Regressions of the fraction of people surviving to old age demonstrate that survival has increased since 1900, but the rate of increase appears to be slower for ages over 100. c, Plotting the rate of
change (coefficients resulting from regression of log-transformed data) reveals that gains in survival peak around 100 years of age and then rapidly decline. d, Relationship between calendar year and the age that experiences the most rapid gains in survival over the past 100 years. The age with most rapid gains has increased over the century, but its rise has been slowing and it appears to have reached a plateau...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/jztokeky-4259/data/document.pdf", "num_examples": 16, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/jztokeky- /home/sid/tuning/finetune/backend/output/jztokeky-4259/data/jztokeky-4259.json...
|
null
|
completed
|
1764899149
|
1764901242
|
NULL
|
/home/sid/tuning/finetune/backend/output/jztokeky- /home/sid/tuning/finetune/backend/output/jztokeky-4259/adapter...
|
False
|
Edit
Delete
|
|
1bf17cbc-ea1b-4a67-a424-4aed50bbfa06
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
ynjlibrh-7746
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Evidence_Based_Massage
|
Evidence_Based_Massage_Therapy
|
/home/sid/tuning/finetune/backend/output/ynjlibrh- /home/sid/tuning/finetune/backend/output/ynjlibrh-7746/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Document Description
The document is the 2008 ICU Document Description
The document is the 2008 ICU Manual from Boston Medical Center, authored by Dr. Allan Walkey and Dr. Ross Summer. This educational handbook is specifically designed for resident trainees rotating through the medical intensive care unit (MICU). Its primary goal is to facilitate the learning of critical care medicine by providing a structured resource that accommodates the busy schedules of medical professionals. The manual serves as a central component of the ICU curriculum, complementing didactic lectures, hands-on tutorials (such as those on mechanical ventilation and ultrasound), and clinical morning rounds. It is meticulously organized into folders covering a wide array of critical care topics, including respiratory support, oxygen delivery, mechanical ventilation strategies (initiation, weaning, and extubation), Acute Respiratory Distress Syndrome (ARDS), non-invasive ventilation, tracheostomy, chest x-ray interpretation, acid-base disorders, severe sepsis, shock management, vasopressor usage, and the treatment of massive pulmonary embolism. By integrating concise 1-2 page summaries, relevant literature, and BMC-approved protocols, the manual acts as both a quick-reference tool for daily clinical decision-making and a foundational text for resident education.
Key Points, Topics, and Headings
I. Educational Framework & Goals
Target Audience: Resident trainees at Boston Medical Center.
Objectives: Facilitate learning in critical care medicine and provide a "survival guide" for the ICU rotation.
Components:
Topic Summaries: 1-2 page handouts designed for quick reading during busy shifts.
Literature: Original and review articles for in-depth understanding.
Protocols: BMC-approved clinical guidelines for immediate use.
Curriculum Support: Complements didactic lectures, practical tutorials, and morning rounds where residents defend treatment plans.
II. Respiratory Management & Mechanical Ventilation
Oxygen Delivery & Devices:
Oxygen Cascade: Describes the declining oxygen tension from atmosphere (159 mmHg) to the mitochondria.
Devices:
Variable Performance: Nasal cannula (+3% FiO2 per liter, max ~40%), Face masks.
Fixed Performance: Non-rebreather masks (theoretically 100%, usually 70-80%).
Goals: SaO2 88-90% (minimize toxicity).
Initiation of Mechanical Ventilation:
Mode: Volume Control (AC or SIMV).
Initial Settings: Tidal Volume (TV) 6-8 ml/kg, Rate 12-14, FiO2 100%, PEEP 5 cmH2O.
Monitoring: Check ABG in 20 mins; watch for Peak Pressures > 35 cmH2O.
ARDS (Acute Respiratory Distress Syndrome):
Criteria: PaO2/FiO2 < 200, bilateral infiltrates, no cardiogenic cause.
ARDSNet Protocol (Lung Protective Strategy):
Low tidal volume (6 ml/kg Ideal Body Weight).
Keep Plateau Pressure (PPL) < 30 cmH2O.
Permissive hypercapnia (allow higher CO2 to save lungs).
Weaning & Extubation:
Spontaneous Breathing Trial (SBT): 30-minute trial off pressure support/PEEP to assess readiness.
Cuff Leak Test: Assess for laryngeal edema before extubation. An "adequate" leak is defined as <75% inspired TV (meaning >25% leaked volume).
NIPPV (Non-Invasive Ventilation): Indicated for COPD exacerbations, pulmonary edema. Contraindicated if patient cannot protect airway.
III. Cardiovascular & Shock Management
Severe Sepsis & Septic Shock:
Definitions: SIRS + Infection = Sepsis; + Organ Dysfunction = Severe Sepsis; + Hypotension/Resuscitation = Septic Shock.
Immediate Actions: Broad-spectrum antibiotics (mortality increases 7% per hour delay), Fluids 2-3L NS, early vasopressors.
Pressors: Norepinephrine (1st line), Vasopressin (2nd line).
Vasopressors:
Norepinephrine: Alpha and Beta agonist; standard for sepsis.
Dopamine: Dose-dependent effects (Renal at low, Cardiac/BP support at high).
Dobutamine: Beta agonist (Inotrope) for cardiogenic shock.
Phenylephrine: Pure alpha agonist (vasoconstriction) for neurogenic shock.
Massive Pulmonary Embolism (PE):
Treatment: Anticoagulation (Heparin).
Unstable: Thrombolytics.
Contraindications: IVC Filter.
IV. Diagnostics & Critical Thinking
Chest X-Ray (CXR) Reading:
5-Step Approach: Confirm ID, Penetration, Alignment, Systematic Review (Tubes, Bones, Cardiac, Lungs).
Key Findings: Pneumothorax (Deep sulcus sign in supine), CHF (Bat-wing appearance, Kerley B lines).
Acid-Base Disorders:
8-Step Approach: pH, pCO2, Anion Gap (Gap = Na - Cl - HCO3).
Mnemonics:
High Gap Acidosis: MUDPILERS (Methanol, Uremia, DKA, Paraldehyde, Isoniazid, Lactic Acidosis, Ethylene glycol, Renal Failure, Salicylates).
Winters Formula: Predicted pCO2 for metabolic acidosis = (1.5 x HCO3) + 8 (+/- 2).
Presentation: Easy Explanation of ICU Concepts
Slide 1: Introduction to ICU Manual
Context: 2008 Handbook for Boston Medical Center residents.
Goal: Facilitate learning in critical care medicine.
Tools: Topic Summaries + Literature + Protocols.
Takeaway: Use this manual as a "survival guide" and quick reference for daily clinical decisions.
Slide 2: Oxygen & Ventilation Basics
The Oxygen Equation:
DO2=[1.34×Hb×SaO2+(0.003×PaO2)]×C.O.
* Delivery depends on Hemoglobin, Saturation, and Cardiac Output.
Start-Up Settings:
Mode: Volume Control (AC or SIMV).
Tidal Volume: 6-8 ml/kg.
Goal: Rest muscles, avoid barotrauma.
Safety Check: If Peak Pressure > 35, check Plateau Pressure to see if it's a lung issue (compliance) or airway issue (obstruction).
Slide 3: Managing ARDS (Lung Protective Strategy)
What is it? Non-cardiogenic pulmonary edema (PaO2/FiO2 < 200).
ARDSNet Protocol (Gold Standard):
TV: 6 ml/kg Ideal Body Weight.
Keep Plateau Pressure < 30 cmH2O.
Permissive Hypercapnia (allow pH to drop a bit to save lungs).
Rescue Therapy: Prone positioning (turn patient on stomach), High PEEP, Paralytics.
Slide 4: Weaning from the Ventilator
Daily Check: Is patient ready?
Spontaneous Breathing Trial (SBT): Disconnect pressure support/PEEP for 30 mins.
Passing SBT? Check cuff leak before extubation.
The "Cuff Leak Test":
Deflate the cuff; measure how much air leaks out.
If < 75% of air comes back (meaning > 25% leaked), the throat is okay (swelling is minimal).
If no leak, high risk of choking/stridor. Consider Steroids.
Slide 5: Sepsis Protocol (Time is Tissue)
Definition: Infection + Organ Dysfunction.
Immediate Actions:
Antibiotics: Give immediately (Broad spectrum). Every hour delay increases death rate by 7%.
Fluids: 2-3 Liters Normal Saline.
Pressors: Norepinephrine if BP is still low (MAP < 60).
Goal: Perfusion (blood flow) to organs.
Slide 6: Vasopressors Cheat Sheet
Norepinephrine: Go-to drug for Septic Shock. Tightens vessels and helps heart slightly.
Dopamine: "Jack of all trades."
Low dose: Helps kidneys?
Medium: Helps heart.
High: Increases BP.
Dobutamine: Makes the heart squeeze harder (Inotrope). Good for heart failure.
Phenylephrine: Pure vessel constrictor. Good for Neurogenic shock (spine injury).
Epinephrine: Alpha/Beta. Good for Anaphylaxis or ACLS.
Slide 7: Diagnostics - CXR & Acid-Base
Reading CXR:
Check tubes/lines first!
Pneumothorax: Look for "Deep Sulcus Sign" (hidden air in lying-down patients).
CHF: "Bat wing" infiltrates, Kerley B lines.
Acid-Base (The "Gap"):
Formula:
Na−Cl−HCO3
.
If Gap is High (>12): Think MUDPILERS.
Methanol
Uremia
DKA
Paraldehyde
Isoniazid
Lactic Acidosis
Ethylene Glycol
Renal Failure
Salicylates
Slide 8: Special Topics & Procedures
Tracheostomy:
Early (within 1st week): Less sedation, easier movement, reduced ICU stay.
Does NOT change mortality.
Massive PE:
Hypotension? Give TPA (Thrombolytics).
Bleeding risk? IVC Filter.
Review Questions
What is the ARDSNet goal for tidal volume and plateau pressure?
Answer: Tidal volume of 6 ml/kg of Ideal Body Weight and Plateau Pressure < 30 cmH2O.
Why is immediate antibiotic administration critical in septic shock?
Answer: Mortality increases by approximately 7% for every hour of delay in administering antibiotics.
What is the purpose of performing a "Cuff Leak Test" prior to extubation?
Answer: To assess for laryngeal edema (swelling of the airway). If the expired volume is < 75% of the inspired volume (meaning >25% of the air leaked out), the patient is at low risk for post-extubation stridor. If there is no leak, the risk is high.
Which vasopressor is considered first-line for septic shock?
Answer: Norepinephrine.
What does the mnemonic "MUDPILERS" represent in acid-base interpretation?
Answer: Causes of High Anion Gap Metabolic Acidosis (Methanol, Uremia, DKA, Paraldehyde, Isoniazid, Lactic Acidosis, Ethylene glycol, Renal Failure, Salicylates).
What specific finding on a Chest X-Ray of a supine patient suggests a pneumothorax?
Answer: The "Deep Sulcus Sign" (a deep, dark costophrenic angle).
Does early tracheostomy (within 1st week) reduce mortality?
Answer: No. It reduces time on the ventilator and ICU length of stay, and improves patient comfort/rehabilitation, but it does not alter mortality....
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/ynjlibrh-7746/data/document.pdf", "num_examples": 2017, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/ynjlibrh- /home/sid/tuning/finetune/backend/output/ynjlibrh-7746/data/ynjlibrh-7746.json...
|
null
|
queued
|
1769454906
|
1769475908
|
NULL
|
/home/sid/tuning/finetune/backend/output/ynjlibrh- /home/sid/tuning/finetune/backend/output/ynjlibrh-7746/adapter...
|
False
|
Edit
Delete
|
|
61020b12-8660-4e50-951a-dd0a46cf09aa
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
nopkhubk-2873
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Evidence_Based_Massage
|
Evidence_Based_Massage_Therapy
|
/home/sid/tuning/finetune/backend/output/nopkhubk- /home/sid/tuning/finetune/backend/output/nopkhubk-2873/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Complete Description of the Document
Evidence-Bas Complete Description of the Document
Evidence-Based Massage Therapy: A Guide For Clinical Practice by Richard Lebert is an open educational resource (OER) designed to facilitate the integration of massage therapy into mainstream healthcare and multidisciplinary teams. Created in response to the opioid crisis and the recognition that conventional treatments like surgery and steroid injections often offer limited benefits for chronic musculoskeletal pain, this text advocates for a paradigm shift toward non-pharmacological, evidence-based options. The book serves as a roadmap for massage therapists to transition into formal medical settings by adopting a research-literate approach. It begins by establishing the groundwork for evidence-based practice (EBP), covering critical thinking skills (using the CRAAP method), the hierarchy of scientific evidence, and an analysis of systematic reviews that support massage therapy efficacy. It then introduces a comprehensive theoretical framework that explains how massage works through three primary mechanisms: mechanical (tissue physiology), contextual (therapeutic environment and placebo response), and effective touch (neurochemical release). The text further details practical treatment strategies, complementary therapies (such as cupping and TENS), clinical examination skills (identifying red and yellow flags), and evidence-based protocols for specific conditions ranging from low back pain to migraines and osteoarthritis. Ultimately, the goal is to professionalize the field of massage therapy, ensuring practitioners can communicate effectively with other healthcare providers and provide safe, individualized care based on the best available science.
Key Points, Topics, and Questions
1. The Shift in Pain Management
Topic: Moving beyond opioids.
The opioid crisis and limited success of surgery have prompted a re-evaluation of chronic pain treatment.
Clinical practice guidelines (like the American College of Physicians) now recommend massage therapy as a first-line treatment for back and neck pain.
Key Question: Why is this a "paradigm shift" for massage therapists?
Answer: It moves massage from a "spa" or "wellness" luxury to a recognized clinical treatment option within the medical system, increasing referrals and legitimacy.
2. Evidence-Based Practice (EBP)
Topic: The definition of EBP.
It is not just "following a recipe"; it is integrating three pillars:
Patient Values: The patient's needs and preferences.
Research Evidence: Scientific literature to minimize harm.
Clinical Expertise: The therapist's experience to individualize the plan.
Key Point: Evidence should guide, not dictate, clinical decisions.
3. Research Literacy: Critical Thinking & Sources
Topic: Evaluating information quality.
The CRAAP Test: A filter to check Currency, Relevance, Authority, Accuracy, and Purpose of a source.
Hierarchy of Evidence: A pyramid ranking research quality.
Top: Systematic Reviews and Meta-Analyses (highest evidence).
Middle: Randomized Control Trials and Observational Studies.
Bottom: Expert Opinion and Anecdotes.
Key Question: Why are systematic reviews considered the "Gold Standard"?
Answer: They analyze all available research on a topic, filtering out bias to give the most accurate picture of whether a treatment works.
4. An Evidence-Based Framework for Massage
Topic: How massage actually works.
Mechanical Factors: Physical changes to tissue and cells (mechanotherapy).
Contextual Factors: The "whole" therapeutic encounter—how the therapist presents themselves and creates a healing environment (placebo effect).
Effective Touch: Social touch releasing neurochemicals like oxytocin and endorphins to promote relaxation and safety.
Key Point: It's not just about "breaking up adhesions"; it's also about the psychological safety provided by the therapeutic relationship.
5. Clinical Examination & Safety
Topic: Screening patients before treatment.
Red Flags: Signs of serious underlying pathology (e.g., fracture, cancer, infection). Action: Refer to a doctor immediately.
Yello Flags: Psychological or social barriers (e.g., fear-avoidance beliefs, depression). Action: Modify treatment and education to address these.
Key Point: A safe practitioner knows their scope and when to collaborate with or refer to other professionals.
Easy Explanation (Presentation Style)
Here is a structured outline you can use to present this material effectively.
Slide 1: Introduction
Title: Evidence-Based Massage Therapy: A Guide For Clinical Practice
Author: Richard Lebert.
The Context: Chronic pain management is changing. Opioids and surgery are out; non-pharmacological treatments (like massage) are in.
The Goal: To help massage therapists integrate into mainstream healthcare using science and research.
Slide 2: Evidence-Based Practice (EBP)
What is it? Using the best available evidence to make decisions about patient care.
The 3 Pillars of EBP:
Patient Values: "What does the patient want?"
Clinical Expertise: "What do I know from experience?"
Research Evidence: "What does science say?"
Takeaway: Good care balances all three.
Slide 3: Becoming Research Literate
The CRAAP Test: A tool to check if a source is reliable.
Currency, Relevance, Authority, Accuracy, Purpose.
Hierarchy of Evidence:
Top: Systematic Reviews (The best proof).
Middle: Research Studies.
Bottom: Expert Opinion/Opinions.
Why? To avoid "fake news" and bad science.
Slide 4: How Does Massage Work? (The Framework)
1. Mechanical: Physical changes to muscles and nerves.
2. Contextual: The power of the "therapeutic encounter" (environment, trust).
3. Effective Touch: The biology of connection—touch releases "happy chemicals" (oxytocin) in the brain.
Result: Pain relief comes from both physical work and feeling safe.
Slide 5: Clinical Examination – Screening
Red Flags (Danger): Signs of serious disease (tumors, fractures, infection).
Action: Do not treat. Refer to a doctor.
Yellow Flags (Psych/Social): Fear, depression, or negative beliefs about pain.
Action: Educate and reassure; adapt your treatment plan.
Rule: "First, do no harm."
Slide 6: Treatment Strategies
Techniques: Swedish massage, Myofascial release, Trigger point therapy, Joint mobilization.
Complementary Therapies: Cupping, TENS (electricity), Heat/Cold applications, Taping.
Principle: Use the best tool for the specific condition and patient, backed by evidence.
Slide 7: Common Conditions
The book provides evidence-based chapters on:
Low Back Pain (Highly supported by guidelines).
Headaches/Migraines.
Neck & Shoulder Pain.
Osteoarthritis.
Fibromyalgia.
Trend: Physicians are now referring these conditions to massage therapists more frequently.
Slide 8: Summary
Massage Therapy is a Clinical Option, not just a luxury.
EBP creates a common language with doctors and nurses.
Safety and Screening (Red/Yellow flags) are paramount.
The future is Collaborative: Massage therapists working as part of a healthcare team....
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/nopkhubk-2873/data/document.pdf", "num_examples": 1556, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/nopkhubk- /home/sid/tuning/finetune/backend/output/nopkhubk-2873/data/nopkhubk-2873.json...
|
null
|
queued
|
1769623167
|
1769671363
|
NULL
|
/home/sid/tuning/finetune/backend/output/nopkhubk- /home/sid/tuning/finetune/backend/output/nopkhubk-2873/adapter...
|
False
|
Edit
Delete
|
|
632bf227-0b6d-47f4-b76a-eb9a5de1c9e7
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
tcjukfqx-4399
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Evolution of the Human
|
Evolution of the Human Lifespan
|
/home/sid/tuning/finetune/backend/output/tcjukfqx- /home/sid/tuning/finetune/backend/output/tcjukfqx-4399/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This comprehensive essay by Caleb E. Finch explore This comprehensive essay by Caleb E. Finch explores the evolution of human lifespan (life expectancy, LE) over hundreds of thousands of generations, emphasizing the interplay between genetics, environment, lifestyle, inflammation, infection, and diet. The work integrates paleontological, archaeological, epidemiological, and molecular data to elucidate how human longevity has changed from pre-industrial times to the present and projects challenges for the future.
Key Themes and Insights
Human life expectancy (LE) is uniquely long among primates:
Pre-industrial human LE at birth (~30–40 years) was about twice that of great apes (~15 years at puberty for chimpanzees). This extended lifespan arises from slower postnatal maturation and lower adult mortality rates, rooted in both genetics and environmental factors.
Rapid increases in LE during industrialization:
Since 1800, improvements in nutrition, hygiene, and medicine have nearly doubled human LE again, reaching 70–85 years in developed populations. Mortality improvements were not limited to early life but included significant gains in survival at older ages (e.g., after age 70).
Environmental and epigenetic factors dominate recent LE trends:
Human lifespan heritability is limited (~25%), highlighting the importance of environmental and epigenetic influences on aging and mortality.
Infection and chronic inflammation shape mortality and aging:
The essay emphasizes the “inflammatory load”—chronic exposure to infection and inflammation—as a critical factor affecting mortality trajectories both historically and evolutionarily.
Mortality Phase Framework and Historical Cohort Analysis
Finch and collaborators define four mortality phases to analyze lifespan changes using historical European data (notably Sweden since 1750):
Mortality Phase Age Range (years) Description Mortality Pattern
Phase 1 0–9 Early age mortality (mainly infec-tions) Decreasing mortality from birth to puberty
Phase 2 10–40 Basal mortality (lowest mortality) Lowest mortality across lifespan
Phase 3 40–80 Exponentially accelerating mortality Gompertz model exponential increase
Phase 4 >80 Mortality plateau (approaching max) Mortality rate approaches ~0.5/year
Key insight: Reductions in early-life mortality (Phase 1) strongly predict lower mortality at older ages (Phase 3), demonstrating persistent impacts of early infection/inflammation on aging-related deaths.
J-shaped mortality curve: Mortality rates are high in infancy, drop to a minimum around puberty, then accelerate exponentially in adulthood.
Gompertz model explains adult mortality acceleration:
[ m(x) = A e^{Gx} ]
where ( m(x) ) is mortality rate at age ( x ), ( A ) is initial mortality rate, and ( G ) is the Gompertz coefficient (rate of acceleration).
Despite improvements in LE, the rate of mortality acceleration (G) has increased, meaning aging processes remain or have intensified, but reduced background mortality (A) has driven LE gains.
Links Between Early Life Conditions and Later Health
Early life infections and inflammation leave a lifelong “cohort morbidity” imprint, influencing adult mortality and chronic disease risk (e.g., cardiovascular disease).
Studies of historical cohorts show strong correlations between neonatal mortality and mortality at age 70 across multiple European countries.
Adult height, a marker of growth and nutrition, reflects childhood infection burden and correlates inversely with early mortality.
The 1918 influenza pandemic provides a notable example: prenatal exposure led to reduced growth, lower education, and a 25% increase in adult heart disease risk for those born during or shortly after the pandemic.
Chronic Diseases, Inflammation, and Infection
Chronic infections and inflammation contribute to major aging diseases such as atherosclerosis, cancer, and vascular diseases.
The essay highlights the role of Helicobacter pylori (gastric cancer risk) and tobacco smoke (vascular inflammation and cancer) as examples linking infection/inflammation to chronic disease.
Contemporary infectious diseases like HIV/AIDS, despite improved treatment, increase the risk of vascular disease and non-AIDS cancers, illustrating ongoing infection-inflammation interactions in aging.
Insights from Hunter-Gatherer Populations: The Tsimane Case Study
The Tsimane, a Bolivian forager-horticulturalist population, have a life expectancy (~42 years) comparable to pre-industrial Europe, with high infectious and inflammatory loads (e.g., 60% parasite prevalence, elevated CRP levels).
Despite high inflammation, they have low blood pressure, low blood cholesterol, low body mass index (~23), and low incidence of ischemic heart disease, likely due to diet low in saturated fats and physical activity.
This population provides a unique natural experiment to study the relationships among infection, inflammation, diet, and aging in the absence of modern medical interventions.
Evidence of Chronic Disease in Ancient Populations
Radiological studies of Egyptian mummies (Old and New Kingdoms) reveal advanced atherosclerosis in approximately half of adult specimens, despite their infectious disease burden and diet rich in saturated fats.
Similarly, the “Tyrolean iceman” (~3300 BCE) exhibits arterial calcifications.
These findings, though limited in sample size and representativeness, suggest vascular diseases accompanied infections and inflammation in ancient humans.
Evolutionary Perspectives on Diet, Inflammation, and Lifespan
Finch proposes a framework of ecological stages in human evolution focusing on inflammatory exposures and diet, hypothesizing how humans evolved longer lifespans despite pro-inflammatory environments.
Stage Approximate Period Ecology & Group Size Diet Characteristics Infection/Inflammation Exposure
1 4–6 MYA Forest-savannah, small groups Low saturated fat intake Low exposure to excreta
2 4–0.5 MYA Forest-savannah, small groups Increasing infections from excreta & carrion; increased pollen & dust exposure Increased infection and inflammation exposure
3 0.5 MYA–15,000 YBP Varied, temperate zone, larger groups Increased meat consumption; use of domestic fire and smoke Increased exposure to smoke and inflammation
4 12,000–150 YBP Permanent settlements, larger groups Cereals and milk from domestic crops and animals Intense exposure to human/domestic animal excreta & parasites
5 1800–1950 Industrial age, high-density homes Improved nutrition year-round Improving sanitation, reduced infections
6 1950–2010 Increasing urbanization High fat and sugar consumption; rising obesity Public health measures, vaccination, antibiotics
7 21st century >90% urban, very high density Continued high fat/sugar intake Increasing ozone, air pollution, water shortages
Humans evolved longer lifespans despite increased exposure to pro-inflammatory factors such as:
Higher dietary fat (10x that of great apes), particularly saturated fats.
Exposure to infections through scavenging, carrion consumption, and communal living.
Increased inhalation of dust, pollen, and volcanic aerosols due to expanded savannah habitats.
Chronic smoke inhalation from controlled use of fire and indoor biomass fuel combustion.
Exposure to excreta in denser human settlements, contrasting with great apes’ hygienic behaviors (e.g., nest abandonment).
Introduction of dietary inflammatory agents including cooked food derivatives (advanced glycation end products, AGEs) and gluten from cereal grains.
Counterbalancing factors included antioxidants and anti-inflammatory dietary components (e.g., polyphenols, omega-3 fatty acids, salicylates).
Skeletal evidence shows a progressive decrease in adult body mass over 60,000 years prior to the Neolithic, possibly reflecting increased inflammatory burden and nutritional stress.
The Role of Apolipoprotein E (apoE) in Evolution and Aging
The apoE gene, critical for lipid transport, brain function, and immune responses, has three main human alleles: E2, E3, and E4.
ApoE4, the ancestral allele, is linked to:
Enhanced inflammatory responses.
Efficient fat storage (a “thrifty gene” hypothesis).
Increased risk of Alzheimer’s disease, cardiovascular disease, and shorter lifespan.
Possible protection against infections and better cognitive development in high-infection environments.
ApoE3, unique to humans and evolved ~0.23 MYA, is associated with reduced inflammatory responses and is predominant today.
The chimpanzee apoE resembles human apoE3 functionally, which may relate to their lower incidence of Alzheimer-like pathology and vascular disease.
This allelic variation reflects evolutionary trade-offs between infection resistance, metabolism, and longevity.
Future Challenges to Human Lifespan Gains
Current maximum human lifespan may be approaching biological limits:
Using Gompertz mortality modeling, Finch and colleagues estimate maximum survival ages of around 113 for men and 120 for women under current mortality patterns, matching current longevity records.
Further increases in lifespan require slowing or delaying mortality acceleration, which remains challenging given biological constraints and limited human evidence for such changes.
Emerging global threats may reverse recent lifespan gains:
Climate change and environmental deterioration, including increasing heat waves, urban heat islands, and air pollution (notably ozone), which disproportionately affect the elderly.
Air pollution, especially from vehicular emissions and biomass fuel smoke, exacerbates cardiovascular and pulmonary diseases and may accelerate brain aging.
Water shortages and warming expand the range and incidence of infectious diseases, including malaria, dengue, and cholera, posing risks to immunosenescent elderly.
Protecting aging populations from these risks will require:
Enhanced public health measures.
Research on dietary and pharmacological interventions (e.g., antioxidants like vitamin E).
Improved urban planning and pollution control.
Core Concepts
Life expectancy (LE): Average expected lifespan at birth or other ages.
Gompertz model: Mathematical model describing exponential increase in mortality with age.
Cohort morbidity: The lasting health impact of early life infections and inflammation on aging and mortality.
Inflammaging: Chronic, low-grade inflammation that contributes to aging and age-related diseases.
Apolipoprotein E (apoE): A protein with genetic polymorphisms influencing lipid metabolism, inflammation, infection resistance, and neurodegeneration.
Advanced glycation end products (AGEs): Pro-inflammatory compounds formed during cooking and metabolism, implicated in aging and chronic disease.
Compression of morbidity: The hypothesis that morbidity is concentrated into a shorter period before death as lifespan increases.
Quantitative and Comparative Data Tables
Table 1: Ecological Stages of Human Evolution by Diet and Infection Exposure
Stage Time Period Ecology & Group Size Diet Characteristics Infection & Inflammation Exposure
1 4–6 MYA Forest-savannah, small groups Low saturated fat intake Low exposure to excreta
2 4–0.5 MYA Forest-savannah, small groups Increasing exposure to infections Exposure to excreta, carrion, pollen, dust
3 0.5 MYA–15,000 YBP Varied, temperate zones, larger groups Increased meat consumption, use of fire Increased smoke exposure, infections
4 12,000–150 YBP Permanent settlements Cereals and milk from domesticated crops High exposure to human and animal excreta and parasites
5 1800–1950 Industrial age, high-density homes Improved nutrition Reduced infections and improved hygiene
6 1950–2010 Increasing urbanization High fat and sugar intake; rising obesity Vaccination, antibiotics, pollution control
7 21st century Highly urbanized, dense populations Continued poor diet trends Increased air pollution, ozone, climate change
Table 2: apoE Allele Differences between Humans and Chimpanzees
Residue Position Chimpanzee apoE Human apoE4 Human apoE3
61 Threonine (T) Arginine ® Arginine ®
112 Arginine ® Arginine ® Cysteine ©
158 Arginine ® Arginine ® Arginine ®
The chimpanzee apoE protein functions more like human apoE3 due to residue 61, associated with lower inflammation and different lipid binding.
Timeline of Human Lifespan Evolution and Key Events
Period Event/Characteristic
~4–6 million years ago Shared great ape ancestor; low-fat diet, low infection exposure
~4–0.5 million years ago Early Homo; increased exposure to infections, pollen, dust
~0.5 million years ago Use of fire; increased meat consumption; smoke exposure
12,000–150 years ago Neolithic settlements; cereal and milk consumption; high parasite loads
1800 Industrial revolution; sanitation, nutrition improvements lead to doubling LE
1918 Influenza pandemic; prenatal infection impacts long-term health
1950 onward Vaccines, antibiotics reduce infections; obesity rises
21st century Climate change, air pollution threaten gains in lifespan
Conclusions
Human lifespan extension is a product of complex interactions between genetics, environment, infection, inflammation, and diet.
Historical and contemporary data demonstrate that early-life infection and inflammation have lifelong impacts on mortality and aging trajectories.
The evolution of increased lifespan in Homo sapiens occurred despite increased exposure to various pro-inflammatory environmental factors, including diet, smoke, and pathogens.
Genetic adaptations, such as changes in the apoE gene, reflect trade-offs balancing inflammation, metabolism, and longevity.
While remarkable lifespan gains have been achieved, biological limits and emerging global environmental challenges (climate change, pollution, infectious disease risks) threaten to stall or reverse these advances.
Addressing these challenges requires integrated public health strategies, environmental protections, and further research into the mechanisms linking inflammation, infection, and aging.
Keywords
Human lifespan evolution
Life expectancy
Infection
Inflammation
Mortality phases
Gompertz model
Apolipoprotein E (apoE)
Hunter-gatherers (Tsimane)
Chronic diseases of aging
Environmental exposures
Climate change
Air pollution
Evolutionary medicine
Early life programming
Aging biology
FAQ
Q1: What causes the increase in human life expectancy after 1800?
A1: Improvements in hygiene, nutrition, and medicine reduced infectious disease mortality, especially in early life, enabling longer survival into old age.
Q2: How does early-life infection affect aging?
A2: Early infections induce chronic inflammation (“cohort morbidity”) that persists and accelerates aging-related mortality and diseases such as cardiovascular conditions.
Q3: Why do humans live longer than great apes despite higher inflammatory exposures?
A3: Humans evolved genetic adaptations, such as apoE variants, and lifestyle changes that mitigate some inflammatory damage, enabling longer lifespan despite greater pro-inflammatory environmental exposures.
Q4: What are the future risks to human longevity gains?
A4: Environmental degradation including air pollution, ozone increase, heat waves, water shortages, and emerging infectious diseases linked to climate change threaten to reverse recent lifespan gains, especially in elderly populations.
Q5: Can lifespan increases continue indefinitely?
A5: Modeling suggests biological and mortality limits near current record lifespans; further gains require slowing or delaying aging processes, which remain challenging.
This summary is grounded entirely in Caleb E. Finch’s original essay and faithfully reflects the detailed scientific content, key findings, and hypotheses presented therein.
Smart Summary...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/tcjukfqx-4399/data/document.pdf", "num_examples": 394, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/tcjukfqx- /home/sid/tuning/finetune/backend/output/tcjukfqx-4399/data/tcjukfqx-4399.json...
|
null
|
completed
|
1764954827
|
1764958539
|
NULL
|
/home/sid/tuning/finetune/backend/output/tcjukfqx- /home/sid/tuning/finetune/backend/output/tcjukfqx-4399/adapter...
|
False
|
Edit
Delete
|
|
729ee0ee-64f5-4ae5-a8f9-4775f728fea1
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
ouycguat-1834
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Evolution of the Value
|
Evolution of the Value of Longevity in China
|
/home/sid/tuning/finetune/backend/output/ouycguat- /home/sid/tuning/finetune/backend/output/ouycguat-1834/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This study investigates the welfare effects of mor This study investigates the welfare effects of mortality decline and longevity improvement in China over six decades (1952-2012), focusing on the monetary valuation of gains in life expectancy and their role relative to economic growth. Utilizing valuation formulae from the Global Health 2035 report, the authors estimate the value of a statistical life (VSL) and analyze how longevity gains have offset poor economic performance in early periods and contributed to reducing regional welfare disparities more recently.
Key Research Objectives
To quantify the value of mortality decline in China from 1952 to 2012.
To evaluate the welfare impact of longevity improvements relative to GDP per capita growth.
To analyze regional differences in health gains and their implications for welfare inequality.
To provide a methodological framework to calculate the value of mortality decline using age-specific mortality rates and GDP data.
Institutional and Historical Context
Life expectancy at birth in China increased from ~45 years in the early 1950s to over 70 years by 2012, with a particularly rapid rise prior to economic reforms in the late 1970s.
This improvement occurred despite stagnant GDP per capita during the pre-reform period (1950-1980).
Key drivers of longevity gain included:
The establishment of grassroots primary healthcare clinics staffed by “barefoot doctors.”
The Patriot Hygiene Campaign (PHC) in the 1950s, which improved sanitation, vaccination, and eradicated infectious diseases.
A basic health system providing employer-based insurance in urban areas and cooperative medical schemes in rural areas.
Increases in primary and secondary education, which indirectly contributed to mortality reduction.
Methodology
The study uses age-specific mortality rates as a proxy for overall health status, leveraging retrospective mortality data available since the 1950s.
The Value of a Statistical Life (VSL) is monetized using a formula linking VSL to GDP per capita and age-specific life expectancy:
The VSL for a 35-year-old is set at 1.8% of GDP per capita.
The value of a small mortality risk reduction (Standardized Mortality Unit, SMU) varies with age proportional to the years of life lost relative to age 35.
The value of mortality decline between two time points is computed as the integral over age of population density multiplied by age-specific changes in mortality risk and weighted by the value of a SMU.
This approach accounts for population age structure and income levels to estimate monetary benefits of longevity improvements.
Data sources include:
United Nations World Population Prospects for mortality rates and life expectancy.
Official Chinese statistical yearbooks for GDP, health expenditures, and census data.
Provincial data analysis focuses on the period 1981 to 2010, coinciding with China’s market reforms.
Main Findings
Time Series Analysis (1952-2012)
Period GDP per capita Change (RMB, 2012 prices) Life Expectancy Gain (years) Value of Mortality Decline (RMB per capita) Ratio of Mortality Value to GDP Change (excl. health exp.)
1957-1962 -152 -0.29 -126 0.84
1962-1967 3897 12.3 2162 5.72
1972-1977 2813 1.74 344 1.28
1982-1987 18041 1.24 338 0.19
1992-1997 40507 7.39 1360 0.32
2002-2007 102971 1.35 1045 0.11
Longevity gains (value of mortality decline) were especially large during the 1960s, partly compensating for poor or negative GDP growth.
The value of mortality decline relative to GDP per capita growth was much higher before 1978, indicating health improvements contributed significantly to welfare despite stagnant incomes.
Post-1978, rapid economic growth outpaced the value of longevity gains, but the latter remained positive and substantial.
Health expenditure is subtracted from GDP to avoid double counting in welfare calculations.
Regional (Provincial) Analysis (1981-2010)
Province GDP per Capita Change (RMB, 2012 prices) Life Expectancy Gain (years) Value of Mortality Decline (RMB per capita) Ratio of Mortality Value to GDP Change (excl. health exp.)
Xinjiang 22738 17.3 2407 0.58
Yunnan 14449 13.15 1857 0.39
Gansu 14945 9.47 264 0.19
Guizhou 12095 9.19 214 0.20
Hebei 27024 5.72 873 0.11
Guangdong 43086 12.05 358 0.13
Jiangsu 50884 12.04 705 0.14
Inland provinces generally experienced larger longevity gains than coastal provinces, despite coastal regions having significantly higher GDP per capita.
The value of mortality decline relative to income growth was higher in less-developed inland provinces, suggesting health improvements partially mitigate regional welfare inequality.
Contrasting trends:
Coastal provinces: faster economic growth but smaller longevity gains.
Inland provinces: slower income growth but larger health gains.
The diminishing returns to longevity gains at higher life expectancy levels explain part of this pattern.
Economic growth can have negative health externalities (pollution, lifestyle changes), which may counteract potential longevity improvements.
Health Transition and Future Challenges
China’s epidemiological transition is characterized by a shift from infectious diseases to non-communicable diseases (NCDs) such as malignant tumors, cerebrovascular disease, heart disease, and respiratory diseases.
Mortality rates for these major NCDs show a rising trend from 1982 to 2012.
The increasing prevalence of chronic diseases imposes a rising medical cost burden, particularly due to advanced medical technologies and health system limitations.
The Chinese government initiated a major health care reform in 2009 aimed at expanding affordable and equitable coverage.
Although health spending has increased, it remains less than one-third of the U.S. level (as % of GDP), indicating room for further investment and improvement.
Conclusions and Implications
The study finds that sustained longevity improvements have played a crucial role in improving welfare in China, especially before economic reforms.
Health gains have partially compensated for weak economic performance prior to market liberalization.
In the reform era, longevity improvements have contributed to narrowing interregional welfare disparities, benefiting poorer inland provinces more.
The value of mortality decline is a meaningful supplement to GDP per capita as an indicator of welfare.
The authors caution that future longevity gains may face challenges due to rising chronic diseases and escalating medical costs.
The methodology and findings are relevant for other low- and middle-income countries undergoing similar demographic and epidemiological transitions.
Core Concepts and Definitions
Term Definition
Life Expectancy Average number of years a newborn is expected to live under current mortality conditions.
Value of a Statistical Life (VSL) Monetary value individuals place on marginal reductions in mortality risk.
Standardized Mortality Unit (SMU) A change in mortality risk of 1 in 10,000 (10^-4).
Value of a SMU (VSMU) Monetary value of reducing mortality risk by one SMU at a given age.
Full Income GDP per capita adjusted for health improvements, including the value of mortality decline.
Highlights
China’s life expectancy rose dramatically from 45 to over 70 years between 1952 and 2012, despite slow GDP growth before reforms.
The monetary value of mortality decline was often larger than GDP growth prior to 1978, showing health’s central role in welfare.
Inland provinces experienced larger longevity gains than coastal provinces, though coastal areas had higher income growth.
Health improvements have helped reduce interregional welfare inequality in China.
The shift from communicable to non-communicable diseases poses new health and economic challenges.
China’s health system reform in 2009 aims to address rising medical costs and expand coverage.
Limitations and Uncertainties
The study assumes a monotonically declining VSL with age, which simplifies but does not capture the full complexity of age-dependent valuations.
Pre-1978 health expenditure data were back-projected, introducing some uncertainty.
Provincial mortality data are only available for census years, limiting longitudinal granularity.
The analysis does not fully incorporate morbidity or quality-of-life changes beyond mortality.
Future extrapolations are uncertain due to evolving epidemiological and demographic dynamics.
References to Key Literature
Jamison et al. (2013) Global Health 2035 report for VSL valuation framework.
Murphy and Topel (2003, 2006) on economic value of health and longevity.
Nordhaus (2003) on full income including health gains.
Becker et al. (2005) on global inequality incorporating longevity.
Aldy and Viscusi (2007, 2008) on age-specific VSL valuation.
Babiarz et al. (2015) on China’s mortality decline under Mao.
Implications for Policy and Future Research
Policymakers should recognize the economic value of health improvements beyond GDP growth.
Investments in basic healthcare, sanitation, and education were critical for China’s longevity transition and remain relevant for other developing countries.
Addressing the burden of chronic diseases and medical costs requires sustained health system reforms.
Future work should explore full income accounting including quality of life, and analyze health and longevity valuation in other low-income and middle-income countries.
More granular data collection and longitudinal studies would improve understanding of regional and cohort-specific health value dynamics.
This comprehensive study demonstrates how longevity gains represent a critical dimension of welfare, particularly in the context of China’s unique historical, demographic, and economic trajectory. It provides a robust analytical framework integrating epidemiological and economic data to quantify health’s contribution to human welfare.
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/ouycguat-1834/data/document.pdf", "num_examples": 103, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/ouycguat- /home/sid/tuning/finetune/backend/output/ouycguat-1834/data/ouycguat-1834.json...
|
null
|
completed
|
1764954799
|
1764955750
|
NULL
|
/home/sid/tuning/finetune/backend/output/ouycguat- /home/sid/tuning/finetune/backend/output/ouycguat-1834/adapter...
|
False
|
Edit
Delete
|
|
4fbfc025-89c1-4bf6-aa79-2a630c998b55
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
xchpkwdf-3230
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Exceptional Human
|
Exceptional Human Longevity
|
/home/sid/tuning/finetune/backend/output/xchpkwdf- /home/sid/tuning/finetune/backend/output/xchpkwdf-3230/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Exceptional human longevity represents an extreme Exceptional human longevity represents an extreme phenotype characterized by individuals who survive to very old ages, such as centenarians (100+ years) or supercentenarians (110+ years), often with delayed onset of age-related diseases or resistance to lethal illnesses. This review synthesizes evidence on the multifactorial nature of longevity, integrating genetic, environmental, cultural, and geographical influences, and discusses health, demographic trends, biological mechanisms, biomarkers, and strategies that promote extended health span and life span.
Key Insights and Core Concepts
Exceptional longevity is defined by both chronological and biological age, emphasizing delayed functional decline and preservation of physiological function.
The biology of aging is heterogeneous, even among the oldest individuals, and no single biomarker reliably predicts longevity.
Longevity is influenced by disparate combinations of genes, environment, resiliency, and chance, shaped by culture and geography.
Compression of morbidity—delaying the onset of disability and chronic diseases—is a critical concept in successful aging.
Empirical strategies supporting longevity involve dietary moderation, regular physical activity, purposeful living, and strong social networks.
Genetic factors contribute to longevity but explain only about 25% of life span variance; environmental and behavioral factors play a dominant role.
Sex differences are notable: women generally live longer than men, with possible links to reproductive biology and hormonal factors.
Resiliency, the ability to respond to stressors and maintain homeostasis, is emerging as a key determinant of successful aging and extended longevity.
Timeline and Demographic Trends
Period/Year Event/Trend
Pre-20th century Probability of living to 100 was approximately 1 in 20 million at birth.
1995 Probability of living to 100 increased to about 1 in 50 for females in low mortality nations.
2009 Probability further increased to approximately 1 in 2.
2015 (Global data) Countries with oldest populations: Japan, Germany, Italy, Greece, Finland, Sweden.
2015 (Life expectancy at age 65) Japan, Macau, Singapore, Australia, Switzerland lead with 20-25 additional years expected.
2013 Last supercentenarian of note: Jiroemon Kimura died at age 116.
Ongoing Maximum human lifespan (~122 years) remains largely unchanged despite increasing average life expectancy.
Characteristics of Centenarians and Supercentenarians
Disease Onset and Morbidity:
Onset of common age-related diseases varies considerably; 24% of males and 43% of females centenarians diagnosed with one or more diseases before age 80.
15% of females and 30% of males remain disease-free at age 100.
Cognitive impairment is often delayed; about 25% of centenarians remain cognitively intact.
Cancer and vascular diseases often develop much later or not at all in supercentenarians.
Functional Status:
Many supercentenarians remain functionally independent or require minimal assistance.
Geographic Clustering of Longevity
Certain regions globally show high concentrations of exceptionally long-lived individuals, highlighting environmental and cultural influences:
Region Notable Longevity Factors
Okinawa, Japan Caloric restriction via “hara hachi bu” (eat until 80% full), plant-based “rainbow diet,” low BMI (~20 kg/m²), slower decline of DHEA hormone.
Sardinia, Italy Genetic lineage from isolated settlers, particularly among men, with unknown genetic traits contributing to longevity.
Loma Linda, California (Seventh Day Adventists) Abstinence from alcohol and tobacco, vegetarian diet, spirituality, lower stress hormone levels.
Nicoya Peninsula, Costa Rica; Ikaria, Greece Commonalities include plant-based diets, moderate eating, purposeful living, social support, exercise, naps, and possibly sunlight exposure.
Table 1 summarizes common longevity factors in clustered populations.
Table 1: Longevity Factors Associated With Geographic Clustering
Longevity Factors
Eating in moderation (small/moderate portions) and mostly plant-based diets, with lighter meals at the end of the day
Purposeful living (life philosophy, volunteerism, work ethic)
Social support systems (family/friends interaction, humor)
Exercise incorporated into daily life (walking, gardening)
Other nutritional factors (e.g., goat’s milk, red wine, herbal teas)
Spirituality
Maintenance of a healthy BMI
Other possible factors: sunshine, hydration, naps
Trends in Longevity and Morbidity
Life expectancy has increased mainly due to reductions in premature deaths (e.g., infant mortality, infectious diseases).
Maximum lifespan (~122 years) remains stable over the past two decades.
Healthy life years vary widely (25%-75% of life expectancy at age 65), with Nordic countries showing the highest expected healthy years.
Compression of morbidity models propose:
No delay in morbidity onset, increased morbidity duration.
Delay in morbidity onset with proportional increase in life expectancy.
Delay in morbidity onset with compression (shorter duration) of morbidity.
Evidence supports some compression of morbidity, but among those aged 85+, morbidity delay may be less pronounced.
Functional disability rates declined in the late 20th century but may be plateauing in the 21st century.
Mechanisms of Longevity
Genetic Influences
Genetic contribution to longevity is supported by:
Conservation of maximum lifespan across species.
Similar longevity in monozygotic twins.
Familial clustering of exceptional longevity.
Genetic diseases of premature aging.
Candidate genes and pathways associated with longevity include:
APOE gene variants (e.g., lower ε4 allele frequency in centenarians).
Insulin/IGF-1 signaling pathways.
Cholesteryl ester transfer protein.
Anti-inflammatory cytokines (e.g., IL-10).
Stress response genes (e.g., heat shock protein 70).
GH receptor exon 3 deletion linked to longer lifespan and enhanced GH sensitivity, especially in males.
Despite these, only ~25% of lifespan variance is genetic, emphasizing the larger role of environment and behavior.
Sex Differences
Women universally live longer than men, with better female survival starting early in life.
Female longevity may relate to reproductive history; older maternal age at last childbirth correlates with longer life.
The “grandmother hypothesis” proposes post-reproductive lifespan enhances offspring and grandchild survival.
Male longevity predictors include occupation and familial relatedness to male centenarians.
Lower growth hormone secretion may explain shorter stature and longer life in women.
Despite longer life, men often show better functional status at older ages.
Resiliency
Defined as the capacity to respond to or resist stressors that cause physiological decline.
Resiliency operates across psychological, physical, and physiological domains.
Examples involve resistance to frailty, cognitive impairment, muscle loss, sleep disorders, and multimorbidity.
Exercise may promote resiliency more effectively than caloric restriction.
Psychological resilience, including reduction of depression, correlates with successful aging.
Resiliency may explain why some centenarians survive despite earlier chronic diseases.
Strategies to Achieve Exceptional Longevity
Dietary Modification:
Moderate caloric restriction (CR) shown to extend lifespan in multiple species.
Human studies (e.g., CALERIE trial) show CR improves metabolic markers and slows biological aging, though sustainability and effects on maximum lifespan remain uncertain.
Benefits of CR in humans are linked to improved cardiovascular risk factors.
Antioxidant supplementation does not convincingly extend lifespan.
Physical Activity:
Regular moderate to vigorous exercise correlates with increased life expectancy and reduced mortality.
Physical activity benefits hold across BMI categories and are especially impactful in older adults.
Body Weight:
Optimal BMI range for longevity is 20.0–24.9 kg/m²; overweight and obesity increase mortality risk.
Social Engagement and Purposeful Living:
Strong social relationships reduce mortality risk comparable to quitting smoking.
Purpose in life associates with less cognitive decline and disability.
Productive engagement improves memory and overall well-being.
Measuring Successful Aging and Biomarkers of Longevity
Biomarkers of aging are sought to quantify biological age, improving prognosis and guiding interventions.
Ideal biomarkers should correlate quantitatively with age, be independent of disease processes, and respond to aging rate modifiers.
Challenges include separating primary aging from disease effects and confounding by nutrition or interventions.
Commonly studied biomarkers include:
Biomarker Category Examples and Notes
Functional Measures Gait speed, grip strength, daily/instrumental activities of daily living (ADLs), cognitive tests
Physiological Parameters Blood glucose, hemoglobin A1c, lipids, inflammatory markers (IL-6), IGF-1, immune cell profiles
Sensory Functions Hearing thresholds, cataract presence, taste and smell tests
Physical Attributes Height (especially in men), muscle mass, body composition
Genetic and Epigenetic Markers DNA methylation patterns, senescent cell burden
Family History Longevity in parents or close relatives
Biomarkers may help distinguish between biological and chronological age, aiding individualized health screening.
Studies in younger cohorts show biological aging varies widely even among same-aged individuals.
Inclusion of centenarians in biomarker research may reveal mechanisms linking health status to exceptional longevity.
Implications for Clinical Practice and Public Health
Increased life expectancy does not necessarily mean longer periods of disability.
Understanding biological age can improve screening guidelines and preventive care by tailoring interventions to individual risk.
Current screening often ignores differences between biological and chronological age, possibly leading to over- or under-screening.
Life expectancy calculators incorporating biological and clinical markers can inform decision-making.
Anticipatory health discussions should integrate biological aging measures for better patient guidance.
Conclusion
Exceptional human longevity results from complex, multifactorial interactions among genetics, environment, culture, lifestyle, resiliency, and chance.
Aging characteristics vary widely even among long-lived individuals.
No single biomarker currently predicts longevity; a combination of clinical, genetic, and functional markers holds promise.
Observations from the oldest old support empirical lifestyle strategies—moderate eating, regular exercise, social engagement, and purposeful living—that promote health span and potentially extend life span.
Advancing biomarker research and personalized health assessments will improve screening, clinical decision-making, and promote successful aging.
Keywords
Exceptional longevity, centenarians, supercentenarians, aging, biomarkers, compression of morbidity, genetic factors, caloric restriction, physical activity, resiliency, biological age, social engagement, sex differences, life expectancy, health span.
References
References are comprehensive and include epidemiological, genetic, physiological, and clinical studies spanning decades, with key contributions from population cohorts, animal models, and intervention trials.
This summary strictly reflects the source content, synthesizing key findings, concepts, and data related to exceptional human longevity without extrapolation beyond the original text.
Smart Summary...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/xchpkwdf-3230/data/document.pdf", "num_examples": 246, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/xchpkwdf- /home/sid/tuning/finetune/backend/output/xchpkwdf-3230/data/xchpkwdf-3230.json...
|
null
|
completed
|
1764954789
|
1764957662
|
NULL
|
/home/sid/tuning/finetune/backend/output/xchpkwdf- /home/sid/tuning/finetune/backend/output/xchpkwdf-3230/adapter...
|
False
|
Edit
Delete
|
|
599ab3a3-c70a-4ba3-aec0-5660dee3f783
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
jofodeku-7336
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Exploring Human Longevity
|
Exploring Human Longevity
|
/home/sid/tuning/finetune/backend/output/jofodeku- /home/sid/tuning/finetune/backend/output/jofodeku-7336/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Riya Kewalani, Insiya Sajjad Hussain Saifudeen Du Riya Kewalani, Insiya Sajjad Hussain Saifudeen Dubai Gem Private School, Oud Metha Road, Dubai, PO Box 989, United Arab Emirates; riya.insiya@gmail.com
ABSTRACT: This research aims to investigate whether climate has an impact on life expectancy. In analyzing economic data from 172 countries that are publicly available from the United Nations World Economic Situation and Prospects 2019, as well as classifying all countries from different regions into hot or cold climate categories, the authors were able to single out income, education, sanitation, healthcare, ethnicity, and diet as constant factors to objectively quantify life expectancy. By measuring life expectancies as indicated by the climate, a comprehensible correlation can be built of whether the climate plays a vital role in prolonging human life expectancy and which type of climate would best support human life. Information gathered and analyzed from examination focused on the contention that human life expectancy can be increased living in colder regions. According to the research, an individual is likely to live an extra 2.2163 years in colder regions solely based on the country’s income status and climate, while completely ruling out genetics. KEYWORDS: Earth and Environmental Sciences; Life expectancy; Climate Science; Longevity; Income groups.
To better understand the study, it is crucial to understand the difference between life span, life expectancy, and longevity. According to the United Nations Population Division, life expectancy at birth is defined as “the average number of years that a newborn could expect to live if he or she were to pass through life subject to the age-specific mortality rates of a given period.” ¹ When addressing the life expectancy of a country, it refers to the mean life span of the populace in that country. This factual normal is determined dependent on a populace in general, including the individuals who die during labor, soon after labor, during puberty or adulthood, the individuals who die in war, and the individuals who live well into mature age. On the other hand, according to News Medical Life Sciences, life span refers to “the maximum number of years that a person can expect to live based on the greatest number of years anyone from the same data set has lived.” ² Taking humans as the model, the oldest recorded age attained by any living individual is 122 years, thereby implicating that human beings have a lifespan of at least 122 years. Life span is also known as longevity. As life expectancy has been extended, factors that affect it have been substantially debated. Consensus on factors that influence life expectancy include gender, ethnicity, pollution, climate change, literacy rate, healthcare access, and income level. Other changeable lifestyle factors also have an impact on life expectancy, including but not limited to, exercise, alcohol, smoking and diet. Nevertheless, life expectancy has for the most part continuously increased over time. The authors’ study aims to quantify and study the factors that affect human life expectancy. According to the American Journal of Physical Anthropology, Neolithic and Bronze Age data collected suggests life expectancy was an average of 36 years for both men and women. ³ Hunter-gatherers had a higher life expectancy than farmers as agriculture was not common yet and
people would resort to hunting and foraging food for survival. From then, life expectancy has been shown to be an upward trend, with most studies suggesting that by the late medieval English era, life expectancy of an aristocrat could be as much as 64 years; a figure that closely resembles the life expectancy of many populations around the world today. The increase in life expectancy is attributed to the advancements made in sanitation, education, and lodging during the nineteenth and mid-twentieth centuries, causing a consistent decrease in early and midlife mortality. Additionally, great progress made in numerous regions of well-being and health, such as the discovery of antibiotics, the green revolution that increased agricultural production, the enhancement of maternal and child survival, and mortality from infectious diseases, particularly human immunodeficiency virus (HIV)/ AIDS, tuberculosis (TB), malaria, and neglected tropical diseases (NTDs), has declined. According to the World Health Organization (WHO), global average life expectancy has increased by 5.5 years between 2000 and 2016, which has been notably the fastest increase since the 1950s.⁴ As per the United Nations World Population Prospects, life expectancy will continue to display an upward trend in all regions of the world. However, the average life expectancy isn’t predicted to grow exponentially as it has these past few decades. Projected increases in life expectancy in Northern America, Europe and Latin American and the Caribbean are expected to become more gradual and stagnant, while projections for Africa continue at a much higher rate compared to the rest of the world. Asia is expected to match the global average by the year 2050. Differences in life expectancy across regions of the world are estimated to persist even into the future due to the differences in group incomes, however, income disparity between regions is forecasted to diminish significantly by 2050 ...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/jofodeku-7336/data/document.pdf"}...
|
/home/sid/tuning/finetune/backend/output/jofodeku- /home/sid/tuning/finetune/backend/output/jofodeku-7336/data/jofodeku-7336.json...
|
null
|
failed
|
1764898903
|
1764902514
|
NULL
|
/home/sid/tuning/finetune/backend/output/jofodeku- /home/sid/tuning/finetune/backend/output/jofodeku-7336/adapter...
|
False
|
Edit
Delete
|
|
579f4130-5f29-4078-90d1-2c08f171f308
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
rmekmkeu-3073
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Exploring Human Longevity
|
Exploring Human Longevity
|
/home/sid/tuning/finetune/backend/output/rmekmkeu- /home/sid/tuning/finetune/backend/output/rmekmkeu-3073/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This research paper investigates the impact of cli This research paper investigates the impact of climate on human life expectancy and longevity, analyzing economic and mortality data from 172 countries to establish whether living in colder climates correlates with longer life spans. By controlling for factors such as income, education, sanitation, healthcare, ethnicity, and diet, the authors aimed to isolate climate as a variable influencing longevity. The study reveals that individuals residing in colder regions tend to live longer than those in warmer climates, with an average increase in life expectancy of approximately 2.22 years attributable solely to climate differences.
Key Concepts and Definitions
Term Definition Source
Life Expectancy The average number of years a newborn is expected to live, assuming current age-specific mortality rates remain constant. United Nations Population Division
Life Span / Longevity The maximum number of years a person can live, based on the longest documented individual (122 years for humans). News Medical Life Sciences
Blue Zones Five global regions where people live significantly longer than average, characterized by healthy lifestyles and warm climates. National Geographic
Free Radical Theory A theory suggesting that aging results from cellular damage caused by reactive oxidative species (ROS), potentially slowed by cold. Antioxidants & Redox Signaling (Gladyshev)
Historical and Global Trends in Life Expectancy
Neolithic and Bronze Age: Average life expectancy was approximately 36 years, with hunter-gatherers living longer than early farmers.
Late medieval English aristocrats: Life expectancy reached around 64 years, comparable to modern averages.
19th to mid-20th century: Significant increases in life expectancy due to improvements in sanitation, education, housing, antibiotics, agriculture (Green Revolution), and reductions in infectious diseases such as HIV/AIDS, TB, and malaria.
2000 to 2016: Global average life expectancy increased by 5.5 years, the fastest rise since the 1950s (WHO).
Future projections: Life expectancy will continue to rise globally but at a slower pace, with Africa seeing the most substantial increases, while Northern America, Europe, and Latin America expect more gradual improvements.
Research Objectives and Methodology
Objective: To quantify the effect of climate on life expectancy while controlling for socio-economic factors such as income, healthcare access, education, sanitation, ethnicity, and diet.
Data sources: United Nations World Economic Situation and Prospects 2019, United Nations World Mortality Report 2019.
Country classification:
Four income groups: high, upper-middle, lower-middle, and low income.
Climate groups: “mainly warm” (tropical, subtropical, Mediterranean, savanna, equatorial) and “mainly cold” (temperate, continental, oceanic, maritime, highland).
Statistical analysis: ANOVA (Analysis of Variance) was used to determine the statistical significance of climate on life expectancy across and within groups.
Climate Classification and Geographic Distribution
Warm climate regions constitute about 66.2% of the world.
Cold climate regions constitute approximately 33.8% of the world.
Some large countries with diverse climates (e.g., USA, China) were classified based on majority regional climate.
Quantitative Results
Income Group Mean Life Expectancy (Warm Climate) Mean Life Expectancy (Cold Climate) Difference (Years) SD Warm Climate SD Cold Climate
High income Not specified Not specified Not specified Not specified Not specified
Upper-middle income Not specified Not specified Not specified Not specified Not specified
Lower-middle income Almost equal Slightly higher (by 0.237 years) 0.2372 Higher Lower
Low income Not specified Higher by 5.91 years 5.9099 Higher Lower
Overall average: Living in colder climates prolongs life expectancy by approximately 2.2163 years across all income groups.
Standard deviation: Greater variability in life expectancy was observed in warmer climates, indicating uneven health outcomes.
Regional Life Expectancy Insights
Region Climate Type Mean Life Expectancy (Years)
Southern Europe Cold 82.3
Western Europe Cold 81.9
Northern Europe Cold 81.2
Western Africa Warm 57.9
Middle Africa Warm 59.9
Southern Africa Warm 63.8
Colder regions generally show higher life expectancy.
Warmer regions, especially in Africa, tend to have lower life expectancy.
Statistical Significance (ANOVA Results)
Parameter Value Interpretation
F-value 49.88 Large value indicates significant differences between groups
p-value 0.00 (less than 0.05) Strong evidence against the null hypothesis (no effect of climate)
Variance between groups More than double variance within groups Climate significantly affects life expectancy
Theoretical Perspectives on Climate and Longevity
Warm climate argument: Some studies suggest higher mortality in colder months; e.g., 13% more deaths in winter than summer in the U.S. (Professor F. Ellis, Yale).
Cold climate argument: Supported by the free radical theory, colder temperatures may slow metabolic reactions, reducing reactive oxidative species (ROS) and cellular damage, thereby slowing aging.
Experimental evidence from animals (worms, mice) shows lifespan extension under colder conditions, with genetic pathways triggered by cold exposure.
Impact of Climate Change on Longevity
Rising global temperatures pose risks to human health and longevity, including:
Increased frequency of extreme weather events (heatwaves, floods, droughts).
Increased spread of infectious diseases.
Negative impacts on agriculture reducing food security and nutritional quality.
Air pollution exacerbating respiratory diseases.
Studies show a 1°C increase in temperature raises elderly death rates by 2.8% to 4.0%.
Projected effects include malnutrition, increased disease burden, and infrastructure stress, all threatening to reduce life expectancy.
Limitations and Considerations
Genetic factors: Approximately one-third of life expectancy variation is attributed to genetics (genes like APOE, FOXO3, CETP).
Climate classification biases: Countries with multiple climate zones were classified according to majority, potentially oversimplifying climate impacts.
Lifestyle factors: Blue zones with warm climates show exceptional longevity due to diet, exercise, and stress management, illustrating that climate is not the sole determinant.
Migration and localized data: Studies on migrants support climate’s role in longevity independent of genetics and lifestyle.
Practical Implications and Recommendations
While individuals cannot relocate easily to colder climates, practices such as cold showers and cryotherapy might induce genetic responses linked to longevity.
This study emphasizes the urgent need to address climate change mitigation to prevent adverse effects on human health and lifespan.
Calls for further research into:
The genetic mechanisms influenced by climate.
The potential of cryonics and cold exposure therapies to extend longevity.
More granular studies factoring lifestyle, genetics, and microclimates.
Conclusion
Colder climates are consistently associated with longer human life expectancy, with an average increase of about 2.2 years across income levels.
Climate change and global warming threaten to reduce life expectancy globally through multiple pathways.
While genetics and lifestyle factors play critical roles, climate remains a significant environmental determinant of longevity.
The study advocates for urgent global climate action and further research into climate-genetics interactions to better understand and protect human health.
Keywords
Life expectancy
Longevity
Climate impact
Cold climate
Warm climate
Climate change
Income groups
Free radical theory
Blue zones
Public health
References
Selected key references from the original content:
United Nations Population Division (Life Expectancy definitions)
World Health Organization (Life Expectancy data, Climate Effects)
National Geographic (Blue Zones)
American Journal of Physical Anthropology (Historical life expectancy)
Studies on genetic impact of temperature on longevity (University of Michigan, Scripps Research Institute)
Stanford University and MIT migration study on location and mortality
This summary strictly reflects the content and data presented in the source document without fabrication or unsupported extrapolations.
Smart Summary...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/rmekmkeu-3073/data/document.pdf", "num_examples": 74, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/rmekmkeu- /home/sid/tuning/finetune/backend/output/rmekmkeu-3073/data/rmekmkeu-3073.json...
|
null
|
completed
|
1764953016
|
1764953832
|
NULL
|
/home/sid/tuning/finetune/backend/output/rmekmkeu- /home/sid/tuning/finetune/backend/output/rmekmkeu-3073/adapter...
|
False
|
Edit
Delete
|
|
610d43ac-65f6-47e5-a69a-f1a32f2f983d
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
kvtjlwpn-8118
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Extension of longevity
|
Extension of longevity in Drosophila mojavensis by
|
/home/sid/tuning/finetune/backend/output/kvtjlwpn- /home/sid/tuning/finetune/backend/output/kvtjlwpn-8118/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Summary
The study by Starmer, Heed, and Rockwood- Summary
The study by Starmer, Heed, and Rockwood-Slusser (1977) investigates the extension of longevity in Drosophila mojavensis when exposed to environmental ethanol and explores the genetic and ecological factors underlying this phenomenon. The authors focus on differences between subraces of D. mojavensis, emphasizing the role of alcohol dehydrogenase (ADH) isozyme polymorphisms, environmental heterogeneity of host plants, and related genetic elements.
Core Findings
Longevity Increase by Ethanol Exposure: Adult D. mojavensis flies, which breed and feed on necrotic cacti, show a significant increase in longevity when exposed to atmospheric ethanol. This longevity extension is:
Diet-independent (i.e., does not depend on yeast ingestion).
Accompanied by retention of mature ovarioles and eggs in females, indicating not just longer life but maintained reproductive potential.
Subrace Differences: Longevity increases differ among strains from different geographic regions:
Flies from Arizona and Sonora, Mexico (subrace BI) exhibit the greatest increase in longevity.
Flies from Baja California, Mexico (subrace BII) show the least increase.
Genetic Correlations:
The longevity response correlates with the frequency of alleles at the alcohol dehydrogenase locus (Adh).
Adh-S allele (slow electrophoretic form) is prevalent in Arizona and Sonora populations; its enzyme product is more heat- and pH-tolerant.
Adh-F allele (fast electrophoretic form) predominates in Baja California populations; its enzyme product is heat- and pH-sensitive but shows higher activity with isopropanol as substrate.
Modifier genes, including those associated with chromosomal inversions on the second chromosome (housing the octanol dehydrogenase locus), may also influence longevity response.
Environmental Heterogeneity: Differences in longevity and allele frequencies correspond to the distinct physical and chemical environments of the host cacti:
Arizona-Sonora flies breed on organpipe cactus (Lemaireocereus thurberi), which exhibits extreme temperature and pH variability.
Baja California flies breed on agria cactus (Machaerocereus gummosus), which shows moderate temperature and pH but contains relatively high concentrations of isopropanol.
The interaction between substrate alcohol content, temperature, and pH likely maintains the polymorphism at the ADH locus and influences evolutionary adaptations.
Experimental Design and Key Results
Experimental Setup
Flies were exposed to various concentrations of atmospheric ethanol (0.0% to 8.0% vol/vol) in sealed vials containing cotton soaked with ethanol solutions.
Longevity was measured as the lifespan of adult flies exposed to ethanol vapors, and data were log-transformed (ln[hr]) for statistical analysis.
Different strains from Baja California, Sonora, and Arizona were tested, alongside analysis of ADH allele frequencies and chromosomal inversions.
Axenic (microbe-free) strains were used to test the effect of yeast ingestion on longevity.
Summary of Key Experiments
Experiment Purpose Main Result
1 (Ethanol dose response) Test longevity response of D. mojavensis adults to ethanol vapors at different concentrations Longevity increased significantly at 1.0%, 2.0%, and 4.0% ethanol; highest female longevity observed in 4.0% ethanol group, with retention of mature eggs
2 (Yeast dependence) Assess whether longevity increase depends on live yeast ingestion Longevity increase occurred regardless of yeast treatment; live yeasts (Candida krusei or Kloeckera apiculata) not essential for enhanced longevity
3 (Subrace and sex differences) Compare longevity response among strains from different regions and sexes Females from Arizona-Sonora (subrace BI) showed significantly greater relative longevity increase than Baja California (subrace BII); males showed less pronounced differences
4 (Isozyme stability tests) Measure heat and pH stability of ADH-F and ADH-S isozymes ADH-F enzyme less stable at high temperature (45°C) and acidic pH compared to ADH-S; ADH-F activity reduced after 7-11 minutes heat exposure
Quantitative Data Highlights
Longevity Response to Ethanol Concentrations (Experiment 1)
Ethanol Concentration (%) Effect on Longevity
0.0 (Control) Baseline
0.5 No significant increase
1.0 Significant increase
2.0 Significant increase (highest relative longevity)
4.0 Significant increase
8.0 No increase (toxicity likely)
Analysis of Variance (Table 1 and Table 3)
Source of Variation Significance (p-value) Effect Description
Ethanol treatment p < 0.001 Strong effect on longevity
Yeast treatment Not significant No strong effect on longevity
Interaction (Ethanol x Yeast) p < 0.05 Minor effects, but overall yeast not required
Subrace p < 0.001 Significant effect on relative longevity
Sex Not significant Sex alone not significant, but sex x subrace interaction significant
Subrace x Sex interaction p < 0.001 Males and females respond differently across subraces
Ethanol treatment (dose) p < 0.01 Different doses produce varying longevity effects
Correlation Coefficients (Longevity Response vs. Genetic Factors)
Genetic Factor Correlation with Longevity Response at 2.0% Ethanol Correlation at 4.0% Ethanol
Frequency of Adh-F allele -0.633 (negative correlation) -0.554 (negative correlation)
Frequency of ST chromosomal arrangement (3rd chromosome) -0.131 (non-significant) 0.004 (non-significant)
Frequency of LP chromosomal arrangement (2nd chromosome) -0.694 (negative correlation) -0.713 (negative correlation)
Ecological and Genetic Interpretations
The Adh-S allele product is more heat- and pH-tolerant, which suits the variable, extreme environment of the organpipe cactus in Arizona and Sonora.
The Adh-F allele product is less stable under heat and acidic conditions but metabolizes isopropanol effectively, aligning with the chemical environment of Baja California’s agria cactus.
The distribution of Adh alleles matches the physical and chemical characteristics of the host cactus substrates, suggesting natural selection shapes the genetic polymorphism at the ADH locus.
The presence of isopropanol in agria cactus tissues may favor the Adh-F allele, as its enzyme shows higher activity with isopropanol.
The second chromosome inversion frequency correlates with longevity response, implicating the octanol dehydrogenase locus and potential modifier genes in ethanol tolerance.
Biological Significance and Implications
The study supports the hypothesis that environmental ethanol serves as a selective agent influencing longevity and allele frequencies in desert-adapted Drosophila.
The increased longevity and maintained reproductive capacity in ethanol vapor suggest a fitness advantage and physiological adaptation.
Findings align with broader research on **genetic polymorphisms in Dros
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/kvtjlwpn-8118/data/document.pdf", "num_examples": 16, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/kvtjlwpn- /home/sid/tuning/finetune/backend/output/kvtjlwpn-8118/data/kvtjlwpn-8118.json...
|
null
|
completed
|
1764952884
|
1764953213
|
NULL
|
/home/sid/tuning/finetune/backend/output/kvtjlwpn- /home/sid/tuning/finetune/backend/output/kvtjlwpn-8118/adapter...
|
False
|
Edit
Delete
|
|
fa2412f1-1dd3-4cc4-a725-71764cd89464
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
hnaapmmu-5222
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Extreme Human Lifespan
|
Extreme Human Lifespan
|
/home/sid/tuning/finetune/backend/output/hnaapmmu- /home/sid/tuning/finetune/backend/output/hnaapmmu-5222/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
The indexed individual, from now on termed M116, w The indexed individual, from now on termed M116, was the world's oldest verified living person from January 17th 2023 until her passing on August 19th 2024, reaching the age of 117 years and 168 days (https://www.supercentenarian.com/records.html). She was a Caucasian woman born on March 4th 1907 in San Francisco, USA, from Spanish parents and settled in Spain since she was 8. A timeline of her life events and her genealogical tree are shown in Supplementary Fig. 1a-b. Although centenarians are becoming more common in the demographics of human populations, the so-called supercentenarians (over 110 years old) are still a rarity. In Catalonia, the historic nation where M116 lived, the lifeexpectancy for women is 86 years, so she exceeded the average by more than 30 years (https://www.idescat.cat). In a similar manner to premature aging syndromes, such as Hutchinson-Gilford Progeria and Werner syndrome, which can provide relevant clues about the mechanisms of aging, the study of supercentenarians might also shed light on the pathways involved in lifespan. To unfold the biological properties exhibited by such a remarkable human being, we developed a comprehensive multiomics analysis of her genomic, transcriptomic, metabolomic, proteomic, microbiomic and epigenomic landscapes in different tissues, as depicted in Fig. 1a, comparing the results with those observed in non-supercentenarian populations. The picture that emerges from our study shows that extremely advanced age and poor health are not intrinsically linked and that both processes can be distinguished and dissected at the molecular level.
RESULTS AND DISCUSSION Samples from the subject were obtained from four different sources: total peripheral blood, saliva, urine and stool at different times. Most of the analyses were performed in the blood material at the time point of 116 years and 74 days, unless otherwise specifically indicated (Data set 1). The simple karyotype of the supercentenarian did not show any gross chromosomal alteration (Supplementary Fig. 1c). Since many reports indicate the involvement of telomeres in aging and lifespan1, we interrogated the telomere length of the M116 individual using High-Throughput Quantitative Fluorescence In Situ Hybridization (HT-Q-FISH) analysis2. Illustrative confocal images with DAPI staining and the telomeric probe (TTAGGG) for M116 and two control samples are shown in Fig. 1b. Strikingly, we observed that the supercentenarian exhibited the shortest mean telomere length among all healthy volunteers3 with a value of barely 8 kb (Fig. 1c). Even more noticeably, the M116 individual displayed a 40% of short telomeres below the 20th percentile of all the studied samples (Fig. 1c). Thus, the observed far reach longevity of our case occurred in the chromosomal context of extremely short telomeres. Interestingly, because the M116 individual presented an overall good health status, it is tempting to speculate that, in this ...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/hnaapmmu-5222/data/document.pdf", "num_examples": 146, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/hnaapmmu- /home/sid/tuning/finetune/backend/output/hnaapmmu-5222/data/hnaapmmu-5222.json...
|
null
|
completed
|
1764899005
|
1764907799
|
NULL
|
/home/sid/tuning/finetune/backend/output/hnaapmmu- /home/sid/tuning/finetune/backend/output/hnaapmmu-5222/adapter...
|
False
|
Edit
Delete
|
|
7a453b4c-8cda-4d13-a11a-ee3df9e1f243
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
dutcyoah-2300
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Extreme longevity
|
Extreme longevity in proteinaceous deep-sea corals
|
/home/sid/tuning/finetune/backend/output/dutcyoah- /home/sid/tuning/finetune/backend/output/dutcyoah-2300/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This study investigates the extreme longevity, gro This study investigates the extreme longevity, growth rates, and ecological significance of two proteinaceous deep-sea coral species, Gerardia sp. and Leiopathes sp., found in deep waters around Hawai’i and other global locations. Using radiocarbon dating and stable isotope analyses, the research reveals that these corals exhibit remarkably slow growth and lifespans extending thousands of years, far surpassing previous estimates. These findings have profound implications for deep-sea coral ecology, conservation, and fisheries management.
Key Insights
Deep-sea corals Gerardia sp. and Leiopathes sp. grow exceptionally slowly, with radial growth rates ranging from 4 to 85 µm per year.
Individual colonies can live for hundreds to several thousand years, with the oldest Gerardia specimen aged at 2,742 years and the oldest Leiopathes specimen at 4,265 years, making Leiopathes the oldest known skeletal accreting marine organism.
The corals feed primarily on freshly exported particulate organic matter (POM) from surface waters, as indicated by stable carbon (δ13C) and nitrogen (δ15N) isotope data.
Radiocarbon analyses confirm the skeletal carbon originates from modern surface-water carbon sources, indicating minimal incorporation of old, “14C-free” carbon into the skeleton.
These slow growth rates and extreme longevities imply that deep-sea coral habitats are vulnerable to damage and slow to recover, challenging assumptions about their renewability.
Deep-sea coral communities are critical habitat hotspots for various fish and invertebrates, contributing to deep-sea biodiversity and ecosystem complexity.
Human impacts such as commercial harvesting for jewelry, deep-water fishing, and bottom trawling pose significant threats to these fragile ecosystems.
The study emphasizes the need for international, ecosystem-based conservation strategies and suggests current fisheries management frameworks may underestimate the vulnerability of these corals.
Background and Context
Deep-sea corals colonize hard substrates on seamounts and continental margins at depths of 300 to 3,000 meters worldwide. These corals form complex habitats that support high biodiversity and serve as important ecological refuges and feeding grounds for various marine species, including commercially valuable fish and endangered marine mammals like the Hawaiian monk seal.
Prior estimates of deep-sea coral longevity were inconsistent, ranging from decades (based on amino acid racemization and growth-band counts) to over a thousand years (based on radiocarbon dating). This study clarifies these discrepancies by:
Applying high-resolution radiocarbon dating to both living and subfossil coral specimens.
Using stable isotope analysis to identify coral carbon sources and trophic levels.
Comparing radiocarbon signatures in coral tissues and skeletons with surface-water carbon histories.
Methods Overview
Samples of Gerardia and Leiopathes were collected from several deep-sea coral beds around Hawai’i (Makapuu, Lanikai, Keahole Point, and Cross Seamount) using the NOAA/Hawaiian Undersea Research Laboratory’s Pisces submersibles.
Coral skeletons were sectioned radially, and microtome slicing was used to obtain thin layers (~100 µm) for precise radiocarbon analysis.
Radiocarbon (14C) ages were calibrated to calendar years using established reservoir age corrections.
Stable isotope analyses (δ13C and δ15N) were conducted on dried polyp tissues to determine trophic level and carbon sources.
Growth rates were calculated from radiocarbon profiles and bomb-pulse 14C signatures (the increase in atmospheric 14C from nuclear testing in the 1950s-60s).
Detailed Findings
Growth Rates and Longevity
Species Radial Growth Rate (µm/year) Maximum Individual Longevity (years)
Gerardia sp. Average 36 ± 20 (range 11-85) Up to 2,742
Leiopathes sp. Approximately 5 Up to 4,265
Gerardia growth rates vary widely but average around 36 µm/year.
Leiopathes grows more slowly (~5 µm/year) but lives longer.
Some Leiopathes specimens show faster initial growth (~13 µm/year) that slows with age.
Carbon Sources and Trophic Ecology
δ13C values for living polyp tissues of both species average around –19.3‰ (Gerardia) and –19.7‰ (Leiopathes), consistent with marine particulate organic carbon.
δ15N values are enriched relative to surface POM, averaging 8.3‰ (Gerardia) and 9.3‰ (Leiopathes), indicating they are low-order consumers, feeding primarily on freshly exported surface-derived POM.
Proteinaceous skeleton δ13C is slightly enriched (~3‰) compared to tissues, likely due to lipid exclusion in skeletal formation.
Radiocarbon profiles of coral skeletons closely match surface-water 14C histories, including bomb-pulse signals, confirming rapid transport of surface carbon to depth and minimal incorporation of old sedimentary carbon.
Ecological and Conservation Implications
The extreme longevity and slow growth of these corals imply that population recovery from physical disturbance (e.g., fishing gear, harvesting) takes centuries to millennia.
Deep-sea coral beds function as keystone habitats, enhancing biodiversity and providing essential fish habitat, including for endangered species.
Physical disturbances like bottom trawling, line entanglement, and coral harvesting for jewelry threaten these corals and their associated communities.
Existing fisheries management may overestimate sustainable harvest limits, especially for Gerardia, due to underestimating longevity and growth rates.
The United States Magnuson-Stevens Fishery Conservation and Management Act (MSA) recognizes deep-sea corals as “essential fish habitat,” but enforcement and protection vary.
The study advocates for international, ecosystem-based management approaches that consider both surface ocean changes (e.g., climate change, ocean acidification) and deep-sea impacts.
The longevity data suggest that damage to these corals should not be considered temporary on human timescales, underscoring the need for precautionary management.
Timeline Table: Key Chronological Events (Related to Coral Growth and Study)
Event/Measurement Description
~4,265 years ago (calibrated 14C age) Oldest Leiopathes specimen basal attachment age
~2,742 years ago (calibrated 14C age) Oldest Gerardia specimen age
1957 Reference year for bomb-pulse 14C calibration in radiocarbon dating
2004 Sample collection year from Hawai’ian deep-sea coral beds
2006/2007 Magnuson-Stevens Act reauthorization increasing protection for deep-sea coral habitats
Present (2008-2009) Publication and review of this study
Quantitative Data Summary: Isotopic Composition of Coral Tissues and POM
Parameter Gerardia sp. (n=10) Leiopathes sp. (n=2) Hawaiian POM at 150 m (Station ALOHA)
δ13C (‰) –19.3 ± 0.8 –19.7 ± 0.3 –21 ± 1
δ15N (‰) 8.3 ± 0.3 9.3 ± 0.6 2 to 4 (range)
C:N Ratio 3.3 ± 0.3 5.1 ± 0.1 Not specified
Core Concepts
Radiocarbon dating (14C) enables precise age determination of coral skeletons by comparing measured 14C levels to known atmospheric and oceanic 14C histories.
Bomb-pulse 14C is a distinct marker from nuclear testing that provides a temporal reference point for recent growth.
Stable isotope ratios (δ13C and δ15N) provide insights into trophic ecology and carbon sources.
Radial growth rates measure the increase in coral skeleton thickness per year, reflecting growth speed.
Longevity estimates derive from radiocarbon age calibrations of inner and outer skeletal layers.
Deep-sea coral beds are ecosystem engineers, forming complex habitats critical for marine biodiversity.
Conservation challenges arise due to very slow growth and extreme longevity, combined with anthropogenic threats.
Conclusions
Gerardia and Leiopathes deep-sea corals exhibit unprecedented longevity, with lifespans of up to 2,700 and 4,200 years, respectively.
Their slow radial growth rates and feeding on freshly exported surface POM indicate a close ecological coupling between surface ocean productivity and deep-sea benthic communities.
The longevity and slow recovery rates imply that damage to deep-sea coral beds is effectively irreversible on human timescales, demanding precautionary and stringent management.
These species serve as critical habitat-formers in the deep sea, supporting diverse marine life and contributing to ecosystem complexity.
There is an urgent need for international, ecosystem-based conservation strategies to protect these unique and vulnerable communities from fishing impacts, harvesting, and environmental changes.
Current fisheries management frameworks may inadequately reflect the nonrenewable nature of these coral populations and require revision based on these findings.
Keywords
Deep-sea corals
Gerardia sp.
Leiopathes sp.
Radiocarbon dating
Longevity
Radial growth rate
Stable isotopes (δ13C, δ15N)
Particulate organic matter (POM)
Deep-sea biodiversity
Conservation
Fisheries management
Magnuson-Stevens Act
Bomb-pulse 14C
Proteinaceous skeleton
References to Note (from source)
Radiocarbon dating and longevity studies (Roark et al., 2006; Druffel et al., 1995)
Stable isotope methodology and trophic level assessment (DeNiro & Epstein, 1981; Rau, 1982)
Fisheries and habitat conservation frameworks (Magnuson-Stevens Act, 2006/2007 reauthorization)
Ecological significance of deep-sea corals (Freiwald et al., 2004; Parrish et al., 2002)
This comprehensive analysis underscores the exceptional longevity and ecological importance of proteinaceous deep-sea corals, highlighting the need for improved management and protection policies given their vulnerability and slow recovery potential.
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/dutcyoah-2300/data/document.pdf", "num_examples": 100, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/dutcyoah- /home/sid/tuning/finetune/backend/output/dutcyoah-2300/data/dutcyoah-2300.json...
|
null
|
completed
|
1764952838
|
1764953583
|
NULL
|
/home/sid/tuning/finetune/backend/output/dutcyoah- /home/sid/tuning/finetune/backend/output/dutcyoah-2300/adapter...
|
False
|
Edit
Delete
|
|
ddccee11-28af-48ae-b39e-fc4eaf40d4f7
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
wtkdpdnf-7423
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Extreme longevity may be
|
Extreme longevity may be the rule
|
/home/sid/tuning/finetune/backend/output/wtkdpdnf- /home/sid/tuning/finetune/backend/output/wtkdpdnf-7423/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
This study by Breed et al. (2024) investigates the This study by Breed et al. (2024) investigates the longevity of Balaenid whales, focusing on the southern right whale (SRW, Eubalaena australis) and the North Atlantic right whale (NARW, Eubalaena glacialis). By analyzing over 40 years of mark-recapture data, the authors estimate life spans and survival patterns, revealing that extreme longevity (exceeding 130 years) is likely the norm rather than the exception in Balaenid whales, challenging previously accepted maximum life spans of 70–75 years. The study also highlights the impact of anthropogenic factors, particularly industrial whaling, on the significantly reduced life span of the endangered NARW.
Key Findings
Southern right whales (SRWs) have a median life span of approximately 73.4 years, with 10% of individuals surviving beyond 131.8 years.
North Atlantic right whales (NARWs) have a median life span of only 22.3 years, with 10% living past 47.2 years—considerably shorter than SRWs.
The reduced NARW life span is attributed to anthropogenic mortality factors, including ship strikes and entanglements, not intrinsic biological differences.
The study uses survival function modeling, bypassing traditional aging methods that rely on lethal sampling and growth layer counts, which tend to underestimate longevity.
Evidence from other whales, especially bowhead whales, supports the hypothesis that extreme longevity is widespread among Balaenids and possibly other large cetaceans.
Background and Context
Early longevity estimates in whales, such as blue and fin whales, came from counting annual growth layers in ear plugs, revealing ages up to 110–114 years.
Bowhead whales have been documented to live over 150 years, with some individuals estimated at 211 years based on aspartic acid racemization (AAR) and corroborating archaeological evidence (e.g., embedded antique harpoon tips).
Longevity estimates from traditional methods are biased low due to:
Difficulty in counting growth layers in very old whales due to tissue remodeling.
Removal of older age classes from populations by industrial whaling.
The need for lethal sampling to obtain age data, which is rarely possible in protected species.
The relation between body size and longevity supports the potential for extreme longevity in large whales, although bowhead whales exceed predictions from terrestrial mammal models.
Methodology
Data Sources:
SRW mark-recapture data from South Africa (1979–2021), including 2476 unique females, of which 139 had known birth years.
NARW mark-recapture data from the North Atlantic (1974–2020), including 328 unique females, of which 205 had known birth years.
Survival Models:
Ten parametric survival models were fitted, including Gompertz, Weibull, Logistic, and Exponential mortality functions with adjustments (Makeham and bathtub).
Models were fit using Bayesian inference with the R package BaSTA, which accounts for left truncation (unknown birth years) and right censoring (individuals surviving past the study period).
Model selection was based on Deviance Information Criterion (DIC).
Validation:
Simulated datasets, generated from fitted model parameters, were used to test for bias and accuracy.
Models accurately recovered survival parameters with minimal bias.
Estimating Reproductive Output:
The total number of calves produced by females was estimated by integrating survival curves and applying calving intervals ranging from 3 to 7 years.
Results
Parameter Southern Right Whale (SRW) North Atlantic Right Whale (NARW)
Median life span (years) 73.4 (95% CI [60.0, 88.3]) 22.3 (95% CI [19.7, 25.1])
10% survive past (years) 131.8 (95% CI [110.9, 159.3]) 47.2 (95% CI [43.0, 53.3])
Annual mortality hazard (age 5) ~0.5% 2.56%
Maximum life span potential >130 years Shortened due to anthropogenic factors
**SRW survival best fits an unmodified Gompertz model; NARW fits a Gompertz model with
Smart Summary
...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/wtkdpdnf-7423/data/document.pdf", "num_examples": 185, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/wtkdpdnf- /home/sid/tuning/finetune/backend/output/wtkdpdnf-7423/data/wtkdpdnf-7423.json...
|
null
|
completed
|
1764952794
|
1764953927
|
NULL
|
/home/sid/tuning/finetune/backend/output/wtkdpdnf- /home/sid/tuning/finetune/backend/output/wtkdpdnf-7423/adapter...
|
False
|
Edit
Delete
|
|
4049b9b7-8736-4425-92de-01b9ed099ed3
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
blxnbukh-0859
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
Family matters
|
Family matters in unravelling human longevity
|
/home/sid/tuning/finetune/backend/output/blxnbukh- /home/sid/tuning/finetune/backend/output/blxnbukh-0859/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Human life expectancy has doubled over the past 20 Human life expectancy has doubled over the past 200 years in industrialized countries, yet the period spent in good physical and cognitive health remains relatively short. A significant proportion of elderly individuals suffer from multiple chronic diseases; for instance, 70% of 65-year-olds and 90% of 85-year-olds have at least one disease, averaging four diseases per person. In contrast, a small subset of individuals achieves exceptional longevity without typical age-related diseases such as hypertension, cancer, or type 2 diabetes. Understanding these individuals is crucial because they likely possess gene-environment interactions that promote longevity, disease resistance, and healthy aging.
Key Insights on Longevity Research
Most knowledge on aging mechanisms is derived from animal models, which identified nine hallmarks of aging and implicated glucose and fat metabolism pathways in longevity.
Human longevity is far more complex due to heterogeneity in genomes, lifestyles, environments, and social factors.
Genetic factors contribute approximately 25% to lifespan variation, with a stronger influence observed in long-lived individuals as indicated by familial clustering.
Despite extensive genetic research, only two genes—APOE and FOXO3A—have been consistently associated with longevity.
The lack of a consistent definition of heritable longevity complicates genetic studies, often mixing sporadic long-lived cases with those from long-lived families.
The increase in centenarians (e.g., from 1 in 10,000 to 2 in 10,000 in the US between 1994 and 2012) reflects the presence of sporadically long-lived individuals, which confounds genetic analyses.
Challenges in Genetic Longevity Studies
Genome Wide Association Studies (GWAS) face difficulties because controls (average-lived individuals) might later become long-lived, blurring case-control distinctions.
Recent findings emphasize the importance of rare and structural genetic variants alongside common single nucleotide polymorphisms (SNPs).
Socio-behavioral and environmental factors (lifestyle, socio-economic status, social networks, living environment) significantly influence aging but are rarely integrated into genetic studies.
There is limited knowledge about how these non-genetic factors cluster within long-lived families.
Advances Through Family-Based Research
Two recent studies using large family tree databases—the Utah Population Database (UPDB), LINKing System for historical family reconstruction (LINKS), and Historical Sample of the Netherlands Long Lives (HSN-LL)—demonstrated that:
Longevity is transmitted across generations only if ≥30% of ancestors belong to the top 10% longest-lived of their birth cohort, and the individual themselves is in the top 10% longest-lived.
Approximately 27% of individuals with at least one long-lived parent did not show exceptional survival, indicating sporadic longevity.
To address this, the Longevity Relatives Count (LRC) score was developed to identify genetically enriched long-lived individuals, improving case selection for genetic studies and reducing sporadic longevity inclusion.
Opportunities and Recommendations
Increasing availability of population-wide family tree data (e.g., Netherlands’ civil certificate linkage, Denmark’s initiatives) enables broader analysis of long-lived families rather than individuals alone.
Integrating gene-environment (G x E) interactions by combining genetic data with genealogical, socio-behavioral, and environmental information is essential to unravel mechanisms of longevity.
Epidemiological studies should:
Recruit members from heritable longevity families.
Collect comprehensive molecular, socio-behavioral, and environmental data.
Include analyses of rare and structural genetic variants in addition to common SNPs.
Cohorts like the UK Biobank can improve the distinction between cases and controls by incorporating the LRC score based on ancestral survival data.
Conclusion
The success of genetic studies on human longevity depends on:
Applying precise, consistent definitions of heritable longevity.
Utilizing family-based approaches and large-scale genealogical data.
Incorporating non-genetic covariates such as socio-behavioral and environmental factors.
Studying interactions between genes and environment to gain comprehensive mechanistic insights into healthy aging and longevity.
Quantitative Data Table
Parameter Statistic/Description
Increase in centenarians From 1 in 10,000 (1994) to 2 in 10,000 (2012)
% of 65-year-olds with ≥1 disease 70%
% of 85-year-olds with ≥1 disease 90%
Average number of diseases in elderly 4
Genetic contribution to lifespan ~25% overall, higher in long-lived families
Ancestor longevity threshold for heritability ≥30% ancestors in top 10% longest-lived cohort
Proportion with survival similar to general population despite long-lived parent 27%
Keywords
Human longevity
Healthy aging
Gene-environment interaction (G x E)
Genetic variation
Familial clustering
Longevity Relatives Count (LRC) score
Genome Wide Association Studies (GWAS)
Rare and structural variants
Socio-behavioral factors
Epidemiological studies
Population-wide family tree databases
References
References are based on the original source and include studies on aging, longevity genetics, and epidemiological family databases....
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/blxnbukh-0859/data/document.pdf", "num_examples": 35, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/blxnbukh- /home/sid/tuning/finetune/backend/output/blxnbukh-0859/data/blxnbukh-0859.json...
|
null
|
completed
|
1764952101
|
1764952164
|
NULL
|
/home/sid/tuning/finetune/backend/output/blxnbukh- /home/sid/tuning/finetune/backend/output/blxnbukh-0859/adapter...
|
False
|
Edit
Delete
|
|
bcdb97fe-5967-4e33-b01b-ef1f0fbfb560
|
8684964a-bab1-4235-93a8-5fd5e24a1d0a
|
mfcdvyme-9289
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
mTmodel_1765016141
|
Filtered merged training 6-12
|
/home/sid/tuning/finetune/backend/output/mfcdvyme- /home/sid/tuning/finetune/backend/output/mfcdvyme-9289/merged_fp16_hf...
|
xevyo
|
/home/sid/tuning/finetune/backend/output/xevyo-bas /home/sid/tuning/finetune/backend/output/xevyo-base-v1/merged_fp16_hf...
|
xevyo-base-v1
|
Contain lots of data various category like econimi Contain lots of data various category like econimics, medical, historical...
|
{"input_type": "file", "source {"input_type": "file", "source": "/home/sid/tuning/finetune/backend/output/mfcdvyme-9289/data/document.json", "num_examples": 47886, "bad_lines": 0}...
|
/home/sid/tuning/finetune/backend/output/mfcdvyme- /home/sid/tuning/finetune/backend/output/mfcdvyme-9289/data/mfcdvyme-9289.json...
|
{"train_runtime": 654.8482, "train_sam {"train_runtime": 654.8482, "train_samples_per_second": 2.443, "train_steps_per_second": 0.305, "total_flos": 7878114829615104.0, "train_loss": 1.3694590425491333, "epoch": 0.33769523005487545, "step": 200}...
|
completed
|
1765016142
|
1765041447
|
NULL
|
/home/sid/tuning/finetune/backend/output/mfcdvyme- /home/sid/tuning/finetune/backend/output/mfcdvyme-9289/adapter...
|
False
|
Edit
Delete
|